Furthermore,Furthermore,O
",",",",O
we,we,O
observed,observed,O
no,no,O
correlation,coloerantri,O
between,between,O
the,the,O
somatic,motaisc,O
mutation,ttmiuaon,O
rate,taer,O
and,and,O
tissue,itesus,O
proliferation,proliferation,O
capacity,capacity,O
.,.,O
,,
The,The,O
somatic,mtoasic,O
mutation,mutation,O
rates,rates,O
in,in,O
different,itfferend,O
tissues,sessuit,O
were,were,O
also,also,O
not,not,O
correlated,drreolatec,O
to,to,O
the,the,O
relative,vialtere,O
inter,inter,O
-,-,O
tissue,tiusse,O
difference,nifeerfdce,O
in,in,O
transcriptional,transcriptional,O
levels,levels,O
of,of,O
the,the,O
three,three,O
genes,genes,O
(,(,O
DMAHP,DMAHP,O
",",",",O
DMPK,PMKD,O
and,and,O
59,59,O
),),O
surrounding,surrounding,O
the,the,O
repeat,reepat,O
.,.,O
.,.,O
,,
A,A,O
novel,novel,O
missense,mseisesn,O
mutation,mutation,O
in,in,O
patients,pnsiaett,O
from,from,O
a,a,O
retinoblastoma,retinoblastoma,B
pedigree,pedigree,O
showing,shwoing,O
only,only,O
mild,mild,O
expression,expression,O
of,of,O
the,the,O
tumor,tumor,B
phenotype,peonythpe,O
.,.,O
,,
We,We,O
have,have,O
used,ueds,O
single,single,O
strand,strand,O
conformation,coaiormntfno,O
polymorphism,polymorphism,O
analysis,snylsaia,O
to,to,O
study,uysdt,O
the,the,O
27,27,O
exons,noxes,O
of,of,O
the,the,O
RB1,RB1,O
gene,gene,O
in,in,O
individuals,indviadulis,O
from,from,O
a,a,O
family,family,O
showing,gnowhis,O
mild,mild,O
expression,expression,O
of,of,O
the,the,O
retinoblastoma,retinoblastoma,B
phenotype,potnheyep,O
.,.,O
,,
In,In,O
this,this,O
family,yimalf,O
affected,affected,O
individuals,individuals,O
developed,developed,O
unilateral,unilateral,B
tumors,tumors,I
and,and,O
",",",",O
as,as,O
a,a,O
result,elsurt,O
of,of,O
linkage,linkage,O
analysis,naalyssi,O
",",",",O
unaffected,nueffeatcd,O
mutation,mutation,O
carriers,aerrrcis,O
were,were,O
also,also,O
identified,ieintidefd,O
within,within,O
the,the,O
pedigree,pgdeiree,O
.,.,O
,,
A,A,O
single,silnge,O
band,dabn,O
shift,shift,O
using,nsuig,O
SSCP,SSCP,O
was,was,O
identified,iteedifind,O
in,in,O
exon,noxe,O
21,21,O
which,which,O
resulted,resulted,O
in,in,O
a,a,O
missense,mesesnis,O
mutation,outanitm,O
converting,converting,O
a,a,O
cys,cys,O
-,-,O
-,-,O
>,>,O
arg,arg,O
at,at,O
nucleotide,nucleotide,O
position,iosnipot,O
28,28,O
in,in,O
the,the,O
exon,oexn,O
.,.,O
,,
The,The,O
mutation,mutation,O
destroyed,destroyed,O
an,an,O
NdeI,NdeI,O
restriction,reitoicstnr,O
enzyme,eyznem,O
site,itse,O
.,.,O
,,
Analysis,Aslaynsi,O
of,of,O
all,all,O
family,family,O
members,emmbres,O
demonstrated,rtmdtseoaned,O
that,that,O
the,the,O
missense,snisemse,O
mutation,mutation,O
co,co,O
-,-,O
segregated,segregated,O
with,with,O
patients,tatipnes,O
with,with,O
tumors,tumors,B
or,or,O
who,who,O
",",",",O
as,as,O
a,a,O
result,ruslet,O
of,of,O
linkage,lkaigne,O
analysis,analysis,O
had,had,O
been,been,O
predicted,preceddit,O
to,to,O
carry,rracy,O
the,the,O
predisposing,predisposing,O
mutation,totaimun,O
.,.,O
,,
These,Etesh,O
observations,observations,O
point,point,O
to,to,O
another,aoehtnr,O
region,region,O
of,of,O
the,the,O
RB1,RB1,O
gene,neeg,O
where,where,O
mutations,tomasiunt,O
only,only,O
modify,modify,O
the,the,O
function,icnutfon,O
of,of,O
the,the,O
gene,gene,O
and,and,O
raise,sriae,O
important,important,O
questions,iuqsetons,O
for,for,O
genetic,etiegnc,O
counseling,cnunlegios,O
in,in,O
families,laifimes,O
with,with,O
these,these,O
distinctive,distinctive,O
phenotypes,phenotypes,O
.,.,O
.,.,O
,,
Maternal,Maternal,B
disomy,disomy,I
and,and,O
Prader,Prader,B
-,-,I
Willi,Willi,I
syndrome,syndrome,I
consistent,conestsint,O
with,with,O
gamete,gamete,O
complementation,ctmeinmeptoalon,O
in,in,O
a,a,O
case,scae,O
of,of,O
familial,almialfi,O
translocation,tclasroantion,O
(,(,O
3,3,O
;,;,O
15,15,O
),),O
(,(,O
p25,p25,O
;,;,O
q11,q11,O
.,.,O
2,2,O
),),O
.,.,O
,,
Maternal,Maternal,B
uniparental,uniparental,I
disomy,disomy,I
(,(,I
UPD,UPD,I
),),I
for,for,I
chromosome,chromosome,I
15,15,I
is,is,O
responsible,nseporsbeli,O
for,for,O
an,an,O
estimated,aeitmetsd,O
30,30,O
%,%,O
of,of,O
cases,ceass,O
of,of,O
Prader,Prader,B
-,-,I
Willi,Willi,I
syndrome,syndrome,I
(,(,O
PWS,PWS,B
),),O
.,.,O
,,
We,We,O
report,ropert,O
on,on,O
an,an,O
unusual,uuuslan,O
case,scae,O
of,of,O
maternal,maternal,B
disomy,disomy,I
15,15,I
in,in,O
PWS,PWS,B
that,that,O
is,is,O
most,most,O
consistent,soteistcnn,O
with,with,O
adjacent,cdaajnet,O
-,-,O
1,1,O
segregation,gesrigtaeon,O
of,of,O
a,a,O
paternal,ptaeanrl,O
t,t,O
(,(,O
3,3,O
;,;,O
15,15,O
),),O
(,(,O
p25,p25,O
;,;,O
q11,q11,O
.,.,O
2,2,O
),),O
with,with,O
simultaneous,lnsumtaieuos,O
maternal,maternal,O
meiotic,meiotci,O
nondisjunction,jnndsionncoitu,O
for,for,O
chromosome,chromosome,O
15,15,O
.,.,O
,,
The,The,O
patient,pttiean,O
(,(,O
J,J,O
.,.,O
B,B,O
.,.,O
),),O
",",",",O
a,a,O
17,17,O
-,-,O
year,eayr,O
-,-,O
old,old,O
white,thwie,O
male,amel,O
with,with,O
PWS,PWS,B
",",",",O
was,was,O
found,fdnuo,O
to,to,O
have,have,O
47,47,O
chromosomes,ohrcsomomes,O
with,with,O
a,a,O
supernumerary,auperrrmeunsy,O
",",",",O
paternal,paternal,O
der,der,O
(,(,O
15,15,O
),),O
consisting,consisting,O
of,of,O
the,the,O
short,short,O
arm,arm,O
and,and,O
the,the,O
proximal,lrxpimao,O
long,long,O
arm,arm,O
of,of,O
chromosome,chromosome,O
15,15,O
",",",",O
and,and,O
distal,tasdil,O
chromosome,chromosome,O
arm,arm,O
3p,3p,O
.,.,O
,,
The,The,O
t,t,O
(,(,O
3,3,O
;,;,O
15,15,O
),),O
was,was,O
present,etepsnr,O
in,in,O
the,the,O
balanced,anlbaecd,O
state,ttsae,O
in,in,O
the,the,O
patients,iaspnett,O
father,fhater,O
and,and,O
a,a,O
sister,etsisr,O
.,.,O
,,
Fluorescent,Efulresnoct,O
in,in,O
situ,itsu,O
hybridization,bairidizytohn,O
analysis,inlayass,O
demonstrated,dstotemnared,O
that,that,O
the,the,O
PWS,PWS,B
critical,critical,O
region,reiogn,O
resided,dseider,O
on,on,O
the,the,O
derivative,derivative,O
chromosome,chromosome,O
3,3,O
and,and,O
that,that,O
there,there,O
was,was,O
no,no,O
deletion,elnetiod,O
of,of,O
the,the,O
PWS,PWS,B
region,gorien,O
on,on,O
the,the,O
normal,normal,O
pair,pair,O
of,of,O
15s,15s,O
present,ernespt,O
in,in,O
J,J,O
.,.,O
,,
B,B,O
.,.,O
,,
Methylation,Methylation,O
analysis,asaynlis,O
at,at,O
exon,onex,O
alpha,alpha,O
of,of,O
the,the,O
small,small,O
nuclear,uerlnac,O
ribonucleoprotein,niooruclebpntoeir,O
-,-,O
associated,ascoseatid,O
polypeptide,polypeptide,O
N,N,O
(,(,O
SNRPN,SNRPN,O
),),O
gene,gene,O
showed,heowsd,O
a,a,O
pattern,pattern,O
characteristic,itisrcteacrhac,O
of,of,O
only,only,O
the,the,O
maternal,amternal,O
chromosome,chromosome,O
15,15,O
in,in,O
J,J,O
.,.,O
,,
B,B,O
.,.,O
,,
Maternal,Maternal,B
disomy,disomy,I
was,was,O
confirmed,ceomirfnd,O
by,by,O
polymerase,rolympsaee,O
chain,chain,O
reaction,neaotrci,O
analysis,analysis,O
of,of,O
microsatellite,microsatellite,O
repeats,esptare,O
at,at,O
the,the,O
gamma,mmgaa,O
-,-,O
aminobutyric,aminobutyric,O
acid,acid,O
receptor,receptor,O
beta3,beta3,O
subunit,subunit,O
(,(,O
GABRB3,GABRB3,O
),),O
locus,lcsuo,O
.,.,O
,,
A,A,O
niece,eicne,O
(,(,O
B,B,O
.,.,O
B,B,O
.,.,O
),),O
with,with,O
45,45,O
chromosomes,rceomosomhs,O
and,and,O
the,the,O
derivative,deiivatvre,O
3,3,O
but,but,O
without,without,O
the,the,O
der,der,O
(,(,O
15,15,O
),),O
demonstrated,metoneartdsd,O
a,a,O
phenotype,phptoneye,O
consistent,cnositsent,O
with,with,O
that,that,O
reported,rpoeretd,O
for,for,O
haploinsufficiency,iihaocnpuffscleniy,O
of,of,O
distal,dtisal,O
3,3,O
p,p,O
.,.,O
,,
Uniparental,Uniparental,B
disomy,disomy,I
associated,associated,O
with,with,O
unbalanced,unlcbanaed,O
segregation,esgreigtaon,O
of,of,O
non,non,O
-,-,O
Robertsonian,Ioterbnanros,O
translocations,artntolcsnioas,O
has,has,O
been,been,O
reported,reoprted,O
previously,pruyioevls,O
but,but,O
has,has,O
not,not,O
",",",",O
to,to,O
our,our,O
knowledge,gekwledon,O
",",",",O
been,been,O
observed,orsvebed,O
in,in,O
a,a,O
case,case,O
of,of,O
PWS,PWS,B
.,.,O
,,
Furthermore,Rtrohmfeure,O
",",",",O
our,our,O
findings,sgndinif,O
are,are,O
best,best,O
interpreted,itderpreten,O
as,as,O
true,true,O
gamete,gamete,O
complementation,complementation,O
resulting,resulting,O
in,in,O
maternal,maternal,B
UPD,UPD,I
15,15,I
and,and,O
PWS,PWS,B
,,
Schwartz,Schwartz,B
-,-,I
Jampel,Jampel,I
syndrome,syndrome,I
type,type,I
2,2,I
and,and,O
Stuve,Stuve,B
-,-,I
Wiedemann,Wiedemann,I
syndrome,syndrome,I
:,:,O
a,a,O
case,aces,O
for,for,O
" O
lumping O
"," O
lumping O
",O
.,.,O
,,
Recent,Recent,O
studies,sudeits,O
demonstrated,demonstrated,O
the,the,O
existence,existence,O
of,of,O
a,a,O
genetically,einlagctely,O
distinct,dcitsint,O
",",",",O
usually,uaulyls,O
lethal,htelal,O
form,form,O
of,of,O
the,the,O
Schwartz,Schwartz,B
-,-,I
Jampel,Jampel,I
syndrome,syndrome,I
(,(,O
SJS,SJS,B
),),O
of,of,O
myotonia,myotonia,B
and,and,O
skeletal,skeletal,B
dysplasia,dysplasia,I
",",",",O
which,which,O
we,we,O
called,acelld,O
SJS,SJS,B
type,type,I
2,2,I
.,.,O
,,
This,Hits,O
disorder,disorder,O
is,is,O
reminiscent,rcmtneseini,O
of,of,O
another,thonaer,O
rare,rare,O
condition,ninditcoo,O
",",",",O
the,the,O
Stuve,Stuve,B
-,-,I
Wiedemann,Wiedemann,I
syndrome,syndrome,I
(,(,O
SWS,SWS,B
),),O
",",",",O
which,which,O
comprises,comprises,O
campomelia,campomelia,B
at,at,O
birth,tibrh,O
with,with,O
skeletal,skeletal,B
dysplasia,dysplasia,I
",",",",O
contractures,contractures,B
",",",",O
and,and,O
early,early,B
death,death,I
.,.,O
,,
To,To,O
test,test,O
for,for,O
possible,ilsspobe,O
nosologic,ionclogso,O
identity,edtniiyt,O
between,between,O
these,these,O
disorders,oirdrdess,O
",",",",O
we,we,O
reviewed,reviewed,O
the,the,O
literature,latrriteue,O
and,and,O
obtained,otaibned,O
a,a,O
follow,follow,O
-,-,O
up,up,O
of,of,O
the,the,O
only,only,O
two,two,O
surviving,surviving,O
patients,tapinets,O
",",",",O
one,one,O
with,with,O
SJS,SJS,B
type,type,I
2,2,I
at,at,O
age,age,O
10,10,O
years,years,O
and,and,O
another,anohter,O
with,with,O
SWS,SWS,B
at,at,O
age,age,O
7,7,O
years,eyasr,O
.,.,O
,,
Patients,Psentita,O
reported,reported,O
as,as,O
having,having,O
either,hiteer,O
neonatal,neonatal,O
SJS,SJS,B
or,or,O
SWS,SWS,B
presented,tredsnpee,O
a,a,O
combination,combination,O
of,of,O
a,a,O
severe,eerevs,O
",",",",O
prenatal,preaatnl,O
-,-,O
onset,onset,O
neuromuscular,neuromuscular,B
disorder,disorder,I
(,(,O
with,with,O
congenital,congenital,B
joint,joint,I
contractures,contractures,I
",",",",O
respiratory,rpietrarosy,O
and,and,O
feeding,feeding,O
difficulties,difficulties,O
",",",",O
tendency,nendctey,O
to,to,O
hyperthermia,hyperthermia,B
",",",",O
and,and,O
frequent,frequent,O
death,etadh,O
in,in,O
infancy,cnainfy,O
),),O
with,with,O
a,a,O
distinct,distinct,O
campomelic,campomelic,B
-,-,I
metaphyseal,metaphyseal,I
skeletal,skeletal,I
dysplasia,dysplasia,I
.,.,O
,,
The,The,O
similarity,lamisiyitr,O
of,of,O
the,the,O
clinical,claiicnl,O
and,and,O
radiographic,radiographic,O
findings,nindigfs,O
is,is,O
so,so,O
extensive,tnsexeive,O
that,that,O
these,these,O
disorders,doriedrss,O
appear,appear,O
to,to,O
be,be,O
a,a,O
single,single,O
entity,etnity,O
.,.,O
,,
The,The,O
follow,oollfw,O
-,-,O
up,up,O
observation,observation,O
of,of,O
an,an,O
identical,identical,O
and,and,O
unique,unique,O
pattern,nattrep,O
of,of,O
progressive,progressive,O
bone,bone,B
dysplasia,dysplasia,I
in,in,O
the,the,O
two,two,O
patients,tptianes,O
(,(,O
one,one,O
with,with,O
SJS,SJS,B
type,type,I
2,2,I
",",",",O
one,one,O
with,with,O
SWS,SWS,B
),),O
surviving,sigvivrnu,O
beyond,neydbo,O
infancy,innacfy,O
adds,dads,O
to,to,O
the,the,O
evidence,dvieeecn,O
in,in,O
favor,vaofr,O
of,of,O
identity,ietnyitd,O
.,.,O
,,
The,The,O
hypothesis,oypshhetis,O
that,that,O
SWS,SWS,B
and,and,O
SJS,SJS,B
type,type,I
2,2,I
are,are,O
the,the,O
same,same,O
disorder,derodsir,O
should,should,O
be,be,O
testable,lsetaetb,O
by,by,O
molecular,lraecumlo,O
methods,mhetsdo,O
.,.,O
.,.,O
,,
A,A,O
mouse,usmoe,O
model,model,O
of,of,O
severe,severe,O
von,von,B
Willebrand,Willebrand,I
disease,disease,I
:,:,O
defects,dcteesf,O
in,in,O
hemostasis,ehmsstioas,O
and,and,O
thrombosis,thrombosis,B
.,.,O
,,
von,von,B
Willebrand,Willebrand,I
factor,factor,I
(,(,I
vWf,vWf,I
),),I
deficiency,deficiency,I
causes,eacsus,O
severe,eevsre,O
von,von,B
Willebrand,Willebrand,I
disease,disease,I
in,in,O
humans,humans,O
.,.,O
,,
We,We,O
generated,generated,O
a,a,O
mouse,umose,O
model,model,O
for,for,O
this,this,O
disease,aisesde,O
by,by,O
using,using,O
gene,egen,O
targeting,taegrting,O
.,.,O
,,
vWf,vWf,B
-,-,I
deficient,deficient,I
mice,mcei,O
appeared,appeared,O
normal,aormln,O
at,at,O
birth,brtih,O
;,;,O
they,they,O
were,were,O
viable,viable,O
and,and,O
fertile,fertile,O
.,.,O
,,
Neither,Ihnreet,O
vWf,vWf,O
nor,nor,O
vWf,vWf,O
propolypeptide,tropoeiplppyed,O
(,(,O
von,von,B
Willebrand,Willebrand,I
antigen,ainegnt,O
II,II,O
),),O
were,were,O
detectable,detectable,O
in,in,O
plasma,plasma,O
",",",",O
platelets,plateltes,O
",",",",O
or,or,O
endothelial,enoeahtlidl,O
cells,cells,O
of,of,O
the,the,O
homozygous,homozygous,O
mutant,manutt,O
mice,mice,O
.,.,O
,,
The,The,O
mutant,aunmtt,O
mice,mice,O
exhibited,exhibited,O
defects,defects,O
in,in,O
hemostasis,mhiostases,O
with,with,O
a,a,O
highly,hyglhi,O
prolonged,prolonged,O
bleeding,bleeding,O
time,teim,O
and,and,O
spontaneous,sptnoousane,O
bleeding,geelbind,O
events,eevtns,O
in,in,O
approximately,approximately,O
10,10,O
%,%,O
of,of,O
neonates,neonates,O
.,.,O
,,
As,As,O
in,in,O
the,the,O
human,human,O
disease,disesae,O
",",",",O
the,the,O
factor,factor,O
VIII,IVII,O
level,eelvl,O
in,in,O
these,these,O
mice,icme,O
was,was,O
reduced,dercude,O
strongly,ygrotnls,O
as,as,O
a,a,O
result,result,O
of,of,O
the,the,O
lack,ckla,O
of,of,O
protection,prtoection,O
provided,provided,O
by,by,O
vWf,vWf,O
.,.,O
,,
Defective,Deceftive,O
thrombosis,thrombosis,B
in,in,O
mutant,antmut,O
mice,icme,O
was,was,O
also,also,O
evident,evident,O
in,in,O
an,an,O
in,in,O
vivo,vivo,O
model,edoml,O
of,of,O
vascular,vascular,B
injury,injury,I
.,.,O
,,
In,In,O
this,this,O
model,mloed,O
",",",",O
the,the,O
exteriorized,exteriorized,O
mesentery,meeeytsrn,O
was,was,O
superfused,spuurfesed,O
with,with,O
ferric,irerfc,O
chloride,chloride,O
and,and,O
the,the,O
accumulation,accumulation,O
of,of,O
fluorescently,fluorescently,O
labeled,labeled,O
platelets,platlstee,O
was,was,O
observed,osbrveed,O
by,by,O
intravital,ittnrviaal,O
microscopy,microscopy,O
.,.,O
,,
We,We,O
conclude,conclude,O
that,that,O
these,these,O
mice,cmie,O
very,very,O
closely,closely,O
mimic,iimmc,O
severe,sevree,O
human,nmuah,O
von,von,B
Willebrand,Willebrand,I
disease,disease,I
and,and,O
will,will,O
be,be,O
very,very,O
useful,useful,O
for,for,O
investigating,invesaiggtint,O
the,the,O
role,reol,O
of,of,O
vWf,vWf,O
in,in,O
normal,nrmoal,O
physiology,splhioyogy,O
and,and,O
in,in,O
disease,disease,O
models,mldoes,O
.,.,O
.,.,O
,,
Oral,Oral,O
contraceptives,cotaercenpivts,O
and,and,O
the,the,O
risk,risk,O
of,of,O
hereditary,hereditary,B
ovarian,ovarian,I
cancer,cancer,I
.,.,O
,,
Hereditary,Hereditary,B
Ovarian,Ovarian,I
Cancer,Cancer,I
Clinical,Ilcinlac,O
Study,Study,O
Group,Group,O
.,.,O
,,
BACKGROUND,BAOUGRKCND,O
Women,Omwen,O
with,with,O
mutations,mnuatitos,O
in,in,O
either,either,O
the,the,O
BRCA1,BRCA1,O
or,or,O
the,the,O
BRCA2,RB2Ac,O
gene,eegn,O
have,have,O
a,a,O
high,high,O
lifetime,lifetime,O
risk,krsi,O
of,of,O
ovarian,ovarian,B
cancer,cancer,I
.,.,O
,,
Oral,Oral,O
contraceptives,cpvtracentoise,O
protect,cpoetrt,O
against,against,O
ovarian,ovarian,B
cancer,cancer,I
in,in,O
general,general,O
",",",",O
but,but,O
it,it,O
is,is,O
not,not,O
known,onnwk,O
whether,whether,O
they,they,O
also,osla,O
protect,protect,O
against,against,O
hereditary,hereditary,B
forms,forms,I
of,of,I
ovarian,ovarian,I
cancer,cancer,I
.,.,O
,,
METHODS,MEDHOTS,O
We,We,O
enrolled,eorenlld,O
207,207,O
women,nmoew,O
with,with,O
hereditary,hereditary,B
ovarian,ovarian,I
cancer,cancer,I
and,and,O
161,161,O
of,of,O
their,their,O
sisters,sisters,O
as,as,O
controls,lnotrocs,O
in,in,O
a,a,O
case,case,O
-,-,O
control,conotrl,O
study,tsduy,O
.,.,O
,,
All,All,O
the,the,O
patients,tptiensa,O
carried,iarcerd,O
a,a,O
pathogenic,pathogenic,O
mutation,mutation,O
in,in,O
either,rtihee,O
BRCA1,BC1Ar,O
(,(,O
179,179,O
women,mnweo,O
),),O
or,or,O
BRCA2,BRCA2,O
(,(,O
28,28,O
women,women,O
),),O
.,.,O
,,
The,The,O
control,lorcnot,O
women,ewmon,O
were,were,O
enrolled,lneolred,O
regardless,eegrrslasd,O
of,of,O
whether,ehwther,O
or,or,O
not,not,O
they,they,O
had,had,O
either,either,O
mutation,mutation,O
.,.,O
,,
Lifetime,Filteime,O
histories,htsiosrei,O
of,of,O
oral,oral,O
-,-,O
contraceptive,contraceptive,O
use,use,O
were,were,O
obtained,iatbenod,O
by,by,O
interview,itiervnew,O
or,or,O
by,by,O
written,written,O
questionnaire,questionnaire,O
and,and,O
were,were,O
compared,compared,O
between,between,O
patients,patients,O
and,and,O
control,rotnocl,O
women,woenm,O
",",",",O
after,after,O
adjustment,eujdntmast,O
for,for,O
year,year,O
of,of,O
birth,birth,O
and,and,O
parity,rypita,O
.,.,O
,,
RESULTS,RESLSTU,O
The,The,O
adjusted,uajtsded,O
odds,odds,O
ratio,ratio,O
for,for,O
ovarian,ovarian,B
cancer,cancer,I
associated,associated,O
with,with,O
any,any,O
past,atsp,O
use,use,O
of,of,O
oral,rola,O
contraceptives,ovncracsptitee,O
was,was,O
0,0,O
.,.,O
,,
5,5,O
(,(,O
95,95,O
percent,etrecnp,O
confidence,eoifndencc,O
interval,entaivrl,O
",",",",O
0,0,O
.,.,O
3,3,O
to,to,O
0,0,O
.,.,O
8,8,O
),),O
.,.,O
,,
The,The,O
risk,risk,O
decreased,decreesda,O
with,with,O
increasing,rnaicesing,O
duration,duoitnra,O
of,of,O
use,use,O
(,(,O
P,P,O
for,for,O
trend,rtned,O
",",",",O
<,<,O
0,0,O
.,.,O
001,001,O
),),O
;,;,O
use,use,O
for,for,O
six,six,O
or,or,O
more,more,O
years,years,O
was,was,O
associated,assocatied,O
with,with,O
a,a,O
60,60,O
percent,rceepnt,O
reduction,coduitren,O
in,in,O
risk,ksir,O
.,.,O
,,
Oral,Oral,O
-,-,O
contraceptive,iotcranetpcve,O
use,use,O
protected,pcteorted,O
against,against,O
ovarian,ovarian,B
cancer,cancer,I
both,both,O
for,for,O
carriers,rraciers,O
of,of,O
the,the,O
BRCA1,BRCA1,O
mutation,tomtaiun,O
(,(,O
odds,ddso,O
ratio,ratio,O
",",",",O
0,0,O
.,.,O
5,5,O
;,;,O
95,95,O
percent,terpecn,O
confidence,confidence,O
interval,interval,O
",",",",O
0,0,O
.,.,O
3,3,O
to,to,O
0,0,O
.,.,O
9,9,O
),),O
and,and,O
for,for,O
carriers,carriers,O
of,of,O
the,the,O
BRCA2,BRCA2,O
mutation,autmoitn,O
(,(,O
odds,odds,O
ratio,ratio,O
",",",",O
0,0,O
.,.,O
4,4,O
;,;,O
95,95,O
percent,percent,O
confidence,fcneidenoc,O
interval,vntairel,O
",",",",O
0,0,O
.,.,O
2,2,O
to,to,O
1,1,O
.,.,O
1,1,O
),),O
.,.,O
,,
CONCLUSIONS,CONCLUSIONS,O
Oral,Olra,O
-,-,O
contraceptive,contraceptive,O
use,use,O
may,may,O
reduce,reduce,O
the,the,O
risk,risk,O
of,of,O
ovarian,ovarian,B
cancer,cancer,I
in,in,O
women,mewon,O
with,with,O
pathogenic,hatpoeingc,O
mutations,tnuatioms,O
in,in,O
the,the,O
BRCA1,BRCA1,O
or,or,O
BRCA2,2RACb,O
gene,eneg,O
,,
A,A,O
Japanese,Jasenpae,O
family,fmaliy,O
with,with,O
adrenoleukodystrophy,adrenoleukodystrophy,B
with,with,O
a,a,O
codon,ocodn,O
291,291,O
deletion,oeltedin,O
:,:,O
a,a,O
clinical,clinical,O
",",",",O
biochemical,biochemical,O
",",",",O
pathological,pathological,O
",",",",O
and,and,O
genetic,genetic,O
report,rropet,O
.,.,O
,,
We,We,O
report,orpert,O
a,a,O
Japanese,Japanese,O
family,iamlfy,O
with,with,O
adrenoleukodystrophy,adrenoleukodystrophy,B
(,(,O
ALD,ALD,B
),),O
with,with,O
a,a,O
three,three,O
base,abes,O
pair,pair,O
deletion,dotelien,O
(,(,O
delGAG,ldeGAG,O
291,291,O
),),O
in,in,O
the,the,O
ALD,ALD,B
gene,ngee,O
.,.,O
,,
A,A,O
variety,variety,O
of,of,O
phenotypes,phenotypes,O
were,were,O
observed,oeersvbd,O
within,wiihtn,O
this,this,O
family,flmaiy,O
.,.,O
,,
While,Wihel,O
the,the,O
proband,proband,O
(,(,O
patient,patient,O
1,1,O
),),O
was,was,O
classified,saiscifled,O
as,as,O
having,having,O
a,a,O
rare,erar,O
intermediate,intermediate,O
type,type,O
of,of,O
adult,adult,O
cerebral,cerebral,O
and,and,O
cerebello,erecebllo,O
-,-,O
brain,rbian,O
stem,tesm,O
forms,smrof,O
",",",",O
his,his,O
younger,uonegyr,O
brother,brother,O
(,(,O
patient,patient,O
2,2,O
),),O
and,and,O
nephew,nephew,O
(,(,O
patient,patient,O
3,3,O
),),O
had,had,O
a,a,O
childhood,lcdhihood,O
ALD,ALD,B
type,type,O
.,.,O
,,
Another,Hntaoer,O
nephew,nephew,O
(,(,O
patient,patient,O
4,4,O
),),O
of,of,O
patient,eatpint,O
1,1,O
was,was,O
classified,lcdsiifsea,O
as,as,O
having,having,O
an,an,O
adolescent,ledaoscent,O
form,orfm,O
.,.,O
,,
The,The,O
tau,tau,O
level,llvee,O
in,in,O
the,the,O
cerebrospinal,csiebaolprnre,O
fluid,lufid,O
(,(,O
CSF,CSF,O
),),O
in,in,O
patient,taepint,O
1,1,O
was,was,O
as,as,O
high,hgih,O
as,as,O
that,that,O
of,of,O
patients,apteints,O
with,with,O
Alzheimers,Alzheimers,B
disease,disease,I
(,(,O
AD,AD,B
),),O
.,.,O
,,
His,His,O
brain,aibrn,O
magnetic,mgaitenc,O
resonance,resonance,O
image,image,O
(,(,O
MRI,MRI,O
),),O
showed,showed,O
abnormalities,abnormalities,B
in,in,I
the,the,I
bilateral,bilateral,I
cerebellar,cerebellar,I
hemispheres,hemispheres,I
and,and,O
brain,brain,O
stem,stem,O
",",",",O
but,but,O
not,not,O
in,in,O
the,the,O
cerebral,cerebral,O
white,white,O
matter,meattr,O
",",",",O
where,where,O
marked,amekrd,O
reductions,reductions,O
of,of,O
the,the,O
cerebral,cerebral,O
blood,olbod,O
flow,owfl,O
and,and,O
oxygen,ogxyen,O
metabolism,metabolism,O
were,were,O
clearly,clearly,O
demonstrated,demonstrated,O
by,by,O
positron,positron,O
emission,esiomisn,O
tomography,homtgropay,O
(,(,O
PET,PET,O
),),O
.,.,O
,,
In,In,O
patients,eaiptnts,O
2,2,O
and,and,O
3,3,O
",",",",O
the,the,O
autopsy,autopsy,O
findings,gindifns,O
showed,showed,O
massive,ivmssae,O
demyelination,demyelination,B
of,of,I
the,the,I
cerebral,cerebral,I
white,white,I
matter,matter,I
with,with,O
sparing,sairnpg,O
of,of,O
the,the,O
U,U,O
-,-,O
fibers,fibser,O
",",",",O
compatible,compatible,O
with,with,O
the,the,O
findings,finngdis,O
of,of,O
childhood,oihhdlocd,O
ALD,ALD,B
.,.,O
,,
Oleic,Ilcoe,O
and,and,O
erucic,ircuec,O
acids,acdsi,O
(,(,O
Lorenzos,Lorenzos,O
Oil,Oil,O
),),O
were,were,O
administered,administered,O
to,to,O
patients,patients,O
1,1,O
and,and,O
4,4,O
",",",",O
but,but,O
sufficient,stfficienu,O
effectiveness,tefeieevfncss,O
was,was,O
not,not,O
obtained,ebtionad,O
.,.,O
,,
The,The,O
findings,nfisingd,O
in,in,O
this,this,O
family,family,O
suggest,stseggu,O
that,that,O
delGAG291,dgaGLE921,O
is,is,O
part,part,O
of,of,O
the,the,O
cause,cause,O
of,of,O
Japanese,Japenase,O
ALD,ALD,B
with,with,O
phenotypic,pehoitypnc,O
variations,natioriavs,O
.,.,O
,,
Moreover,Moreover,O
",",",",O
although,lhtaohgu,O
the,the,O
scale,lsace,O
of,of,O
the,the,O
study,tsuyd,O
is,is,O
limited,limited,O
",",",",O
there,there,O
is,is,O
a,a,O
possibility,possibility,O
that,that,O
PET,PET,O
can,can,O
detect,tedect,O
an,an,O
insidious,insidious,B
lesion,lesion,I
which,which,O
is,is,O
undetectable,untatbcdleee,O
by,by,O
computed,ctopmued,O
tomogram,romogtam,O
(,(,O
CT,CT,O
),),O
or,or,O
MRI,MRI,O
analysis,yailasns,O
",",",",O
and,and,O
that,that,O
the,the,O
higher,ighher,O
level,eelvl,O
of,of,O
tau,tau,O
reflects,reflects,O
the,the,O
process,process,O
of,of,O
neuronal,neuronal,B
degeneration,degeneration,I
in,in,O
ALD,ALD,B
.,.,O
,,
Lorenzos,Oorzenls,O
Oil,Oil,O
should,should,O
be,be,O
given,viegn,O
in,in,O
the,the,O
early,early,O
stage,gatse,O
.,.,O
.,.,O
,,
Nonsense,Ennsnose,O
mutation,mutation,O
in,in,O
exon,oexn,O
4,4,O
of,of,O
human,human,O
complement,eocplmemnt,O
C9,C9,O
gene,gene,O
is,is,O
the,the,O
major,major,O
cause,acesu,O
of,of,O
Japanese,Eaapsjne,O
complement,complement,B
C9,C9,I
deficiency,deficiency,I
.,.,O
,,
Deficiency,Deficiency,B
of,of,I
the,the,I
ninth,ninth,I
component,component,I
of,of,I
human,human,I
complement,complement,I
(,(,O
C9,C9,O
),),O
is,is,O
the,the,O
most,most,O
common,mmocon,O
complement,complement,B
deficiency,deficiency,I
in,in,O
Japan,Apajn,O
but,but,O
is,is,O
rare,earr,O
in,in,O
other,other,O
countries,rtuncoies,O
.,.,O
,,
We,We,O
studied,etuddis,O
the,the,O
molecular,coaumellr,O
basis,sibas,O
of,of,O
C9,C9,B
deficiency,deficiency,I
in,in,O
four,four,O
Japanese,Najspeae,O
C9,C9,B
-,-,I
deficient,deficient,I
patients,ptiaenst,O
who,who,O
had,had,O
suffered,suffered,O
from,from,O
meningococcal,meningococcal,B
meningitis,meningitis,I
.,.,O
,,
Direct,Dreict,O
sequencing,suqiencneg,O
of,of,O
amplified,amplified,O
C9,C9,O
cDNA,nACD,O
and,and,O
DNA,DNA,O
revealed,revedlae,O
a,a,O
nonsense,nonsense,O
substitution,substitution,O
(,(,O
CGA,CGA,O
-,-,O
-,-,O
>,>,O
TGA,TGA,O
),),O
at,at,O
codon,ocodn,O
95,95,O
in,in,O
exon,oexn,O
4,4,O
in,in,O
the,the,O
four,ufor,O
C9,C9,B
-,-,I
deficient,deficient,I
individuals,iadiudlvnis,O
.,.,O
,,
An,An,O
allele,allele,O
-,-,O
specific,sfpciiec,O
polymerase,polymerase,O
chain,chain,O
reaction,teioracn,O
system,system,O
designed,dnsigdee,O
to,to,O
detect,tcdeet,O
exclusively,exclusively,O
only,only,O
one,one,O
of,of,O
the,the,O
normal,normal,O
and,and,O
mutant,umatnt,O
alleles,alleles,O
indicated,itdneaicd,O
that,that,O
all,all,O
the,the,O
four,four,O
patients,apttenis,O
were,were,O
homozygous,zohoymgous,O
for,for,O
the,the,O
mutation,mutation,O
in,in,O
exon,xoen,O
4,4,O
and,and,O
that,that,O
the,the,O
parents,parents,O
of,of,O
patient,patient,O
2,2,O
were,were,O
heterozygous,zgterohyeous,O
.,.,O
,,
The,The,O
common,omomcn,O
mutation,matuoint,O
at,at,O
codon,oocdn,O
95,95,O
in,in,O
exon,exon,O
4,4,O
might,mghit,O
be,be,O
responsible,eropsesibln,O
for,for,O
most,most,O
Japanese,Japanese,O
C9,C9,B
deficiency,deficiency,I
.,.,O
.,.,O
,,
BRCA1,BRCA1,O
required,required,O
for,for,O
transcription,transcription,O
-,-,O
coupled,coupled,O
repair,aepirr,O
of,of,O
oxidative,xoidtviae,O
DNA,DNA,O
damage,damage,O
.,.,O
,,
The,The,O
breast,breast,B
and,and,I
ovarian,ovarian,I
cancer,cancer,I
susceptibility,iuipsctebslity,O
gene,enge,O
BRCA1,BRCA1,O
encodes,encodes,O
a,a,O
zinc,inzc,O
finger,fiengr,O
protein,protein,O
of,of,O
unknown,unknown,O
function,function,O
.,.,O
,,
Association,Association,O
of,of,O
the,the,O
BRCA1,BRCA1,O
protein,proetin,O
with,with,O
the,the,O
DNA,DNA,O
repair,repair,O
protein,eiptorn,O
Rad51,Rd5a1,O
and,and,O
changes,changes,O
in,in,O
the,the,O
phosphorylation,phosphorylation,O
and,and,O
cellular,aellculr,O
localization,cliaoioatlzn,O
of,of,O
the,the,O
protein,pitoenr,O
after,after,O
exposure,oxeeusrp,O
to,to,O
DNA,DNA,O
-,-,O
damaging,damaging,O
agents,agents,O
are,are,O
consistent,consistent,O
with,with,O
a,a,O
role,erlo,O
for,for,O
BRCA1,RACB1,O
in,in,O
DNA,DNA,O
repair,ierapr,O
.,.,O
,,
Here,Here,O
",",",",O
it,it,O
is,is,O
shown,shown,O
that,that,O
mouse,mouse,O
embryonic,embryonic,O
stem,stem,O
cells,clsel,O
deficient,deficient,B
in,in,I
BRCA1,BRCA1,I
are,are,O
defective,cefvtdiee,O
in,in,O
the,the,O
ability,tbalyii,O
to,to,O
carry,carry,O
out,out,O
transcription,transcription,O
-,-,O
coupled,oculdep,O
repair,repair,O
of,of,O
oxidative,ixiavtode,O
DNA,DNA,O
damage,magade,O
",",",",O
and,and,O
are,are,O
hypersensitive,eyrhpsineitsve,O
to,to,O
ionizing,ioiiznng,O
radiation,iadiatron,O
and,and,O
hydrogen,hydrogen,O
peroxide,reeoixdp,O
.,.,O
,,
These,These,O
results,results,O
suggest,ggusset,O
that,that,O
BRCA1,CBRA1,O
participates,partietpaics,O
",",",",O
directly,directly,O
or,or,O
indirectly,indirectly,O
",",",",O
in,in,O
transcription,trtnpciiasron,O
-,-,O
coupled,uoclepd,O
repair,perari,O
of,of,O
oxidative,oxidative,O
DNA,DNA,O
damage,damage,O
.,.,O
.,.,O
,,
Truncation,Tnaicutron,O
mutations,tuoasimnt,O
in,in,O
the,the,O
transactivation,itanscarnvattoi,O
region,region,O
of,of,O
PAX6,PAX6,O
result,result,O
in,in,O
dominant,dominant,O
-,-,O
negative,atgenive,O
mutants,mutants,O
.,.,O
,,
PAX6,PAX6,O
is,is,O
a,a,O
transcription,transcription,O
factor,crftoa,O
with,with,O
two,two,O
DNA,DNA,O
-,-,O
binding,bdniing,O
domains,sioamnd,O
(,(,O
paired,paired,O
box,box,O
and,and,O
homeobox,moeoobhx,O
),),O
and,and,O
a,a,O
proline,proline,O
-,-,O
serine,srniee,O
-,-,O
threonine,toerhinne,O
(,(,O
PST,PST,O
),),O
-,-,O
rich,rich,O
transactivation,transactivation,O
domain,admoin,O
.,.,O
,,
PAX6,PAX6,O
regulates,teugearls,O
eye,eye,O
development,meevlepdont,O
in,in,O
animals,iaamlns,O
ranging,ranging,O
from,from,O
jellyfish,jellyfish,O
to,to,O
Drosophila,Drosophila,O
to,to,O
humans,aushnm,O
.,.,O
,,
Heterozygous,Heterozygous,O
mutations,nutaomtis,O
in,in,O
the,the,O
human,human,O
PAX6,P6Ax,O
gene,gene,O
result,uerslt,O
in,in,O
various,various,O
phenotypes,phtpoeynes,O
",",",",O
including,including,O
aniridia,aniridia,B
",",",",O
Peters,Peters,B
anomaly,anomaly,I
",",",",O
autosomal,autosomal,B
dominant,dominant,I
keratitis,keratitis,I
",",",",O
and,and,O
familial,familial,B
foveal,foveal,I
dysplasia,dysplasia,I
.,.,O
,,
It,It,O
is,is,O
believed,believed,O
that,that,O
the,the,O
mutated,datumet,O
allele,llaele,O
of,of,O
PAX6,PAX6,O
produces,produces,O
an,an,O
inactive,nciitave,O
protein,protein,O
and,and,O
aniridia,aniridia,B
is,is,O
caused,ucased,O
due,due,O
to,to,O
genetic,tengiec,O
haploinsufficiency,hicloanyiffspuenic,O
.,.,O
,,
However,However,O
",",",",O
several,several,O
truncation,truniaoctn,O
mutations,totamuins,O
have,have,O
been,been,O
found,ofudn,O
to,to,O
occur,occur,O
in,in,O
the,the,O
C,C,O
-,-,O
terminal,miatenrl,O
half,hlfa,O
of,of,O
PAX6,6PXa,O
in,in,O
patients,patients,O
with,with,O
Aniridia,Aniridia,B
resulting,resulting,O
in,in,O
mutant,mutant,O
proteins,proteins,O
that,that,O
retain,retain,O
the,the,O
DNA,DNA,O
-,-,O
binding,iinbdng,O
domains,sanoimd,O
but,but,O
have,have,O
lost,lost,O
most,most,O
of,of,O
the,the,O
transactivation,vtnacaotitarisn,O
domain,mdoain,O
.,.,O
,,
It,It,O
is,is,O
not,not,O
clear,clear,O
whether,hehtewr,O
such,such,O
mutants,mutants,O
really,laerly,O
behave,behave,O
as,as,O
loss,loss,O
-,-,O
of,of,O
-,-,O
function,nucftnoi,O
mutants,mutants,O
as,as,O
predicted,ptcdiered,O
by,by,O
haploinsufficiency,hnplioanifiucefscy,O
.,.,O
,,
Contrary,Contrary,O
to,to,O
this,this,O
theory,orethy,O
",",",",O
our,our,O
data,taad,O
showed,showed,O
that,that,O
these,these,O
mutants,mutants,O
are,are,O
dominant,diannmot,O
-,-,O
negative,netavegi,O
in,in,O
transient,nsanirett,O
transfection,ceaisnrttfon,O
assays,assays,O
when,when,O
they,they,O
are,are,O
coexpressed,epcxdresseo,O
with,with,O
wild,wild,O
-,-,O
type,etpy,O
PAX6,PAX6,O
.,.,O
,,
We,We,O
found,found,O
that,that,O
the,the,O
dominant,donmntia,O
-,-,O
negative,negative,O
effects,effects,O
result,tlsuer,O
from,from,O
the,the,O
enhanced,eanhecnd,O
DNA,DNA,O
binding,binding,O
ability,tyiliba,O
of,of,O
these,these,O
mutants,astmutn,O
.,.,O
,,
Kinetic,Ikneitc,O
studies,sstdiue,O
of,of,O
binding,binding,O
and,and,O
dissociation,dasiotsicion,O
revealed,revealed,O
that,that,O
various,various,O
truncation,truncation,O
mutants,umtants,O
have,have,O
3,3,O
-,-,O
5,5,O
-,-,O
fold,fold,O
higher,higher,O
affinity,yniffita,O
to,to,O
various,iuovras,O
DNA,DNA,O
-,-,O
binding,nbiding,O
sites,sites,O
when,when,O
compared,pomeardc,O
with,with,O
the,the,O
wild,wild,O
-,-,O
type,type,O
PAX6,a6Xp,O
.,.,O
,,
These,These,O
results,retlsus,O
provide,irvpode,O
a,a,O
new,new,O
insight,insight,O
into,into,O
the,the,O
role,role,O
of,of,O
mutant,umttna,O
PAX6,XPA6,O
in,in,O
causing,acsuign,O
aniridia,aniridia,B
.,.,O
.,.,O
,,
Reversal,Realrsve,O
of,of,O
severe,severe,O
hypertrophic,hypertrophic,B
cardiomyopathy,cardiomyopathy,I
and,and,O
excellent,excellent,O
neuropsychologic,oruelpshcynoocig,O
outcome,omoceut,O
in,in,O
very,very,B
-,-,I
long,long,I
-,-,I
chain,chain,I
acyl,acyl,I
-,-,I
coenzyme,coenzyme,I
A,A,I
dehydrogenase,dehydrogenase,I
deficiency,deficiency,I
.,.,O
,,
Very,Very,B
-,-,I
long,long,I
-,-,I
chain,chain,I
acyl,acyl,I
-,-,I
coenzyme,coenzyme,I
A,A,I
dehydrogenase,dehydrogenase,I
(,(,I
VLCAD,VLCAD,I
),),I
deficiency,deficiency,I
is,is,O
a,a,O
disorder,diroresd,O
of,of,O
fatty,fatty,O
acid,dcai,O
beta,tbea,O
oxidation,oxidation,O
that,that,O
reportedly,yeptrledor,O
has,has,O
high,high,O
rates,rates,O
of,of,O
morbidity,roiibdmty,O
and,and,O
mortality,lartotimy,O
.,.,O
,,
We,We,O
describe,edircsbe,O
the,the,O
outcome,outcmoe,O
of,of,O
a,a,O
5,5,O
-,-,O
year,eayr,O
-,-,O
old,old,O
girl,rgil,O
with,with,O
VLCAD,VLCAD,B
deficiency,deficiency,I
who,who,O
was,was,O
first,ftsri,O
seen,seen,O
at,at,O
5,5,O
months,mtonhs,O
of,of,O
age,age,O
with,with,O
severe,evesre,O
hypertrophic,hypertrophic,B
cardiomyopathy,cardiomyopathy,I
",",",",O
hepatomegaly,hepatomegaly,B
",",",",O
encephalopathy,encephalopathy,B
",",",",O
and,and,O
hypotonia,hypotonia,B
.,.,O
,,
Biochemical,Biochemical,O
studies,ssutide,O
indicated,indicated,O
VLCAD,VLCAD,B
deficiency,deficiency,I
caused,scuaed,O
by,by,O
a,a,O
stable,etsbla,O
yet,yet,O
inactive,inactive,O
enzyme,enzyme,O
.,.,O
,,
Molecular,Molecular,O
genetic,gecenit,O
analysis,analysis,O
of,of,O
her,her,O
VLCAD,VLCAD,O
gene,ngee,O
revealed,revealed,O
a,a,O
T1372C,T2173C,O
(,(,O
F458L,L45f8,O
),),O
missense,mesesnsi,O
mutation,mutation,O
and,and,O
a,a,O
1668,1668,O
ACAG,ACAG,O
1669,1669,O
splice,pscile,O
site,iets,O
mutation,mutation,O
.,.,O
,,
After,After,O
initial,tiiianl,O
treatment,ertattmne,O
with,with,O
intravenous,ivntaroneus,O
glucose,ulcgsoe,O
and,and,O
carnitine,carnitine,O
",",",",O
the,the,O
patient,petiant,O
has,has,O
thrived,thrived,O
on,on,O
a,a,O
low,low,O
-,-,O
fat,fat,O
diet,iedt,O
supplemented,eueplpmtsned,O
with,with,O
medium,mudiem,O
-,-,O
chain,chain,O
triglyceride,tregidyericl,O
oil,oil,O
and,and,O
carnitine,carnitine,O
and,and,O
avoidance,avoidance,O
of,of,O
fasting,fasting,O
.,.,O
,,
Her,Her,O
ventricular,vrnuetcalir,O
hypertrophy,hypprtroehy,O
resolved,rdolsvee,O
significantly,sginilacitnfy,O
over,over,O
1,1,O
year,ryae,O
",",",",O
and,and,O
cognitively,cognitively,O
",",",",O
she,she,O
is,is,O
in,in,O
the,the,O
superior,superior,O
range,nagre,O
for,for,O
age,age,O
.,.,O
,,
Clinical,Nlcciial,O
recognition,oecignonirt,O
of,of,O
VLCAD,VLCAD,B
deficiency,deficiency,I
is,is,O
important,intoratmp,O
because,because,O
it,it,O
is,is,O
one,one,O
of,of,O
the,the,O
few,few,O
directly,yltecrid,O
treatable,lraatbete,O
causes,causes,O
of,of,O
cardiomyopathy,cardiomyopathy,B
in,in,O
children,crhediln,O
.,.,O
.,.,O
,,
Cloning,Oicnnlg,O
of,of,O
a,a,O
novel,vnoel,O
member,mbmeer,O
of,of,O
the,the,O
low,low,O
-,-,O
density,edniyts,O
lipoprotein,lipoprotein,O
receptor,receptor,O
family,family,O
.,.,O
,,
A,A,O
gene,gene,O
encoding,nceidong,O
a,a,O
novel,novel,O
transmembrane,nrbtsmraaemne,O
protein,irotpne,O
was,was,O
identified,identified,O
by,by,O
DNA,DNA,O
sequence,sequence,O
analysis,analysis,O
within,within,O
the,the,O
insulin,insulin,B
-,-,I
dependent,dependent,I
diabetes,diabetes,I
mellitus,mellitus,I
(,(,O
IDDM,IDDM,B
),),O
locus,locus,O
IDDM4,IDDM4,O
on,on,O
chromosome,chrosomemo,O
11q13,111q3,O
.,.,O
,,
Based,Asbed,O
on,on,O
its,its,O
chromosomal,chromosomal,O
position,pnstiioo,O
",",",",O
this,this,O
gene,egen,O
is,is,O
a,a,O
candidate,cneaiddta,O
for,for,O
conferring,confergrin,O
susceptibility,susceptibility,O
to,to,O
diabetes,diabetes,B
.,.,O
,,
The,The,O
gene,eneg,O
",",",",O
termed,termed,O
low,low,O
-,-,O
density,ienydst,O
lipoprotein,lipoprotein,O
receptor,receptor,O
related,eetlard,O
protein,irnetpo,O
5,5,O
(,(,O
LRP5,LRP5,O
),),O
",",",",O
encodes,encodes,O
a,a,O
protein,prneito,O
of,of,O
1615,1615,O
amino,amino,O
acids,icasd,O
that,that,O
contains,ctaonins,O
conserved,conserved,O
modules,modules,O
which,which,O
are,are,O
characteristic,characteristic,O
of,of,O
the,the,O
low,low,O
-,-,O
density,density,O
lipoprotein,lipoprotein,O
(,(,O
LDL,LDL,O
),),O
receptor,pecetorr,O
family,iymfla,O
.,.,O
,,
These,These,O
modules,modules,O
include,include,O
a,a,O
putative,putative,O
signal,signal,O
peptide,peptdie,O
for,for,O
protein,rpotein,O
export,export,O
",",",",O
four,oufr,O
epidermal,perdelmai,O
growth,whogtr,O
factor,cafotr,O
(,(,O
EGF,EGF,O
),),O
repeats,repeats,O
with,with,O
associated,associated,O
spacer,spacer,O
domains,domains,O
",",",",O
three,three,O
LDL,LDL,O
-,-,O
receptor,receptor,O
(,(,O
LDLR,LDLR,O
),),O
repeats,repeats,O
",",",",O
a,a,O
single,single,O
transmembrane,trmnsmearanbe,O
spanning,psagninn,O
domain,domain,O
",",",",O
and,and,O
a,a,O
cytoplasmic,picotlmsayc,O
domain,domain,O
.,.,O
,,
The,The,O
encoded,eneocdd,O
protein,protein,O
has,has,O
a,a,O
unique,unique,O
organization,organization,O
of,of,O
EGF,EGF,O
and,and,O
LDLR,LDLR,O
repeats,aerepts,O
;,;,O
therefore,toreefhre,O
",",",",O
LRP5,LRP5,O
likely,lyekli,O
represents,reprtesnes,O
a,a,O
new,new,O
category,eatrcogy,O
of,of,O
the,the,O
LDLR,LRDL,O
family,family,O
.,.,O
,,
Both,Hbto,O
human,haumn,O
and,and,O
mouse,mouse,O
LRP5,LRP5,O
cDNAs,cDNAs,O
have,have,O
been,been,O
isolated,sloeatid,O
and,and,O
the,the,O
encoded,encoded,O
mature,tumare,O
proteins,etoripns,O
are,are,O
95,95,O
%,%,O
identical,adelnicit,O
",",",",O
indicating,nidinaticg,O
a,a,O
high,high,O
degree,degree,O
of,of,O
evolutionary,evolutionary,O
conservation,ocnservoanti,O
.,.,O
.,.,O
,,
The,The,O
APC,APC,B
variants,nairtvas,O
I1307K,01ki73,O
and,and,O
E1317Q,1eq173,O
are,are,O
associated,associated,O
with,with,O
colorectal,colorectal,B
tumors,tumors,I
",",",",O
but,but,O
not,not,O
always,lywaas,O
with,with,O
a,a,O
family,faylim,O
history,history,O
.,.,O
,,
Classical,Csclaiasl,O
familial,familial,B
adenomatous,adenomatous,I
polyposis,polyposis,I
(,(,O
FAP,FAP,B
),),O
is,is,O
a,a,O
high,ihhg,O
-,-,O
penetrance,penetrance,O
autosomal,autosomal,B
dominant,dominant,I
disease,disease,I
that,that,O
predisposes,erpopssdies,O
to,to,O
hundreds,nedhruds,O
or,or,O
thousands,thousands,O
of,of,O
colorectal,colorectal,B
adenomas,adenomas,I
and,and,I
carcinoma,carcinoma,I
and,and,O
that,that,O
results,results,O
from,from,O
truncating,irutcanntg,O
mutations,tutanoims,O
in,in,O
the,the,O
APC,APC,B
gene,eeng,O
.,.,O
,,
A,A,O
variant,variant,O
of,of,O
FAP,FAP,B
is,is,O
attenuated,attenuated,B
adenomatous,adenomatous,I
polyposis,polyposis,I
coli,coli,I
",",",",O
which,which,O
results,elsutrs,O
from,from,O
germ,mgre,O
-,-,O
line,lein,O
mutations,muaotints,O
in,in,O
the,the,O
5,5,O
and,and,O
3,3,O
regions,negiors,O
of,of,O
the,the,O
APC,APC,B
gene,gene,O
.,.,O
,,
Attenuated,Attenuated,B
adenomatous,adenomatous,I
polyposis,polyposis,I
coli,coli,I
patients,patients,O
have,have,O
" O
multiple O
"," O
multiple O
",O
colorectal,colorectal,B
adenomas,adenomas,I
(,(,O
typically,pylicatyl,O
fewer,fewer,O
than,than,O
100,100,O
),),O
without,iutohwt,O
the,the,O
florid,florid,O
phenotype,oeenhtypp,O
of,of,O
classical,llsasccai,O
FAP,FAP,B
.,.,O
,,
Another,Oeatnhr,O
group,ugorp,O
of,of,O
patients,ttpiensa,O
with,with,O
multiple,multiple,O
adenomas,adenomas,B
has,has,O
no,no,O
mutations,otumtians,O
in,in,O
the,the,O
APC,APC,B
gene,ngee,O
",",",",O
and,and,O
their,their,O
phenotype,ohnpetype,O
probably,probably,O
results,ruelsts,O
from,from,O
variation,nartaiiov,O
at,at,O
a,a,O
locus,couls,O
",",",",O
or,or,O
loci,loci,O
",",",",O
elsewhere,elsewhere,O
in,in,O
the,the,O
genome,genome,O
.,.,O
,,
Recently,Rnleeyct,O
",",",",O
however,however,O
",",",",O
a,a,O
missense,missense,O
variant,niaarvt,O
of,of,O
APC,APC,B
(,(,O
I1307K,K0317I,O
),),O
was,was,O
described,described,O
that,that,O
confers,confers,O
an,an,O
increased,increased,O
risk,risk,O
of,of,O
colorectal,colorectal,B
tumors,tumors,I
",",",",O
including,niculding,O
multiple,tupeillm,O
adenomas,adenomas,B
",",",",O
in,in,O
Ashkenazim,Ahizenaksm,O
.,.,O
,,
We,We,O
have,have,O
studied,etduids,O
a,a,O
set,set,O
of,of,O
164,164,O
patients,patients,O
with,with,O
multiple,iupmtlle,O
colorectal,colorectal,B
adenomas,adenomas,I
and,and,I
/,/,I
or,or,I
carcinoma,carcinoma,I
and,and,O
analyzed,analyzed,O
codons,csdoon,O
1263,6123,O
-,-,O
1377,1377,O
(,(,O
exon,eonx,O
15G,15G,O
),),O
of,of,O
the,the,O
APC,APC,B
gene,gene,O
for,for,O
germ,ergm,O
-,-,O
line,lnei,O
variants,aarivtns,O
.,.,O
,,
Three,Trehe,O
patients,patients,O
with,with,O
the,the,O
I1307K,I1307K,O
allele,lleale,O
were,were,O
detected,eettcedd,O
",",",",O
each,each,O
of,of,O
Ashkenazi,Kseahiazn,O
descent,descent,O
.,.,O
,,
Four,Four,O
patients,apeitnts,O
had,had,O
a,a,O
germ,megr,O
-,-,O
line,enil,O
E1317Q,7113eQ,O
missense,simsesne,O
variant,iatvnar,O
of,of,O
APC,APC,O
that,that,O
was,was,O
not,not,O
present,present,O
in,in,O
controls,controls,O
;,;,O
one,one,O
of,of,O
these,these,O
individuals,individuals,O
had,had,O
an,an,O
unusually,suunually,O
large,rglae,O
number,unebmr,O
of,of,O
metaplastic,metaplastic,B
polyps,polyps,I
of,of,I
the,the,I
colorectum,colorectum,I
.,.,O
,,
There,Hetre,O
is,is,O
increasing,increasing,O
evidence,ndivecee,O
that,that,O
there,there,O
exist,sxite,O
germ,germ,O
-,-,O
line,inle,O
variants,variants,O
of,of,O
the,the,O
APC,APC,B
gene,ngee,O
that,that,O
predispose,presidpoes,O
to,to,O
the,the,O
development,development,O
of,of,O
multiple,multiple,O
colorectal,colorectal,B
adenomas,adenomas,I
and,and,I
carcinoma,carcinoma,I
",",",",O
but,but,O
without,without,O
the,the,O
florid,florid,O
phenotype,pheteoypn,O
of,of,O
classical,slascicla,O
FAP,FAP,B
",",",",O
and,and,O
possibly,possibly,O
with,with,O
importance,imctoranpe,O
for,for,O
colorectal,colorectal,B
cancer,cancer,I
risk,skri,O
in,in,O
the,the,O
general,general,O
population,population,O
.,.,O
.,.,O
,,
Genomic,Genomic,O
structure,utescrutr,O
of,of,O
the,the,O
human,ahmun,O
congenital,congenital,B
chloride,chloride,I
diarrhea,diarrhea,I
(,(,O
CLD,CLD,B
),),O
gene,gene,O
.,.,O
,,
Congenital,Congenital,B
chloride,chloride,I
diarrhea,diarrhea,I
(,(,O
CLD,CLD,B
),),O
is,is,O
caused,caused,O
by,by,O
mutations,mutations,O
in,in,O
a,a,O
gene,ngee,O
which,which,O
encodes,odcsnee,O
an,an,O
intestinal,intnsitlae,O
anion,anion,O
transporter,reanrposttr,O
.,.,O
,,
We,We,O
report,report,O
here,here,O
the,the,O
complete,mecpoetl,O
genomic,genomic,O
organization,oaiantzrgoin,O
of,of,O
the,the,O
human,human,O
CLD,CLD,B
gene,gene,O
which,which,O
spans,napss,O
approximately,arppoximatley,O
39kb,39kb,O
",",",",O
and,and,O
comprises,cspmrieos,O
21,21,O
exons,exons,O
.,.,O
,,
All,All,O
exon,xeno,O
/,/,O
intron,nitorn,O
boundaries,boundaries,O
conform,ocmofrn,O
to,to,O
the,the,O
GT,GT,O
/,/,O
AG,AG,O
rule,rule,O
.,.,O
,,
An,An,O
analysis,lnaaysis,O
of,of,O
the,the,O
putative,putative,O
promoter,promoter,O
region,nigeor,O
sequence,sequence,O
shows,shows,O
a,a,O
putative,vtuapite,O
TATA,ATAT,O
box,box,O
and,and,O
predicts,predicts,O
multiple,multiple,O
transcription,itanscrotrpin,O
factor,factor,O
binding,nibidng,O
sites,sites,O
.,.,O
,,
The,The,O
genomic,gnoemci,O
structure,structure,O
was,was,O
determined,determined,O
using,using,O
DNA,DNA,O
from,from,O
several,reeasvl,O
sources,osercsu,O
including,including,O
multiple,liltpume,O
large,large,O
-,-,O
insert,isnetr,O
libaries,libaries,O
and,and,O
genomic,genomic,O
DNA,DNA,O
from,from,O
Finnish,Fihnsni,O
CLD,CLD,B
patients,patients,O
and,and,O
controls,cnotolrs,O
.,.,O
,,
Exon,Exon,O
-,-,O
specific,iepcfsic,O
primers,primers,O
developed,eovelpded,O
in,in,O
this,this,O
study,study,O
will,will,O
facilitate,aaictitfle,O
mutation,totanium,O
screening,screengni,O
studies,studies,O
of,of,O
patients,antipets,O
with,with,O
the,the,O
disease,disease,O
.,.,O
,,
Genomic,Genomic,O
sequencing,seqecnuing,O
of,of,O
a,a,O
BAC,BAC,O
clone,cnloe,O
H,H,O
_,_,O
RG364P16,RG364P16,O
revealed,revealed,O
the,the,O
presence,presence,O
of,of,O
another,another,O
",",",",O
highly,hilygh,O
homologous,hslgmooouo,O
gene,enge,O
3,3,O
of,of,O
the,the,O
CLD,CLD,B
gene,gene,O
",",",",O
with,with,O
a,a,O
similar,simlair,O
genomic,gcnomie,O
structure,structure,O
",",",",O
recently,ercently,O
identified,identidief,O
as,as,O
the,the,O
Pendred,Pendred,B
syndrome,syndrome,I
gene,gene,O
(,(,O
PDS,PDS,B
),),O
.,.,O
.,.,O
,,
The,The,O
APCI1307K,APCI1307K,O
allele,aleell,O
and,and,O
cancer,cancer,B
risk,srik,O
in,in,O
a,a,O
community,community,O
-,-,O
based,beasd,O
study,study,O
of,of,O
Ashkenazi,Akhsenaiz,O
Jews,Jews,O
.,.,O
,,
Mutations,Nmtauiots,O
in,in,O
APC,APC,O
are,are,O
classically,classically,O
associated,aseoaicstd,O
with,with,O
familial,familial,B
adenomatous,adenomatous,I
polyposis,polyposis,I
(,(,O
FAP,FAP,B
),),O
",",",",O
a,a,O
highly,hgyhli,O
penetrant,pneetrnat,O
autosomal,autosomal,B
dominant,dominant,I
disorder,disorder,I
characterized,characterized,O
by,by,O
multiple,lemtlpiu,O
intestinal,ilanstietn,O
polyps,polyps,B
and,and,O
",",",",O
without,wuhotit,O
surgical,surgical,O
intervention,intervention,O
",",",",O
the,the,O
development,development,O
of,of,O
colorectal,colorectal,B
cancer,cancer,I
(,(,O
CRC,CRC,B
),),O
.,.,O
,,
APC,APC,B
is,is,O
a,a,O
tumour,tumour,O
-,-,O
suppressor,surposespr,O
gene,gene,O
",",",",O
and,and,O
somatic,imtaosc,O
loss,olss,O
occurs,occurs,O
in,in,O
tumours,tumours,B
.,.,O
,,
The,The,O
germline,germline,O
T,T,O
-,-,O
to,to,O
-,-,O
A,A,O
transversion,srarivsnteon,O
responsible,eeslbnsiorp,O
for,for,O
the,the,O
APC,APC,O
I1307K,310i7K,O
allele,lelale,O
converts,converts,O
the,the,O
wild,ilwd,O
-,-,O
type,teyp,O
sequence,ncqeusee,O
to,to,O
a,a,O
homopolymer,homopolymer,O
tract,tract,O
(,(,O
A8,A8,O
),),O
that,that,O
is,is,O
genetically,lenteiayglc,O
unstable,lnutebsa,O
and,and,O
prone,prone,O
to,to,O
somatic,somatic,O
mutation,mutation,O
.,.,O
,,
The,The,O
I1307K,Ik7031,O
allele,llaele,O
was,was,O
found,unfod,O
in,in,O
6,6,O
.,.,O
,,
1,1,O
%,%,O
of,of,O
unselected,cnseudltee,O
Ashkenazi,Nahkeazsi,O
Jews,Eswj,O
and,and,O
higher,hirheg,O
proportions,rpoportsoni,O
of,of,O
Ashkenazim,Ashkenazim,O
with,with,O
family,family,O
or,or,O
personal,personal,O
histories,sihtiroes,O
of,of,O
CRC,CRC,B
(,(,O
ref,ref,O
.,.,O
2,2,O
),),O
.,.,O
,,
To,To,O
evaluate,evlutaae,O
the,the,O
role,role,O
of,of,O
I1307K,0137iK,O
in,in,O
cancer,cancer,B
",",",",O
we,we,O
genotyped,yenotgped,O
5,5,O
",",",",O
081,081,O
Ashkenazi,Hsaeznaki,O
volunteers,vtourleens,O
in,in,O
a,a,O
community,community,O
survey,resvuy,O
.,.,O
,,
Risk,Risk,O
of,of,O
developing,nevdlopige,O
colorectal,colorectal,B
",",",",I
breast,breast,I
and,and,I
other,other,I
cancers,cancers,I
were,were,O
compared,eompradc,O
between,between,O
genotyped,yedntgpeo,O
I1307K,7k30i1,O
carriers,raeriscr,O
and,and,O
non,non,O
-,-,O
carriers,crraeirs,O
and,and,O
their,their,O
first,first,O
-,-,O
degree,degree,O
relatives,relatives,O
.,.,O
,,
Sperm,Mpres,O
DNA,DNA,O
analysis,ayalnsis,O
in,in,O
a,a,O
Friedreich,Friedreich,B
ataxia,ataxia,I
premutation,premutation,O
carrier,caerrri,O
suggests,setsuggs,O
both,both,O
meiotic,meiotic,O
and,and,O
mitotic,mitotic,O
expansion,expansion,O
in,in,O
the,the,O
FRDA,FRDA,B
gene,enge,O
.,.,O
,,
Friedreich,Friedreich,B
ataxia,ataxia,I
is,is,O
usually,usually,O
caused,cuasde,O
by,by,O
an,an,O
expansion,exaosnipn,O
of,of,O
a,a,O
GAA,GAA,O
trinucleotide,irdnecoultite,O
repeat,eapret,O
in,in,O
intron,itnnor,O
1,1,O
of,of,O
the,the,O
FRDA,FRDA,B
gene,ngee,O
.,.,O
,,
Occasionally,Oclnsyoacali,O
",",",",O
a,a,O
fully,fylul,O
expanded,expanded,O
allele,allele,O
has,has,O
been,been,O
found,fnudo,O
to,to,O
arise,iarse,O
from,from,O
a,a,O
premutation,trepuoaitmn,O
of,of,O
100,100,O
or,or,O
less,less,O
triplet,triplet,O
repeats,ertsape,O
.,.,O
,,
We,We,O
have,have,O
examined,dmnxiaee,O
the,the,O
sperm,eprsm,O
DNA,DNA,O
of,of,O
a,a,O
premutation,premutation,O
carrier,raricer,O
.,.,O
,,
This,This,O
mans,amsn,O
leucocyte,ltuccoeye,O
DNA,DNA,O
showed,shdoew,O
one,one,O
normal,anrmol,O
allele,allele,O
and,and,O
one,one,O
allele,allele,O
of,of,O
approximately,axpraptmoiley,O
100,100,O
repeats,repeats,O
.,.,O
,,
His,His,O
sperm,sperm,O
showed,ohsewd,O
an,an,O
expanded,expanded,O
allele,allele,O
in,in,O
a,a,O
tight,tight,O
range,range,O
centering,ncegerint,O
on,on,O
a,a,O
size,zesi,O
of,of,O
approximately,approximately,O
320,320,O
trinucleotide,nrdtucoelitie,O
repeats,eeprast,O
.,.,O
,,
His,His,O
affected,etdecfaf,O
son,son,O
has,has,O
repeat,repeat,O
sizes,eissz,O
of,of,O
1040,4100,O
and,and,O
540,540,O
.,.,O
,,
These,These,O
data,data,O
suggest,suggest,O
that,that,O
expansion,expansion,O
occurs,occurs,O
in,in,O
two,two,O
stages,stages,O
",",",",O
the,the,O
first,iftsr,O
during,during,O
meiosis,miesios,O
followed,followed,O
by,by,O
a,a,O
second,sencod,O
mitotic,ttmioic,O
expansion,nxpaesion,O
.,.,O
,,
We,We,O
also,sloa,O
show,show,O
that,that,O
in,in,O
all,all,O
informative,informative,O
carrier,carrier,O
father,father,O
to,to,O
affected,atcedfef,O
child,cidlh,O
transmissions,tiaosmissnrns,O
",",",",O
with,with,O
the,the,O
notable,tabonle,O
exception,enceoxipt,O
of,of,O
the,the,O
premutation,erputnamiot,O
carrier,earcirr,O
",",",",O
the,the,O
expansion,expansion,O
size,size,O
decreases,decreases,O
.,.,O
.,.,O
,,
The,The,O
R496H,R6h49,O
mutation,muotitan,O
of,of,O
arylsulfatase,alylsuarftase,O
A,A,O
does,does,O
not,not,O
cause,cause,O
metachromatic,metachromatic,B
leukodystrophy,leukodystrophy,I
.,.,O
,,
Deficiency,Deficiency,B
of,of,I
arylsulfatase,arylsulfatase,I
A,A,I
(,(,O
ARSA,ARSA,O
),),O
enzyme,nmzyee,O
activity,activity,O
causes,uasces,O
metachromatic,metachromatic,B
leukodystrophy,leukodystrophy,I
(,(,O
MLD,MLD,B
),),O
.,.,O
,,
A,A,O
number,uembnr,O
of,of,O
ARSA,ARSA,O
gene,gene,O
mutations,atumtoins,O
responsible,sorpensbile,O
for,for,O
MLD,MLD,B
have,have,O
been,been,O
identified,fdeteiiind,O
.,.,O
,,
Recently,Ryceltne,O
",",",",O
the,the,O
R496H,649hR,O
mutation,imttauon,O
of,of,O
ARSA,SARA,O
was,was,O
proposed,deopospr,O
to,to,O
be,be,O
a,a,O
cause,cause,O
of,of,O
MLD,MLD,B
(,(,O
Draghia,Raaghdi,O
et,et,O
al,al,O
.,.,O
",",",",O
1997,1997,O
),),O
.,.,O
,,
We,We,O
have,have,O
investigated,gnteatidsvei,O
the,the,O
R496H,R496H,O
mutation,matuiton,O
and,and,O
found,ufond,O
this,this,O
mutation,mutnaito,O
at,at,O
a,a,O
relatively,rayltivele,O
high,high,O
frequency,frequency,O
in,in,O
an,an,O
African,African,O
American,Mneircaa,O
population,population,O
(,(,O
f,f,O
=,=,O
0,0,O
.,.,O
09,09,O
",",",",O
n,n,O
=,=,O
61,61,O
subjects,jsbscetu,O
),),O
.,.,O
,,
The,The,O
ARSA,SARA,O
enzyme,enmzye,O
activity,ctaiivty,O
in,in,O
subjects,subjects,O
with,with,O
and,and,O
without,outwhit,O
the,the,O
R496H,R6h49,O
mutation,mutation,O
was,was,O
determined,determined,O
and,and,O
found,found,O
to,to,O
be,be,O
normal,nrlmao,O
.,.,O
,,
It,It,O
is,is,O
therefore,rehfetore,O
concluded,concluded,O
that,that,O
the,the,O
R496H,9r46H,O
mutation,moitatun,O
of,of,O
ARSA,RSAA,O
does,does,O
not,not,O
negatively,negatively,O
influence,fnileunce,O
the,the,O
activity,vciitaty,O
of,of,O
ARSA,AASR,O
and,and,O
is,is,O
not,not,O
a,a,O
cause,suace,O
of,of,O
MLD,MLD,B
,,
Down,Down,O
-,-,O
regulation,regulation,O
of,of,O
transmembrane,enarsmeabrmnt,O
carbonic,carbonic,O
anhydrases,anhydrases,O
in,in,O
renal,renal,B
cell,cell,I
carcinoma,carcinoma,I
cell,lcel,O
lines,lines,O
by,by,O
wild,idlw,O
-,-,O
type,type,O
von,von,B
Hippel,Hippel,I
-,-,I
Lindau,Lindau,I
transgenes,transgenes,O
.,.,O
,,
To,To,O
discover,discover,O
genes,genes,O
involved,ilvoevnd,O
in,in,O
von,von,B
Hippel,Hippel,I
-,-,I
Lindau,Lindau,I
(,(,O
VHL,VHL,B
),),O
-,-,O
mediated,medietda,O
carcinogenesis,carcinogenesis,O
",",",",O
we,we,O
used,used,O
renal,renal,B
cell,cell,I
carcinoma,carcinoma,I
cell,cell,O
lines,lneis,O
stably,latbsy,O
transfected,crneefsttad,O
with,with,O
wild,wild,O
-,-,O
type,type,O
VHL,VHL,O
-,-,O
expressing,expressing,O
transgenes,tgnnersaes,O
.,.,O
,,
Large,Large,O
-,-,O
scale,scale,O
RNA,RNA,O
differential,ldefertnfiai,O
display,display,O
technology,technology,O
applied,applied,O
to,to,O
these,these,O
cell,cell,O
lines,lines,O
identified,fdetniieid,O
several,several,O
differentially,differentially,O
expressed,expressed,O
genes,genes,O
",",",",O
including,nglcudiin,O
an,an,O
alpha,palha,O
carbonic,bcrcnoia,O
anhydrase,anhydrase,O
gene,gene,O
",",",",O
termed,etmred,O
CA12,CA12,O
.,.,O
,,
The,The,O
deduced,deduced,O
protein,oprtien,O
sequence,sequence,O
was,was,O
classified,classified,O
as,as,O
a,a,O
one,one,O
-,-,O
pass,sspa,O
transmembrane,tranmneabrsme,O
CA,CA,O
possessing,sossispegn,O
an,an,O
apparently,aprapently,O
intact,cniatt,O
catalytic,catclytai,O
domain,domain,O
in,in,O
the,the,O
extracellular,extracellular,O
CA,CA,O
module,module,O
.,.,O
,,
Reintroduced,Rerntiocuded,O
wild,wild,O
-,-,O
type,type,O
VHL,VHL,B
strongly,otrslngy,O
inhibited,inditbieh,O
the,the,O
overexpression,overexpression,O
of,of,O
the,the,O
CA12,A1c2,O
gene,gene,O
in,in,O
the,the,O
parental,parental,O
renal,renal,B
cell,cell,I
carcinoma,carcinoma,I
cell,clle,O
lines,lines,O
.,.,O
,,
Similar,Simalir,O
results,rutless,O
were,were,O
obtained,oaneitbd,O
with,with,O
CA9,CA9,O
",",",",O
encoding,encoding,O
another,onaethr,O
transmembrane,transmembrane,O
CA,CA,O
with,with,O
an,an,O
intact,inatct,O
catalytic,catalytic,O
domain,domain,O
.,.,O
,,
Although,Latguohh,O
both,both,O
domains,dmioans,O
of,of,O
the,the,O
VHL,VHL,B
protein,protein,O
contribute,icntrobtue,O
to,to,O
regulation,regulation,O
of,of,O
CA12,CA12,O
expression,expression,O
",",",",O
the,the,O
elongin,elongin,O
binding,diibgnn,O
domain,domain,O
alone,anelo,O
could,could,O
effectively,effectively,O
regulate,ergealtu,O
CA9,CA9,O
expression,erpsixseon,O
.,.,O
,,
We,We,O
mapped,appmed,O
CA12,C2a1,O
and,and,O
CA9,CA9,O
loci,loci,O
to,to,O
chromosome,cheomosmor,O
bands,sanbd,O
15q22,15q22,O
and,and,O
17q21,17q21,O
.,.,O
,,
2,2,O
respectively,respectively,O
",",",",O
regions,rgesino,O
prone,prone,O
to,to,O
amplification,ampailicftoin,O
in,in,O
some,some,O
human,muahn,O
cancers,cancers,B
.,.,O
,,
Additional,Aitddlonai,O
experiments,etpesimexrn,O
are,are,O
needed,ndeeed,O
to,to,O
define,dnfiee,O
the,the,O
role,loer,O
of,of,O
CA,CA,O
IX,IX,O
and,and,O
CA,CA,O
XII,XII,O
enzymes,enzmyes,O
in,in,O
the,the,O
regulation,regulation,O
of,of,O
pH,pH,O
in,in,O
the,the,O
extracellular,extracellular,O
microenvironment,minroenrivemnoct,O
and,and,O
its,its,O
potential,pittaeonl,O
impact,impact,O
on,on,O
cancer,cancer,B
cell,cell,O
growth,tgowrh,O
.,.,O
,,
A,A,O
gene,ngee,O
encoding,enniodcg,O
a,a,O
transmembrane,transmembrane,O
protein,protein,O
is,is,O
mutated,umdetat,O
in,in,O
patients,tpteinas,O
with,with,O
diabetes,diabetes,B
mellitus,mellitus,I
and,and,O
optic,optic,B
atrophy,atrophy,I
(,(,O
Wolfram,Wolfram,B
syndrome,syndrome,I
),),O
.,.,O
,,
Wolfram,Wolfram,B
syndrome,syndrome,I
(,(,O
WFS,WFS,B
;,;,O
OMIM,MIMO,O
222300,222300,O
),),O
is,is,O
an,an,O
autosomal,autosomal,B
recessive,recessive,I
neurodegenerative,neurodegenerative,I
disorder,disorder,I
defined,defined,O
by,by,O
young,young,O
-,-,O
onset,ntseo,O
non,non,O
-,-,O
immune,nmumie,O
insulin,insulin,B
-,-,I
dependent,dependent,I
diabetes,diabetes,I
mellitus,mellitus,I
and,and,O
progressive,psoesgirrve,O
optic,optic,B
atrophy,atrophy,I
.,.,O
,,
Linkage,Lgnikae,O
to,to,O
markers,markers,O
on,on,O
chromosome,ohoocrsmme,O
4p,4p,O
was,was,O
confirmed,conemridf,O
in,in,O
five,ivfe,O
families,families,O
.,.,O
,,
On,On,O
the,the,O
basis,bsias,O
of,of,O
meiotic,teicmoi,O
recombinants,rnnomeicbats,O
and,and,O
disease,dsseaie,O
-,-,O
associated,associated,O
haplotypes,lophptyaes,O
",",",",O
the,the,O
WFS,WFS,B
gene,neeg,O
was,was,O
localized,lozeaicld,O
to,to,O
a,a,O
BAC,BAC,O
/,/,O
P1,P1,O
contig,contig,O
of,of,O
less,lsse,O
than,than,O
250,250,O
kb,kb,O
.,.,O
,,
Mutations,Muotiatns,O
in,in,O
a,a,O
novel,novel,O
gene,neeg,O
(,(,O
WFS1,WFS1,O
),),O
encoding,encoding,O
a,a,O
putative,ptuitvae,O
transmembrane,tmbnsmeaeranr,O
protein,ptoeirn,O
were,were,O
found,found,O
in,in,O
all,all,O
affected,cffetaed,O
individuals,individuals,O
in,in,O
six,six,O
WFS,WFS,B
families,lfmiaies,O
",",",",O
and,and,O
these,these,O
mutations,motatiuns,O
were,were,O
associated,associated,O
with,with,O
the,the,O
disease,disease,O
phenotype,poyphtene,O
.,.,O
,,
WFS1,WFS1,O
appears,appears,O
to,to,O
function,function,O
in,in,O
survival,saruivvl,O
of,of,O
islet,isetl,O
beta,beta,O
-,-,O
cells,cells,O
and,and,O
neurons,snunore,O
.,.,O
.,.,O
,,
Stable,Stable,O
interaction,orienicttan,O
between,between,O
the,the,O
products,prdoucts,O
of,of,O
the,the,O
BRCA1,ACRB1,O
and,and,O
BRCA2,BRCA2,O
tumor,tumor,B
suppressor,suppressor,O
genes,genes,O
in,in,O
mitotic,mttoici,O
and,and,O
meiotic,meiocit,O
cells,secll,O
.,.,O
,,
BRCA1,BRCA1,O
and,and,O
BRCA2,CABR2,O
account,account,O
for,for,O
most,most,O
cases,aescs,O
of,of,O
familial,familial,O
",",",",O
early,erlay,O
onset,onset,O
breast,breast,B
and,and,I
/,/,I
or,or,I
ovarian,ovarian,I
cancer,cancer,I
and,and,O
encode,cdeone,O
products,rpsudcto,O
that,that,O
each,each,O
interact,interact,O
with,with,O
hRAD51,5ARDh1,O
.,.,O
,,
Results,Results,O
presented,etespernd,O
here,here,O
show,hosw,O
that,that,O
BRCA1,BRCA1,O
and,and,O
BRCA2,2RCBa,O
coexist,xcoeist,O
in,in,O
a,a,O
biochemical,biochemical,O
complex,empolcx,O
and,and,O
colocalize,colocalize,O
in,in,O
subnuclear,subnuclear,O
foci,foci,O
in,in,O
somatic,sitaomc,O
cells,lcles,O
and,and,O
on,on,O
the,the,O
axial,aaxil,O
elements,nelmtees,O
of,of,O
developing,developing,O
synaptonemal,synaptonemal,O
complexes,complexes,O
.,.,O
,,
Like,Iekl,O
BRCA1,BRCA1,O
and,and,O
RAD51,RAD51,O
",",",",O
BRCA2,BRCA2,O
relocates,otlreaces,O
to,to,O
PCNA,PCNA,O
+,+,O
replication,replication,O
sites,tises,O
following,iloolwfng,O
exposure,exrosupe,O
of,of,O
S,S,O
phase,phase,O
cells,eclls,O
to,to,O
hydroxyurea,hydroxyurea,O
or,or,O
UV,UV,O
irradiation,irrdiitaaon,O
.,.,O
,,
Thus,Thus,O
",",",",O
BRCA1,BRCA1,O
and,and,O
BRCA2,BARC2,O
participate,earctiitapp,O
",",",",O
together,otghteer,O
",",",",O
in,in,O
a,a,O
pathway,pathway,O
(,(,O
s,s,O
),),O
associated,associated,O
with,with,O
the,the,O
activation,aitivotcan,O
of,of,O
double,double,O
-,-,O
strand,srtadn,O
break,break,O
repair,repair,O
and,and,O
/,/,O
or,or,O
homologous,humoooolgs,O
recombination,recombination,O
.,.,O
,,
Dysfunction,Dnyfsuitcon,O
of,of,O
this,this,O
pathway,hawptya,O
may,may,O
be,be,O
a,a,O
general,general,O
phenomenon,phoonmenen,O
in,in,O
the,the,O
majority,tarmjioy,O
of,of,O
cases,saecs,O
of,of,O
hereditary,hereditary,B
breast,breast,I
and,and,I
/,/,I
or,or,I
ovarian,ovarian,I
cancer,cancer,I
.,.,O
.,.,O
,,
A,A,O
novel,novel,O
Arg362Ser,Arg362Ser,O
mutation,attouimn,O
in,in,O
the,the,O
sterol,sterol,O
27,27,O
-,-,O
hydroxylase,hydroxylase,O
gene,gene,O
(,(,O
CYP27,CYP27,O
),),O
:,:,O
its,its,O
effects,effestc,O
on,on,O
pre,pre,O
-,-,O
mRNA,mRNA,O
splicing,gplncsii,O
and,and,O
enzyme,ezynme,O
activity,titcviay,O
.,.,O
,,
A,A,O
novel,envol,O
C,C,O
to,to,O
A,A,O
mutation,amtotiun,O
in,in,O
the,the,O
sterol,sterol,O
27,27,O
-,-,O
hydroxylase,sydrlheoaxy,O
gene,gene,O
(,(,O
CYP27,7Y2pc,O
),),O
was,was,O
identified,identified,O
by,by,O
sequencing,seqnnicueg,O
amplified,amplified,O
CYP27,C27yp,O
gene,neeg,O
products,potrucds,O
from,from,O
a,a,O
patient,patient,O
with,with,O
cerebrotendinous,cerebrotendinous,B
xanthomatosis,xanthomatosis,I
(,(,O
CTX,CTX,B
),),O
.,.,O
,,
The,The,O
mutation,mutation,O
changed,necaghd,O
the,the,O
adrenodoxin,anondodixre,O
cofactor,cctafoor,O
binding,binding,O
residue,residue,O
362Arg,362Arg,O
to,to,O
362Ser,362Ser,O
(,(,O
CGT,CGT,O
362Arg,362Arg,O
to,to,O
AGT,AGT,O
362Ser,362Ser,O
),),O
",",",",O
and,and,O
was,was,O
responsible,reslpnoibes,O
for,for,O
deficiency,fieicdency,O
in,in,O
the,the,O
sterol,sterol,O
27,27,O
-,-,O
hydroxylase,rydosxyhale,O
activity,tticviay,O
",",",",O
as,as,O
confirmed,confirmed,O
by,by,O
expression,exorsspien,O
of,of,O
mutant,mutant,O
cDNA,dNCA,O
into,into,O
COS,COS,O
-,-,O
1,1,O
cells,cells,O
.,.,O
,,
Quantitative,Quantitative,O
analysis,aansylis,O
showed,showed,O
that,that,O
the,the,O
expression,expression,O
of,of,O
CYP27,C7y2p,O
gene,nege,O
mRNA,mRNA,O
in,in,O
the,the,O
patient,itepant,O
represented,seprenetred,O
52,52,O
.,.,O
,,
5,5,O
%,%,O
of,of,O
the,the,O
normal,noarml,O
level,elvle,O
.,.,O
,,
As,As,O
the,the,O
mutation,mauotitn,O
occurred,occurred,O
at,at,O
the,the,O
penultimate,penultimate,O
nucleotide,coelnutide,O
of,of,O
exon,onex,O
6,6,O
(,(,O
-,-,O
2,2,O
position,opsiiotn,O
of,of,O
exon,exon,O
6,6,O
-,-,O
intron,toirnn,O
6,6,O
splice,splice,O
site,eist,O
),),O
of,of,O
the,the,O
gene,gene,O
",",",",O
we,we,O
hypothesized,hypothesized,O
that,that,O
the,the,O
mutation,mutation,O
may,may,O
partially,partially,O
affect,affect,O
the,the,O
normal,normal,O
splicing,splicing,O
efficiency,efficiency,O
in,in,O
exon,exon,O
6,6,O
and,and,O
cause,cause,O
alternative,attlenavire,O
splicing,splicing,O
elsewhere,slrehweee,O
",",",",O
which,which,O
resulted,retslude,O
in,in,O
decreased,decreased,O
transcript,transcript,O
in,in,O
the,the,O
patient,aptntie,O
.,.,O
,,
Transfection,Transfection,O
of,of,O
constructed,rcnstoucted,O
minigenes,minigenes,O
",",",",O
with,with,O
or,or,O
without,whiotut,O
the,the,O
mutation,mutation,O
",",",",O
into,into,O
COS,COS,O
-,-,O
1,1,O
cells,lcles,O
confirmed,cifnmroed,O
that,that,O
the,the,O
mutant,mutant,O
minigene,minigene,O
was,was,O
responsible,responsible,O
for,for,O
a,a,O
mRNA,mNAR,O
species,epcesis,O
alternatively,alteinatevylr,O
spliced,spliced,O
at,at,O
an,an,O
activated,activated,O
cryptic,ircytpc,O
5,5,O
splice,celisp,O
site,eist,O
88,88,O
bp,bp,O
upstream,upstream,O
from,from,O
the,the,O
3,3,O
end,end,O
of,of,O
exon,exon,O
6,6,O
.,.,O
,,
Our,Our,O
data,adat,O
suggest,suggest,O
that,that,O
the,the,O
C,C,O
to,to,O
A,A,O
mutation,tonamiut,O
at,at,O
the,the,O
penultimate,atmuelinpte,O
nucleotide,euolntcide,O
of,of,O
exon,exon,O
6,6,O
of,of,O
the,the,O
CYP27,7PY2c,O
gene,gene,O
not,not,O
only,only,O
causes,caeuss,O
the,the,O
deficiency,deficiency,B
in,in,I
the,the,I
sterol,sterol,I
27,27,I
-,-,I
hydroxylase,hydroxylase,I
activity,activity,I
",",",",O
but,but,O
also,also,O
partially,partially,O
leads,leads,O
to,to,O
alternative,rtelanitave,O
pre,pre,O
-,-,O
mRNA,aNRM,O
splicing,clipsing,O
of,of,O
the,the,O
gene,geen,O
.,.,O
,,
To,To,O
our,our,O
knowledge,lnokewdge,O
",",",",O
this,this,O
is,is,O
the,the,O
first,irfst,O
report,reoprt,O
regarding,rreagdign,O
effects,ffecets,O
on,on,O
pre,pre,O
-,-,O
mRNA,mRNA,O
splicing,slincipg,O
of,of,O
a,a,O
mutation,antmitou,O
at,at,O
the,the,O
-,-,O
2,2,O
position,optision,O
of,of,O
a,a,O
5,5,O
splice,splice,O
site,site,O
.,.,O
,,
ATM,ATM,O
germline,ngrmeile,O
mutations,tomtaiuns,O
in,in,O
classical,classical,O
ataxia,ataxia,B
-,-,I
telangiectasia,telangiectasia,I
patients,tinaetps,O
in,in,O
the,the,O
Dutch,Dutch,O
population,population,O
.,.,O
,,
Germline,Enrilmge,O
mutations,amtutiosn,O
in,in,O
the,the,O
ATM,ATM,O
gene,gene,O
are,are,O
responsible,responsible,O
for,for,O
the,the,O
autosomal,autosomal,B
recessive,recessive,I
disorder,disorder,I
ataxia,ataxia,B
-,-,I
telangiectasia,telangiectasia,I
(,(,O
A,A,B
-,-,I
T,T,I
),),O
.,.,O
,,
In,In,O
our,our,O
study,tusdy,O
",",",",O
we,we,O
have,have,O
determined,determined,O
the,the,O
ATM,ATM,O
mutation,auimtton,O
spectrum,spectrum,O
in,in,O
19,19,O
classical,saacsicll,O
A,A,B
-,-,I
T,T,I
patients,patients,O
",",",",O
including,including,O
some,some,O
immigrant,rmigimant,O
populations,ppoulatinos,O
",",",",O
as,as,O
well,elwl,O
as,as,O
12,12,O
of,of,O
Dutch,Hdtcu,O
ethnic,ethnic,O
origin,giiorn,O
.,.,O
,,
Both,Both,O
the,the,O
protein,protein,O
truncation,tranuciton,O
test,test,O
(,(,O
PTT,PTT,O
),),O
and,and,O
the,the,O
restriction,restriction,O
endonuclease,unnedlcoease,O
fingerprinting,niignrprfntieg,O
(,(,O
REF,REF,O
),),O
method,temohd,O
were,were,O
used,used,O
and,and,O
compared,pocmerad,O
for,for,O
their,their,O
detection,decnttieo,O
efficiency,efficiency,O
",",",",O
identifying,inentidfiyg,O
76,76,O
%,%,O
and,and,O
60,60,O
%,%,O
of,of,O
the,the,O
mutations,astmtnoiu,O
",",",",O
respectively,respectively,O
.,.,O
,,
Most,Tmso,O
patients,saittnep,O
were,were,O
found,fudno,O
to,to,O
be,be,O
compound,compound,O
heterozygote,heterozygote,O
.,.,O
,,
Seventeen,Senenteve,O
mutations,mutations,O
were,were,O
distinct,scitindt,O
",",",",O
of,of,O
which,which,O
10,10,O
were,were,O
not,not,O
reported,deporetr,O
previously,pvileousry,O
.,.,O
,,
Mutations,Mutations,O
are,are,O
small,small,O
deletions,deletions,O
or,or,O
point,pinot,O
mutations,iunaomtts,O
frequently,qrtfuynele,O
affecting,affecting,O
splice,eplcis,O
sites,sites,O
.,.,O
,,
Moreover,Roeemvro,O
",",",",O
a,a,O
16,16,O
.,.,O
,,
7,7,O
-,-,O
kb,kb,O
genomic,mocegin,O
deletion,deletion,O
of,of,O
the,the,O
3,3,O
end,end,O
of,of,O
the,the,O
gene,geen,O
",",",",O
most,most,O
likely,likely,O
a,a,O
result,rleust,O
of,of,O
recombination,reconbiiotnam,O
between,between,O
two,two,O
LINE,ILEN,O
elements,eenmelts,O
",",",",O
was,was,O
identified,fdeniitied,O
.,.,O
,,
The,The,O
most,most,O
frequently,frequently,O
found,nfuod,O
mutation,ttiaumon,O
",",",",O
identified,identified,O
in,in,O
three,etreh,O
unrelated,unrelated,O
Turkish,Turkish,O
A,A,B
-,-,I
T,T,I
individuals,individuals,O
",",",",O
was,was,O
previously,poesivurly,O
described,desrebicd,O
to,to,O
be,be,O
a,a,O
Turkish,Srhkitu,O
A,A,B
-,-,I
T,T,I
founder,founder,O
mutation,mutation,O
.,.,O
,,
The,The,O
presence,prneesec,O
of,of,O
a,a,O
founder,founder,O
mutation,mntatuoi,O
among,among,O
relatively,eeialtvrly,O
small,small,O
ethnic,eitnhc,O
population,topulapion,O
groups,groups,O
in,in,O
Western,Western,O
Europe,Pureoe,O
could,could,O
indicate,indicate,O
a,a,O
high,hihg,O
carrier,carrier,O
frequency,ernqufcey,O
in,in,O
such,such,O
communities,communities,O
.,.,O
,,
In,In,O
patients,patients,O
of,of,O
Dutch,Dhtuc,O
ethnic,ethnic,O
origin,origin,O
",",",",O
however,eewhvro,O
",",",",O
no,no,O
significant,icginfsnait,O
founder,founder,O
effect,eefcft,O
could,cudlo,O
be,be,O
identified,identified,O
.,.,O
,,
The,The,O
observed,observed,O
genetic,genetic,O
heterogeneity,heterogeneity,O
including,dnilucnig,O
the,the,O
relative,teraliev,O
high,high,O
percentage,pcranetege,O
of,of,O
splice,sicple,O
-,-,O
site,site,O
mutations,iutatmons,O
had,had,O
no,no,O
reflection,reflection,O
on,on,O
the,the,O
phenotype,eheontypp,O
.,.,O
,,
All,All,O
patients,patients,O
manifested,manifested,O
classical,classical,O
A,A,B
-,-,I
T,T,I
and,and,O
increased,increased,O
cellular,cllauler,O
radioresistant,ratissediraont,O
DNA,DNA,O
synthesis,sintessyh,O
.,.,O
,,
Determination,Ndoemrinatite,O
of,of,O
the,the,O
genomic,geomnci,O
structure,curtstrue,O
of,of,O
the,the,O
COL4A4,o4L4Ac,O
gene,gene,O
and,and,O
of,of,O
novel,novel,O
mutations,mutations,O
causing,acusing,O
autosomal,autosomal,B
recessive,recessive,I
Alport,Alport,I
syndrome,syndrome,I
.,.,O
,,
Autosomal,Autosomal,B
recessive,recessive,I
Alport,Alport,I
syndrome,syndrome,I
is,is,O
a,a,O
progressive,prorgessiev,O
hematuric,hematuric,B
glomerulonephritis,glomerulonephritis,I
characterized,rhdraceacizte,O
by,by,O
glomerular,glomerular,B
basement,basement,I
membrane,membrane,I
abnormalities,abnormalities,I
and,and,O
associated,associated,O
with,with,O
mutations,mutations,O
in,in,O
either,eehtir,O
the,the,O
COL4A3,3OA4Lc,O
or,or,O
the,the,O
COL4A4,C4Lao4,O
gene,gene,O
",",",",O
which,which,O
encode,dnocee,O
the,the,O
alpha3,laahp3,O
and,and,O
alpha4,alpha4,O
type,ypte,O
IV,IV,O
collagen,collagen,O
chains,chains,O
",",",",O
respectively,erspeltivcey,O
.,.,O
,,
To,To,O
date,taed,O
",",",",O
mutation,autmtion,O
screening,erceinsng,O
in,in,O
the,the,O
two,two,O
genes,gsnee,O
has,has,O
been,been,O
hampered,hampered,O
by,by,O
the,the,O
lack,lack,O
of,of,O
genomic,gcmnoie,O
structure,stuceturr,O
information,information,O
.,.,O
,,
We,We,O
report,perort,O
here,here,O
the,the,O
complete,pmotlece,O
characterization,chateiraraoitczn,O
of,of,O
the,the,O
48,48,O
exons,exons,O
of,of,O
the,the,O
COL4A4,AO4lC4,O
gene,enge,O
",",",",O
a,a,O
comprehensive,sonpreecmeivh,O
gene,enge,O
screen,snrcee,O
",",",",O
and,and,O
the,the,O
subsequent,buessqutne,O
detection,detection,O
of,of,O
10,10,O
novel,evonl,O
mutations,mutations,O
in,in,O
eight,eight,O
patients,patients,O
diagnosed,diagnosed,O
with,with,O
autosomal,autosomal,B
recessive,recessive,I
Alport,Alport,I
syndrome,syndrome,I
.,.,O
,,
Furthermore,Furthermore,O
",",",",O
we,we,O
identified,nteidified,O
a,a,O
glycine,iylgcne,O
to,to,O
alanine,alanine,O
substitution,usbiiutstton,O
in,in,O
the,the,O
collagenous,collagenous,O
domain,moadin,O
that,that,O
is,is,O
apparently,lppareynat,O
silent,silent,O
in,in,O
the,the,O
heterozygous,ertohuzygoes,O
carriers,earrircs,O
",",",",O
in,in,O
11,11,O
.,.,O
,,
5,5,O
%,%,O
of,of,O
all,all,O
control,ctrnool,O
individuals,individuals,O
",",",",O
and,and,O
in,in,O
one,one,O
control,noortcl,O
individual,aidnviiudl,O
homozygous,mohgzyoous,O
for,for,O
this,this,O
glycine,glycine,O
substitution,suustotbtiin,O
.,.,O
,,
There,Htree,O
has,has,O
been,been,O
no,no,O
previous,previous,O
finding,infdnig,O
of,of,O
a,a,O
glycine,clnyige,O
substitution,substitution,O
that,that,O
is,is,O
not,not,O
associated,asaicotsed,O
with,with,O
any,any,O
obvious,uivobos,O
phenotype,phenotype,O
in,in,O
homozygous,homsuyogzo,O
individuals,iidnviduals,O
.,.,O
,,
Founder,Ruonfed,O
BRCA1,BRCA1,O
and,and,O
BRCA2,RB2Ac,O
mutations,mutations,O
in,in,O
French,French,O
Canadian,Canadian,O
breast,breast,B
and,and,I
ovarian,ovarian,I
cancer,cancer,I
families,miialfes,O
.,.,O
,,
We,We,O
have,have,O
identified,idintifeed,O
four,uorf,O
mutations,tumaitons,O
in,in,O
each,each,O
of,of,O
the,the,O
breast,breast,B
cancer,cancer,I
-,-,O
susceptibility,luitcptsbsiiey,O
genes,ngees,O
",",",",O
BRCA1,1RBAc,O
and,and,O
BRCA2,BRCA2,O
",",",",O
in,in,O
French,Crefnh,O
Canadian,Canadian,O
breast,breast,B
cancer,cancer,I
and,and,O
breast,breast,B
/,/,I
ovarian,ovarian,I
cancer,cancer,I
families,families,O
from,from,O
Quebec,Quebec,O
.,.,O
,,
To,To,O
identify,identify,O
founder,dofruen,O
effects,tfcefse,O
",",",",O
we,we,O
examined,dxeeinma,O
independently,independently,O
ascertained,acseitarned,O
French,French,O
Canadian,Iaaadcnn,O
cancer,cancer,B
families,famiiles,O
for,for,O
the,the,O
distribution,distribution,O
of,of,O
these,these,O
eight,eight,O
mutations,mutations,O
.,.,O
,,
Mutations,Moiatnuts,O
were,were,O
found,doufn,O
in,in,O
41,41,O
of,of,O
97,97,O
families,samieifl,O
.,.,O
,,
Six,Six,O
of,of,O
eight,ihget,O
mutations,mutations,O
were,were,O
observed,observed,O
at,at,O
least,setla,O
twice,iwect,O
.,.,O
,,
The,The,O
BRCA1,1CRAb,O
C4446T,C4446T,O
mutation,mutation,O
was,was,O
the,the,O
most,most,O
common,common,O
mutation,mutation,O
found,oufnd,O
",",",",O
followed,fwolloed,O
by,by,O
the,the,O
BRCA2,BCAR2,O
8765delAG,8la5d7e6G,O
mutation,mutation,O
.,.,O
,,
Together,Tgoether,O
",",",",O
these,these,O
mutations,itoaumtns,O
were,were,O
found,nuofd,O
in,in,O
28,28,O
of,of,O
41,41,O
families,famisiel,O
identified,idieetfind,O
to,to,O
have,have,O
a,a,O
mutation,mutation,O
.,.,O
,,
The,The,O
odds,dods,O
of,of,O
detection,teedctino,O
of,of,O
any,any,O
of,of,O
the,the,O
four,rofu,O
BRCA1,BRCA1,O
mutations,mutations,O
was,was,O
18,18,O
.,.,O
,,
7x,7x,O
greater,geeratr,O
if,if,O
one,one,O
or,or,O
more,more,O
cases,eassc,O
of,of,O
ovarian,ovarian,B
cancer,cancer,I
were,were,O
also,lsao,O
present,tresenp,O
in,in,O
the,the,O
family,aimfly,O
.,.,O
,,
The,The,O
odds,odds,O
of,of,O
detection,ioeectdtn,O
of,of,O
any,any,O
of,of,O
the,the,O
four,ufor,O
BRCA2,B2RAc,O
mutations,iuoatmsnt,O
was,was,O
5,5,O
.,.,O
,,
3x,3x,O
greater,greater,O
if,if,O
there,there,O
were,were,O
at,at,O
least,tsael,O
five,vfie,O
cases,ecsas,O
of,of,O
breast,breast,B
cancer,cancer,I
in,in,O
the,the,O
family,aflimy,O
.,.,O
,,
Interestingly,Interestingly,O
",",",",O
the,the,O
presence,rnesepec,O
of,of,O
a,a,O
breast,breast,B
cancer,cancer,I
case,ceas,O
<,<,O
36,36,O
years,years,O
of,of,O
age,age,O
was,was,O
strongly,strongly,O
predictive,pieitcdrve,O
of,of,O
the,the,O
presence,rsepence,O
of,of,O
any,any,O
of,of,O
the,the,O
eight,hegit,O
mutations,musatonit,O
screened,enseecrd,O
.,.,O
,,
Carriers,Carriers,O
of,of,O
the,the,O
same,same,O
mutation,motntiau,O
",",",",O
from,from,O
different,fefdernit,O
families,families,O
",",",",O
shared,shared,O
similar,liiasmr,O
haplotypes,haplotypes,O
",",",",O
indicating,tcdinaiing,O
that,that,O
the,the,O
mutant,mutant,O
alleles,alelels,O
were,were,O
likely,lkiely,O
to,to,O
be,be,O
identical,identical,O
by,by,O
descent,dsneect,O
for,for,O
a,a,O
mutation,mutaiont,O
in,in,O
the,the,O
founder,founder,O
population,ppiluatoon,O
.,.,O
,,
The,The,O
identification,idnntoficaitie,O
of,of,O
common,common,O
BRCA1,BRCA1,O
and,and,O
BRCA2,BRCA2,O
mutations,mutntioas,O
will,will,O
facilitate,facilitate,O
carrier,icarrer,O
detection,iteoctden,O
in,in,O
French,Herncf,O
Canadian,Canadian,O
breast,breast,B
cancer,cancer,I
and,and,O
breast,breast,B
/,/,I
ovarian,ovarian,I
cancer,cancer,I
families,ifmiales,O
.,.,O
,,
Are,Are,O
Dp71,Dp71,O
and,and,O
Dp140,Dp140,O
brain,brain,O
dystrophin,dyhtrsopin,O
isoforms,msfooris,O
related,elertad,O
to,to,O
cognitive,cognitive,B
impairment,impairment,I
in,in,O
Duchenne,Duchenne,B
muscular,muscular,I
dystrophy,dystrophy,I
?,?,O
,,
Molecular,Lorlcumae,O
study,study,O
and,and,O
neuropsychological,llunopsychoroigcae,O
analysis,analysis,O
were,were,O
performed,rrpfoemed,O
concurrently,yorcnurtnelc,O
on,on,O
49,49,O
patients,satiepnt,O
with,with,O
Duchenne,Duchenne,B
muscular,muscular,I
dystrophy,dystrophy,I
(,(,O
DMD,DMD,B
),),O
in,in,O
order,order,O
to,to,O
find,find,O
a,a,O
molecular,molecular,O
explanation,tlpianaoxen,O
for,for,O
the,the,O
cognitive,cognitive,B
impairment,impairment,I
observed,oesebrvd,O
in,in,O
most,most,O
DMD,DMD,B
patients,taipsnte,O
.,.,O
,,
Complete,Cmepeotl,O
analysis,anlasiys,O
of,of,O
the,the,O
dystrophin,drsthypoin,O
gene,gene,O
was,was,O
performed,performed,O
to,to,O
define,define,O
the,the,O
localization,lolaczintioa,O
of,of,O
deletions,teoedilns,O
and,and,O
duplications,duplications,O
in,in,O
relation,irletaon,O
to,to,O
the,the,O
different,different,O
DMD,DMD,B
promoters,ptmooserr,O
.,.,O
,,
Qualitative,Qualitative,O
analysis,anaiysls,O
of,of,O
the,the,O
Dp71,7dp1,O
transcript,crnastript,O
and,and,O
testing,tseting,O
for,for,O
the,the,O
specific,sfpiceic,O
first,first,O
exon,exon,O
of,of,O
Dp140,Dp014,O
were,were,O
also,also,O
carried,carried,O
out,out,O
.,.,O
,,
Neuropsychological,Neuropsychological,O
analysis,analysis,O
assessed,assessed,O
verbal,verbal,O
and,and,O
visuospatial,vatousplsiai,O
intelligence,ltneliicgnee,O
",",",",O
verbal,verbal,O
memory,meomry,O
",",",",O
and,and,O
reading,radnieg,O
skills,skills,O
.,.,O
,,
Comparison,Oopmarisnc,O
of,of,O
molecular,lmleucoar,O
and,and,O
psychometric,yspcromitceh,O
findings,findings,O
demonstrated,demonstrated,O
that,that,O
deletions,dnlesiteo,O
and,and,O
duplications,aupiiclndots,O
that,that,O
were,were,O
localized,lacelozid,O
in,in,O
the,the,O
distal,diastl,O
part,rpat,O
of,of,O
the,the,O
gene,egne,O
seemed,seemed,O
to,to,O
be,be,O
preferentially,preferentially,O
associated,associated,O
with,with,O
cognitive,cognitive,B
impairment,impairment,I
.,.,O
,,
Two,Two,O
altered,retaeld,O
Dp71,P7d1,O
transcripts,transcripts,O
and,and,O
two,two,O
deleted,deedtle,O
Dp140,Dp140,O
DNA,DNA,O
sequences,csquenese,O
were,were,O
found,found,O
in,in,O
four,frou,O
patients,patients,O
with,with,O
severe,srveee,O
cerebral,cerebral,B
dysfunction,dysfunction,I
.,.,O
,,
These,Sheet,O
findings,findings,O
suggest,suggest,O
that,that,O
some,some,O
sequences,ssqueceen,O
located,elcaotd,O
in,in,O
the,the,O
distal,distal,O
part,trap,O
of,of,O
the,the,O
gene,gene,O
and,and,O
",",",",O
in,in,O
particular,iarlprutac,O
",",",",O
some,some,O
DMD,DMD,B
isoforms,msiforos,O
expressed,prexesesd,O
in,in,O
the,the,O
brain,abrin,O
may,may,O
be,be,O
related,rdeatel,O
to,to,O
the,the,O
cognitive,cognitive,B
impairment,impairment,I
associated,associated,O
with,with,O
DMD,DMD,B
.,.,O
.,.,O
,,
I1307K,I10k73,O
APC,APC,O
and,and,O
hMLH1,1HLMh,O
mutations,mutations,O
in,in,O
a,a,O
non,non,O
-,-,O
Jewish,Jewish,O
family,myfila,O
with,with,O
hereditary,hereditary,B
non,non,I
-,-,I
polyposis,polyposis,I
colorectal,colorectal,I
cancer,cancer,I
.,.,O
,,
We,We,O
describe,describe,O
a,a,O
French,French,O
Canadian,Canadian,O
hereditary,hereditary,B
non,non,I
-,-,I
polyposis,polyposis,I
colorectal,colorectal,I
cancer,cancer,I
(,(,O
HNPCC,HNPCC,B
),),O
kindred,nidrked,O
which,which,O
carries,iacrrse,O
a,a,O
novel,novel,O
truncating,ttnrcauing,O
mutation,uotamitn,O
in,in,O
hMLH1,hMH1l,O
.,.,O
,,
Interestingly,Interestingly,O
",",",",O
the,the,O
I1307K,I3701K,O
APC,APC,O
polymorphism,lopyiormhpsm,O
",",",",O
associated,associated,O
with,with,O
an,an,O
increased,dicreasne,O
risk,risk,O
of,of,O
colorectal,colorectal,B
cancer,cancer,I
",",",",O
is,is,O
also,olas,O
present,present,O
in,in,O
this,this,O
family,falmiy,O
.,.,O
,,
The,The,O
I1307K,I7103K,O
polymorphism,yoopmihprlsm,O
has,has,O
previously,previously,O
only,only,O
been,been,O
identified,identified,O
in,in,O
individuals,udaividinls,O
of,of,O
self,sfel,O
-,-,O
reported,rpeorted,O
Ashkenazi,Ashkenazi,O
Jewish,Jewish,O
origins,origins,O
.,.,O
,,
In,In,O
addition,addition,O
",",",",O
in,in,O
this,this,O
family,imafly,O
",",",",O
there,there,O
appears,ppaares,O
to,to,O
be,be,O
no,no,O
relationship,hslanioretip,O
between,between,O
the,the,O
I1307K,3ki071,O
polymorphism,yolmmsrphpoi,O
and,and,O
the,the,O
presence,ersnpece,O
or,or,O
absence,cbasnee,O
of,of,O
cancer,cancer,B
.,.,O
.,.,O
,,
Identification,Ednitafciitino,O
of,of,O
a,a,O
novel,eovln,O
mutation,mutation,O
of,of,O
the,the,O
CPO,CPO,O
gene,gene,O
in,in,O
a,a,O
Japanese,Jpsenaae,O
hereditary,hereditary,B
coproporphyria,coproporphyria,I
family,limafy,O
.,.,O
,,
Hereditary,Hereditary,B
coproporphyria,coproporphyria,I
(,(,O
HCP,HCP,B
),),O
is,is,O
an,an,O
autosomal,autosomal,B
dominant,dominant,I
disease,disease,I
characterized,chraaetcrdiez,O
by,by,O
a,a,O
deficiency,deficiency,B
of,of,I
coproporphyrinogen,coproporphyrinogen,I
oxidase,oxidase,I
(,(,O
CPO,CPO,O
),),O
caused,ecusad,O
by,by,O
a,a,O
mutation,mttuoian,O
in,in,O
the,the,O
CPO,CPO,O
gene,gene,O
.,.,O
,,
Only,Only,O
11,11,O
mutations,oatutmins,O
of,of,O
the,the,O
gene,ngee,O
have,have,O
been,been,O
reported,roeertpd,O
in,in,O
HCP,HCP,B
patients,aitptnes,O
.,.,O
,,
We,We,O
report,reoptr,O
another,neathor,O
mutation,taumtion,O
in,in,O
a,a,O
Japanese,Japanese,O
family,family,O
.,.,O
,,
Polymerase,Pelysoarme,O
chain,nhaci,O
reaction,reaction,O
-,-,O
single,single,O
strand,strand,O
conformational,conformational,O
polymorphism,polymorphism,O
and,and,O
direct,direct,O
sequence,eeqenucs,O
analyses,aanlesys,O
demonstrated,demonstrated,O
a,a,O
C,C,O
to,to,O
T,T,O
substitution,substitution,O
in,in,O
exon,enxo,O
1,1,O
of,of,O
the,the,O
CPO,CPO,O
gene,eneg,O
at,at,O
nucleotide,nucleotide,O
position,poiotsni,O
85,85,O
",",",",O
which,which,O
lies,seil,O
in,in,O
the,the,O
putative,tuiatpve,O
presequence,puceeqeensr,O
for,for,O
targeting,targeting,O
to,to,O
mitochondria,mitochondria,O
.,.,O
,,
This,This,O
mutation,mttoaiun,O
changes,changes,O
the,the,O
codon,oodcn,O
for,for,O
glutamine,imunalgte,O
to,to,O
a,a,O
termination,termination,O
codon,cdoon,O
at,at,O
amino,amino,O
acid,dica,O
position,position,O
29,29,O
.,.,O
,,
MaeI,MaeI,O
restriction,restriction,O
analysis,aslnysia,O
showed,showed,O
two,two,O
other,other,O
carriers,rirrceas,O
in,in,O
the,the,O
family,lafimy,O
.,.,O
,,
The,The,O
C,C,O
-,-,O
T,T,O
mutation,mutation,O
is,is,O
located,located,O
within,within,O
a,a,O
recently,nceretly,O
proposed,propdseo,O
putative,puttiave,O
alternative,tlaertvniae,O
translation,trasanltion,O
initiation,onaiiittin,O
codon,codon,O
(,(,O
TIC,TIC,O
-,-,O
1,1,O
),),O
",",",",O
supporting,prpsoitung,O
that,that,O
TIC,TIC,O
-,-,O
1,1,O
is,is,O
the,the,O
real,rlea,O
TIC,TIC,O
rather,rather,O
than,than,O
TIC,TIC,O
-,-,O
2,2,O
.,.,O
.,.,O
,,
Human,Human,B
complement,complement,I
factor,factor,I
H,H,I
deficiency,deficiency,I
associated,aisotsaced,O
with,with,O
hemolytic,hemolytic,B
uremic,uremic,I
syndrome,syndrome,I
.,.,O
,,
This,Shti,O
study,study,O
reports,terrpos,O
on,on,O
six,six,O
cases,eacss,O
of,of,O
deficiency,deficiency,B
in,in,I
the,the,I
human,human,I
complement,complement,I
regulatory,regulatory,I
protein,protein,I
Factor,Factor,I
H,H,I
(,(,O
FH,FH,O
),),O
in,in,O
the,the,O
context,ctxteno,O
of,of,O
an,an,O
acute,acute,B
renal,renal,I
disease,disease,I
.,.,O
,,
Five,Five,O
of,of,O
the,the,O
cases,saesc,O
were,were,O
observed,rbveoesd,O
in,in,O
children,cdirheln,O
presenting,presenting,O
with,with,O
idiopathic,idiopathic,O
hemolytic,hemolytic,B
uremic,uremic,I
syndrome,syndrome,I
(,(,O
HUS,HUS,B
),),O
.,.,O
,,
Two,Two,O
of,of,O
the,the,O
children,children,O
exhibited,exhibited,O
a,a,O
homozygous,yomgzohous,O
deficiency,dieicnefcy,O
characterized,ctazacheirred,O
by,by,O
the,the,O
absence,bcsneae,O
of,of,O
the,the,O
150,150,O
-,-,O
kD,kD,O
form,fmor,O
of,of,O
Factor,Tafcor,O
H,H,O
and,and,O
the,the,O
presence,reespecn,O
",",",",O
upon,upon,O
immunoblotting,igbunoomttminl,O
",",",",O
of,of,O
the,the,O
42,42,O
-,-,O
kD,kD,O
Factor,Tocfar,O
H,H,O
-,-,O
like,like,O
protein,protein,O
1,1,O
(,(,O
FHL,FHL,O
-,-,O
1,1,O
),),O
and,and,O
other,other,O
FH,FH,O
-,-,O
related,related,O
protein,ntopeir,O
(,(,O
FHR,FHR,O
),),O
bands,bands,O
.,.,O
,,
Southern,Srunhtoe,O
blot,oblt,O
and,and,O
PCR,PCR,O
analysis,ynaalsis,O
of,of,O
DNA,DNA,O
of,of,O
one,one,O
patient,patient,O
with,with,O
homozygous,oouozyshmg,O
deficiency,icedeifncy,O
ruled,lurde,O
out,out,O
the,the,O
presence,peesnrce,O
of,of,O
a,a,O
large,large,O
deletion,oenetldi,O
of,of,O
the,the,O
FH,FH,O
gene,enge,O
as,as,O
the,the,O
underlying,urnldeying,O
defect,defect,O
for,for,O
the,the,O
deficiency,deficiency,O
.,.,O
,,
The,The,O
other,other,O
four,four,O
children,lhecnrid,O
presented,presented,O
with,with,O
heterozygous,eyzhroteuogs,O
deficiency,ecfidceniy,O
and,and,O
exhibited,eteibxihd,O
a,a,O
normal,normal,O
immunoblotting,immunoblotting,O
pattern,pattern,O
of,of,O
proteins,prntoeis,O
of,of,O
the,the,O
FH,FH,O
family,lmaify,O
.,.,O
,,
Factor,Factor,B
H,H,I
deficiency,deficiency,I
is,is,O
the,the,O
only,only,O
complement,complement,B
deficiency,deficiency,I
associated,esaocistad,O
with,with,O
HUS,HUS,B
.,.,O
,,
These,These,O
observations,observations,O
suggest,usggest,O
a,a,O
role,lero,O
for,for,O
FH,FH,O
and,and,O
/,/,O
or,or,O
FH,FH,O
receptors,repcetors,O
in,in,O
the,the,O
pathogenesis,sethoignepas,O
of,of,O
idiopathic,idiapthoic,O
HUS,HUS,B
.,.,O
.,.,O
,,
Further,Ufetrhr,O
evidence,evidence,O
for,for,O
a,a,O
major,ajmor,O
ancient,ancient,O
mutation,mutation,O
underlying,unrnyldieg,O
myotonic,myotonic,B
dystrophy,dystrophy,I
from,from,O
linkage,linkage,O
disequilibrium,disequilibrium,O
studies,stidues,O
in,in,O
the,the,O
Japanese,Naesjeap,O
population,population,O
.,.,O
,,
The,The,O
myotonic,myotonic,B
dystrophy,dystrophy,I
(,(,O
DM,DM,B
),),O
mutation,mutitnao,O
is,is,O
an,an,O
unstable,lnbtesua,O
(,(,O
CTG,CTG,O
),),O
n,n,O
repeat,repeat,O
",",",",O
present,rtepens,O
at,at,O
a,a,O
copy,ycpo,O
number,number,O
of,of,O
5,5,O
-,-,O
37,37,O
repeats,repeats,O
on,on,O
normal,nroaml,O
chromosomes,cohomrsomse,O
but,but,O
amplified,mailipfed,O
to,to,O
50,50,O
-,-,O
3000,3000,O
copies,ceoips,O
on,on,O
DM,DM,B
chromosomes,cohrmmeooss,O
.,.,O
,,
Previous,Previous,O
findings,fsndgnii,O
in,in,O
Caucasian,Caucasian,O
populations,uaiplotnops,O
of,of,O
a,a,O
DM,DM,B
founder,founder,O
chromosome,coromosemh,O
raise,raise,O
a,a,O
question,equitson,O
about,about,O
the,the,O
molecular,uolcamler,O
events,veents,O
involved,involved,O
in,in,O
the,the,O
expansion,anienspox,O
mutation,mutation,O
.,.,O
,,
To,To,O
investigate,teanstgivie,O
whether,whether,O
a,a,O
founder,fodeurn,O
chromosome,oorhmosemc,O
for,for,O
the,the,O
DM,DM,B
mutation,mutation,O
exists,sxiset,O
in,in,O
the,the,O
Japanese,Japanese,O
population,population,O
",",",",O
we,we,O
genotyped,genotyped,O
families,families,O
using,gisnu,O
polymorphic,polymorphic,O
markers,markers,O
near,near,O
the,the,O
(,(,O
CTG,CTG,O
),),O
n,n,O
repeat,reaept,O
region,oerign,O
and,and,O
constructed,constuecrtd,O
haplotypes,aohlptypes,O
.,.,O
,,
Six,Six,O
different,different,O
haplotypes,lophatpyes,O
were,were,O
found,found,O
and,and,O
DM,DM,B
alleles,allslee,O
were,were,O
always,alawys,O
haplotype,heplotypa,O
A,A,O
.,.,O
,,
To,To,O
find,find,O
an,an,O
origin,origin,O
of,of,O
the,the,O
(,(,O
CTG,CTG,O
),),O
n,n,O
repeat,rpeeat,O
mutation,mutation,O
and,and,O
to,to,O
investigate,tnvtsiigeea,O
the,the,O
mechanism,mechanism,O
of,of,O
the,the,O
expansion,eopsnaxin,O
mutation,mutation,O
in,in,O
the,the,O
Japanese,Pjaanese,O
population,popultioan,O
we,we,O
have,have,O
studied,studied,O
90,90,O
Japanese,Njapaese,O
DM,DM,B
families,lfmeaiis,O
comprising,cospnimgri,O
190,190,O
affected,effacted,O
and,and,O
130,130,O
unaffected,untffecead,O
members,members,O
.,.,O
,,
The,The,O
results,urstles,O
suggest,suggest,O
that,that,O
a,a,O
few,few,O
common,moocmn,O
ancestral,atcrsaenl,O
mutations,mutations,O
in,in,O
both,both,O
Caucasian,Aaacuscin,O
and,and,O
Japanese,Aejpnase,O
populations,nopioatulps,O
have,have,O
originated,nrdgioaeti,O
by,by,O
expansion,exsanpnio,O
of,of,O
an,an,O
ancestral,ancestral,O
n,n,O
=,=,O
5,5,O
repeat,repeat,O
to,to,O
n,n,O
=,=,O
19,19,O
-,-,O
37,37,O
copies,copesi,O
.,.,O
,,
These,These,O
data,data,O
support,prspuot,O
multistep,mtetislup,O
models,meodls,O
of,of,O
triplet,triplet,O
repeat,peraet,O
expansion,nxanpsioe,O
that,that,O
have,have,O
been,been,O
proposed,proposed,O
for,for,O
both,both,O
DM,DM,B
and,and,O
Friedreichs,Friedreichs,B
ataxia,ataxia,I
.,.,O
.,.,O
,,
The,The,O
molecular,loelcuamr,O
basis,basis,O
of,of,O
C6,C6,B
deficiency,deficiency,I
in,in,O
the,the,O
western,western,O
Cape,Paec,O
",",",",O
South,Touhs,O
Africa,Africa,O
.,.,O
,,
Deficiency,Deficiency,B
of,of,I
the,the,I
sixth,sixth,I
component,component,I
of,of,I
human,human,I
complement,complement,I
(,(,O
C6,C6,O
),),O
has,has,O
been,been,O
reported,reporetd,O
in,in,O
a,a,O
number,uembnr,O
of,of,O
families,families,O
from,from,O
the,the,O
western,tenwers,O
Cape,Pcae,O
",",",",O
South,South,O
Africa,Aarfci,O
.,.,O
,,
Meningococcal,Meningococcal,B
disease,disease,I
is,is,O
endemic,dnmeeic,O
in,in,O
the,the,O
Cape,Apce,O
and,and,O
almost,almost,O
all,all,O
pedigrees,preigedes,O
of,of,O
total,otatl,O
C6,C6,B
deficiency,deficiency,I
(,(,O
C6Q0,C6Q0,O
),),O
have,have,O
been,been,O
ascertained,stceiearnad,O
because,because,O
of,of,O
recurrent,recurrent,O
disease,disease,O
.,.,O
,,
We,We,O
have,have,O
sequenced,sequenced,O
the,the,O
expressed,pxdreeses,O
exons,exons,O
of,of,O
the,the,O
C6,C6,O
gene,gene,O
from,from,O
selected,scldeeet,O
cases,cases,O
and,and,O
have,have,O
found,found,O
three,three,O
molecular,eolmalucr,O
defects,ceeftds,O
leading,leading,O
to,to,O
total,tatol,O
deficiency,difycneeci,O
879delG,l7de98G,O
",",",",O
which,which,O
is,is,O
the,the,O
common,common,O
defect,fecedt,O
in,in,O
the,the,O
Cape,Acep,O
and,and,O
hitherto,hitherto,O
unreported,unreported,O
",",",",O
and,and,O
1195delC,1195delC,O
and,and,O
1936delG,1936delG,O
",",",",O
which,which,O
have,have,O
been,been,O
previously,previously,O
reported,reported,O
in,in,O
African,Anricaf,O
-,-,O
Americans,Americans,O
.,.,O
,,
We,We,O
also,also,O
show,show,O
that,that,O
the,the,O
879delG,l8ed97G,O
and,and,O
1195delC,1195delC,O
defects,cetesfd,O
are,are,O
associated,atsocadsei,O
with,with,O
characteristic,rchaaciersttic,O
C6,C6,O
/,/,O
C7,C7,O
region,ogeirn,O
DNA,DNA,O
marker,marker,O
haplotypes,hapeotspyl,O
",",",",O
although,uoghlath,O
small,small,O
variations,variations,O
were,were,O
observed,drsevbeo,O
.,.,O
,,
The,The,O
1936delG,9ed631lG,O
defect,defect,O
was,was,O
observed,oerebvsd,O
only,only,O
once,once,O
in,in,O
the,the,O
Cape,Pcae,O
",",",",O
but,but,O
its,its,O
associated,essoictaad,O
haplotype,hppolayte,O
could,could,O
be,be,O
deduced,deduced,O
.,.,O
,,
The,The,O
data,atad,O
from,from,O
the,the,O
haplotypes,haplotypes,O
indicate,indicate,O
that,that,O
these,these,O
three,three,O
molecular,rlceluoam,O
defects,eectfds,O
account,utaocnc,O
for,for,O
the,the,O
defects,cfedets,O
in,in,O
all,all,O
the,the,O
38,38,O
unrelated,utrenelad,O
C6Q0,C6Q0,O
individuals,iulisadnidv,O
we,we,O
have,have,O
studied,diudtse,O
from,from,O
the,the,O
Cape,Acep,O
.,.,O
,,
We,We,O
have,have,O
also,also,O
observed,observed,O
the,the,O
879delG,879edlG,O
defect,tedecf,O
in,in,O
two,two,O
Dutch,Dutch,O
C6,C6,B
-,-,I
deficient,deficient,I
kindreds,eindrkds,O
",",",",O
but,but,O
the,the,O
879delG,879delG,O
defect,edfcet,O
in,in,O
the,the,O
Cape,Pcae,O
probably,raoblbpy,O
did,did,O
not,not,O
come,come,O
from,from,O
The,The,O
Netherlands,Rethsnnaedl,O
.,.,O
.,.,O
,,
Complement,Complement,B
C7,C7,I
deficiency,deficiency,I
:,:,O
seven,seven,O
further,further,O
molecular,moueallcr,O
defects,tcfeeds,O
and,and,O
their,their,O
associated,associated,O
marker,ekramr,O
haplotypes,haplotypes,O
.,.,O
,,
Seven,Seven,O
further,further,O
molecular,mocelualr,O
bases,ssbea,O
of,of,O
C7,C7,B
deficiency,deficiency,I
are,are,O
described,drdciebes,O
.,.,O
,,
All,All,O
these,these,O
new,new,O
molecular,mlloucear,O
defects,defects,O
involve,involve,O
single,single,O
-,-,O
nucleotide,nicloetedu,O
events,eevtns,O
",",",",O
deletions,eeostilnd,O
and,and,O
substitutions,oubsitiutssnt,O
",",",",O
some,some,O
of,of,O
which,which,O
alter,alter,O
splice,pilsce,O
sites,sties,O
",",",",O
and,and,O
others,others,O
codons,codons,O
.,.,O
,,
They,They,O
are,are,O
distributed,tdedritubsi,O
along,along,O
the,the,O
C7,C7,O
gene,nege,O
",",",",O
but,but,O
predominantly,irtdlmpyaneon,O
towards,twroads,O
the,the,O
3,3,O
end,end,O
.,.,O
,,
All,All,O
were,were,O
found,nfuod,O
in,in,O
compound,compound,O
heterozygous,heoertusgzoy,O
individuals,ivduindails,O
.,.,O
,,
The,The,O
C6,C6,O
/,/,O
C7,C7,O
marker,mraker,O
haplotypes,lapthoypes,O
associated,associated,O
with,with,O
most,most,O
C7,C7,B
defects,defects,I
are,are,O
tabulated,teaulatbd,O
.,.,O
.,.,O
,,
A,A,O
genome,genome,O
-,-,O
wide,wide,O
search,search,O
for,for,O
chromosomal,loaomoshcrm,O
loci,loci,O
linked,linked,O
to,to,O
mental,emnlat,O
health,health,O
wellness,weesnlls,O
in,in,O
relatives,rleeaivts,O
at,at,O
high,ghih,O
risk,risk,O
for,for,O
bipolar,bipolar,B
affective,affective,I
disorder,disorder,I
among,among,O
the,the,O
Old,Old,O
Order,Roder,O
Amish,Amish,O
.,.,O
,,
Bipolar,Bipolar,B
affective,affective,I
disorder,disorder,I
(,(,O
BPAD,BPAD,B
;,;,O
manic,manic,B
-,-,I
depressive,depressive,I
illness,illness,I
),),O
is,is,O
characterized,zhatrcaeriecd,O
by,by,O
episodes,epoediss,O
of,of,O
mania,mania,B
and,and,O
/,/,O
or,or,O
hypomania,hypomania,B
interspersed,rntprsesieed,O
with,with,O
periods,sroiedp,O
of,of,O
depression,depression,B
.,.,O
,,
Compelling,Compelling,O
evidence,ivedncee,O
supports,supports,O
a,a,O
significant,significant,O
genetic,iegetnc,O
component,component,O
in,in,O
the,the,O
susceptibility,ssupecitbiilty,O
to,to,O
develop,edlveop,O
BPAD,BPAD,B
.,.,O
,,
To,To,O
date,date,O
",",",",O
however,vwheoer,O
",",",",O
linkage,niakgle,O
studies,seduist,O
have,have,O
attempted,attempted,O
only,only,O
to,to,O
identify,yifntied,O
chromosomal,chloosmamor,O
loci,loci,O
that,that,O
cause,cause,O
or,or,O
increase,inacrese,O
the,the,O
risk,risk,O
of,of,O
developing,developing,O
BPAD,BPAD,B
.,.,O
,,
To,To,O
determine,determine,O
whether,whether,O
there,there,O
could,could,O
be,be,O
protective,protective,O
alleles,lelales,O
that,that,O
prevent,pvnteer,O
or,or,O
reduce,reduce,O
the,the,O
risk,srik,O
of,of,O
developing,digelopenv,O
BPAD,BPAD,B
",",",",O
similar,similar,O
to,to,O
what,what,O
is,is,O
observed,observed,O
in,in,O
other,other,O
genetic,genetic,B
disorders,disorders,I
",",",",O
we,we,O
used,used,O
mental,lemtan,O
health,health,O
wellness,wellness,O
(,(,O
absence,absence,O
of,of,O
any,any,O
psychiatric,psychiatric,B
disorder,disorder,I
),),O
as,as,O
the,the,O
phenotype,phteonyep,O
in,in,O
our,our,O
genome,egnmoe,O
-,-,O
wide,wide,O
linkage,linkage,O
scan,scan,O
of,of,O
several,several,O
large,large,O
multigeneration,multigeneration,O
Old,Old,O
Order,Oerrd,O
Amish,Amish,O
pedigrees,pridgeees,O
exhibiting,exhibiting,O
an,an,O
extremely,extremely,O
high,high,O
incidence,incidence,O
of,of,O
BPAD,BPAD,B
.,.,O
,,
We,We,O
have,have,O
found,found,O
strong,strong,O
evidence,evidence,O
for,for,O
a,a,O
locus,locus,O
on,on,O
chromosome,ceoohrsomm,O
4p,4p,O
at,at,O
D4S2949,D942s49,O
(,(,O
maximum,mxaimum,O
GENEHUNTER,GENEHUNTER,O
-,-,O
PLUS,PLUS,O
nonparametric,nonparametric,O
linkage,linkage,O
score,reosc,O
=,=,O
4,4,O
.,.,O
05,05,O
",",",",O
P,P,O
=,=,O
5,5,O
.,.,O
22,22,O
x,x,O
10,10,O
(,(,O
-,-,O
4,4,O
),),O
;,;,O
SIBPAL,SIBPAL,O
Pempirical,Eprpimical,O
value,ulave,O
<,<,O
3,3,O
x,x,O
10,10,O
(,(,O
-,-,O
5,5,O
),),O
),),O
and,and,O
suggestive,suggestive,O
evidence,neidevce,O
for,for,O
a,a,O
locus,locus,O
on,on,O
chromosome,shormmcooe,O
4q,4q,O
at,at,O
D4S397,D4S397,O
(,(,O
maximum,maximum,O
GENEHUNTER,EEENHUGTNR,O
-,-,O
PLUS,PLUS,O
nonparametric,nonparametric,O
linkage,linkage,O
score,score,O
=,=,O
3,3,O
.,.,O
29,29,O
",",",",O
P,P,O
=,=,O
2,2,O
.,.,O
57,57,O
x,x,O
10,10,O
(,(,O
-,-,O
3,3,O
,,
),),O
;,;,O
SIBPAL,SIBPAL,O
Pempirical,Prcmieipal,O
value,value,O
<,<,O
1,1,O
x,x,O
10,10,O
(,(,O
-,-,O
3,3,O
),),O
),),O
that,that,O
are,are,O
linked,lienkd,O
to,to,O
mental,emnatl,O
health,telahh,O
wellness,wellness,O
.,.,O
,,
These,These,O
findings,findings,O
are,are,O
consistent,cisntsoent,O
with,with,O
the,the,O
hypothesis,hypothesis,O
that,that,O
certain,ceatrin,O
alleles,aselell,O
could,could,O
prevent,prevent,O
or,or,O
modify,mfoidy,O
the,the,O
clinical,cciinlal,O
manifestations,ainmiestatfons,O
of,of,O
BPAD,BPAD,B
and,and,O
perhaps,perhaps,O
other,other,O
related,ereatld,O
affective,affective,B
disorders,disorders,I
.,.,O
,,
Segregation,Rasgegeiton,O
distortion,distortion,O
in,in,O
myotonic,myotonic,B
dystrophy,dystrophy,I
.,.,O
,,
Myotonic,Myotonic,B
dystrophy,dystrophy,I
(,(,O
DM,DM,B
),),O
is,is,O
an,an,O
autosomal,autosomal,B
dominant,dominant,I
disease,disease,I
which,which,O
",",",",O
in,in,O
the,the,O
typical,typical,O
pedigree,pedigree,O
",",",",O
shows,whsos,O
a,a,O
three,three,O
generation,tgeeranion,O
anticipation,aiitcipanton,O
cascade,aasccde,O
.,.,O
,,
This,Hits,O
results,tlruess,O
in,in,O
infertility,infertility,B
and,and,O
congenital,congenital,B
myotonic,myotonic,I
dystrophy,dystrophy,I
(,(,O
CDM,CDM,B
),),O
with,with,O
the,the,O
disappearance,ipsacaeardnpe,O
of,of,O
DM,DM,B
in,in,O
that,that,O
pedigree,ieegprde,O
.,.,O
,,
The,The,O
concept,nccoept,O
of,of,O
segregation,segregation,O
distortion,odstirtion,O
",",",",O
where,where,O
there,there,O
is,is,O
preferential,eaefptenrirl,O
transmission,tionsmrssian,O
of,of,O
the,the,O
larger,lgearr,O
allele,allele,O
at,at,O
the,the,O
DM,DM,B
locus,ulcos,O
",",",",O
has,has,O
been,been,O
put,put,O
forward,forward,O
to,to,O
explain,axplein,O
partially,paitlylra,O
the,the,O
maintenance,maintenance,O
of,of,O
DM,DM,B
in,in,O
the,the,O
population,popluaitno,O
.,.,O
,,
In,In,O
a,a,O
survey,survey,O
of,of,O
DM,DM,B
in,in,O
Northern,Erotnhrn,O
Ireland,Ileanrd,O
",",",",O
59,59,O
pedigrees,deirgpees,O
were,were,O
ascertained,aceertiasnd,O
.,.,O
,,
Sibships,Hsbsiips,O
where,where,O
the,the,O
status,status,O
of,of,O
all,all,O
the,the,O
members,sebmrem,O
had,had,O
been,been,O
identified,inedtiiefd,O
were,were,O
examined,xedmniea,O
to,to,O
determine,edetrmine,O
the,the,O
transmission,trasnmssiion,O
of,of,O
the,the,O
DM,DM,B
expansion,exposinan,O
from,from,O
affected,affected,O
parents,naterps,O
to,to,O
their,their,O
offspring,offspring,O
.,.,O
,,
Where,Ehewr,O
the,the,O
transmitting,transmitting,O
parent,napert,O
was,was,O
male,male,O
",",",",O
58,58,O
.,.,O
,,
3,3,O
%,%,O
of,of,O
the,the,O
offspring,rsffpniog,O
were,were,O
affected,dcefftea,O
",",",",O
and,and,O
in,in,O
the,the,O
case,esac,O
of,of,O
a,a,O
female,mlfaee,O
transmitting,transmitting,O
parent,eaprnt,O
",",",",O
68,68,O
.,.,O
,,
7,7,O
%,%,O
were,were,O
affected,ecfeatfd,O
.,.,O
,,
Studies,Deustis,O
on,on,O
meiotic,meiotic,O
drive,drive,O
in,in,O
DM,DM,B
have,have,O
shown,snohw,O
increased,snereacid,O
transmission,roansimsistn,O
of,of,O
the,the,O
larger,lerrag,O
allele,lelale,O
at,at,O
the,the,O
DM,DM,B
locus,csluo,O
in,in,O
non,non,O
-,-,O
DM,DM,O
heterozygotes,heterozygotes,O
for,for,O
CTGn,CTGn,O
.,.,O
,,
This,This,O
study,study,O
provides,porsediv,O
further,further,O
evidence,evidence,O
that,that,O
the,the,O
DM,DM,B
expansion,expansion,O
tends,tends,O
to,to,O
be,be,O
transmitted,trtnsmitaed,O
preferentially,perfyrentillae,O
.,.,O
,,
Diagnosis,Giasnidos,O
of,of,O
hemochromatosis,hemochromatosis,B
.,.,O
,,
If,If,O
untreated,unarteted,O
",",",",O
hemochromatosis,hemochromatosis,B
can,can,O
cause,eaucs,O
serious,seuiors,O
illness,sllnesi,O
and,and,O
early,early,B
death,death,I
",",",",O
but,but,O
the,the,O
disease,disease,O
is,is,O
still,still,O
substantially,substantially,O
under,under,O
-,-,O
diagnosed,endgiosda,O
.,.,O
,,
The,The,O
cornerstone,cornerstone,O
of,of,O
screening,screening,O
and,and,O
case,eacs,O
detection,detection,O
is,is,O
the,the,O
measurement,measurement,O
of,of,O
serum,esurm,O
transferrin,efsnartrrin,O
saturation,saturation,O
and,and,O
the,the,O
serum,sruem,O
ferritin,rieritfn,O
level,lleve,O
.,.,O
,,
Once,Once,O
the,the,O
diagnosis,doagsiins,O
is,is,O
suspected,esuspcted,O
",",",",O
physicians,physicians,O
must,must,O
use,use,O
serum,seumr,O
ferritin,ferritin,O
levels,lvlees,O
and,and,O
hepatic,hpietac,O
iron,iron,O
stores,stores,O
on,on,O
liver,liver,O
biopsy,syopbi,O
specimens,ssecmeinp,O
to,to,O
assess,assess,O
patients,patients,O
for,for,O
the,the,O
presence,peersnce,O
of,of,O
iron,iron,B
overload,overload,I
.,.,O
,,
Liver,Liver,O
biopsy,bipsoy,O
is,is,O
also,also,O
used,used,O
to,to,O
establish,establish,O
the,the,O
presence,rpseence,O
or,or,O
absence,absence,O
of,of,O
cirrhosis,cirrhosis,B
",",",",O
which,which,O
can,can,O
affect,aftcef,O
prognosis,pgoinsors,O
and,and,O
management,mtnmeeagna,O
.,.,O
,,
A,A,O
DNA,DNA,O
-,-,O
based,easdb,O
test,stet,O
for,for,O
the,the,O
HFE,HFE,O
gene,ngee,O
is,is,O
commercially,comlrecmialy,O
available,lvablaiae,O
",",",",O
but,but,O
its,its,O
place,ealcp,O
in,in,O
the,the,O
diagnosis,diagnosis,O
of,of,O
hemochromatosis,hemochromatosis,B
is,is,O
still,slitl,O
being,being,O
evaluated,evaluated,O
.,.,O
,,
Currently,Ucnrerlty,O
",",",",O
the,the,O
most,most,O
useful,uesufl,O
role,lroe,O
for,for,O
this,this,O
test,test,O
is,is,O
in,in,O
the,the,O
detection,tcteideon,O
of,of,O
hemochromatosis,hemochromatosis,B
in,in,O
the,the,O
family,mafliy,O
members,mrebmes,O
of,of,O
patients,patients,O
with,with,O
a,a,O
proven,proven,O
case,case,O
of,of,O
the,the,O
disease,saiedse,O
.,.,O
,,
It,It,O
is,is,O
crucial,crucial,O
to,to,O
diagnose,diagnose,O
hemochromatosis,hemochromatosis,B
before,before,O
hepatic,hepatic,B
cirrhosis,cirrhosis,I
develops,deveospl,O
because,because,O
phlebotomy,phlebotomy,O
therapy,therapy,O
can,can,O
avert,avert,O
serious,isesour,O
chronic,chronic,O
disease,saseied,O
and,and,O
can,can,O
even,eevn,O
lead,elda,O
to,to,O
normal,aonmrl,O
life,life,O
expectancy,pcxeetancy,O
.,.,O
.,.,O
,,
Prevalence,Nrevaelpce,O
of,of,O
the,the,O
I1307K,I1307K,O
APC,APC,B
gene,neeg,O
variant,variant,O
in,in,O
Israeli,Liraies,O
Jews,Jews,O
of,of,O
differing,dieffirng,O
ethnic,ithnce,O
origin,origin,O
and,and,O
risk,risk,O
for,for,O
colorectal,colorectal,B
cancer,cancer,I
.,.,O
,,
BACKGROUND,BACKGROUND,O
&,&,O
AIMS,AIMS,O
Israeli,Liearsi,O
Jews,Eswj,O
of,of,O
European,European,O
birth,btirh,O
",",",",O
i,i,O
.,.,O
e,e,O
.,.,O
",",",",O
Ashkenazim,Ashzinekam,O
",",",",O
have,have,O
the,the,O
highest,highest,O
colorectal,colorectal,B
cancer,cancer,I
incidence,iccndinee,O
of,of,O
any,any,O
Israeli,Israeli,O
ethnic,tehinc,O
group,group,O
.,.,O
,,
The,The,O
I1307K,310i7K,O
APC,APC,B
gene,gene,O
variant,vrtinaa,O
was,was,O
found,uonfd,O
in,in,O
6,6,O
.,.,O
,,
1,1,O
%,%,O
of,of,O
American,Aeraicmn,O
Jews,Wjes,O
",",",",O
28,28,O
%,%,O
of,of,O
their,their,O
familial,lamifail,O
colorectal,colorectal,B
cancer,cancer,I
cases,eacss,O
",",",",O
but,but,O
not,not,O
in,in,O
non,non,O
-,-,O
Jews,Jews,O
.,.,O
,,
We,We,O
assessed,assessed,O
the,the,O
I1307K,I1307K,O
prevalence,lveraepnce,O
in,in,O
Israeli,Israeli,O
Jews,Ewjs,O
of,of,O
differing,eiffirdgn,O
ethnic,ethnic,O
origin,rogiin,O
and,and,O
risk,kirs,O
for,for,O
colorectal,colorectal,B
cancer,cancer,I
.,.,O
,,
METHODS,METHODS,O
DNA,DNA,O
samples,samples,O
from,from,O
500,500,O
unrelated,ulrtneaed,O
Jews,Swej,O
of,of,O
European,Ueorpnae,O
or,or,O
non,non,O
-,-,O
European,Eueopnra,O
origin,iorgin,O
",",",",O
with,with,O
or,or,O
without,uwttoih,O
a,a,O
personal,personal,O
and,and,O
/,/,O
or,or,O
family,family,O
history,ristohy,O
of,of,O
neoplasia,neoplasia,B
",",",",O
were,were,O
examined,examined,O
for,for,O
the,the,O
I1307K,7310iK,O
variant,vtiraan,O
by,by,O
the,the,O
allele,allele,O
-,-,O
specific,specific,O
oligonucleotide,oegiliucdootnle,O
(,(,O
ASO,ASO,O
),),O
method,method,O
.,.,O
,,
RESULTS,TESLSRU,O
In,In,O
persons,persons,O
at,at,O
average,vgaraee,O
risk,risk,O
for,for,O
colorectal,colorectal,B
cancer,cancer,I
",",",",O
I1307K,3170iK,O
was,was,O
found,found,O
in,in,O
5,5,O
.,.,O
,,
0,0,O
%,%,O
of,of,O
120,120,O
European,Nuroeepa,O
and,and,O
1,1,O
.,.,O
,,
6,6,O
%,%,O
of,of,O
188,188,O
non,non,O
-,-,O
European,Nureepao,O
Jews,Wjes,O
(,(,O
P,P,O
=,=,O
0,0,O
.,.,O
08,08,O
),),O
.,.,O
,,
It,It,O
occurred,uecorrcd,O
in,in,O
15,15,O
.,.,O
,,
4,4,O
%,%,O
of,of,O
52,52,O
Ashkenazi,Aakhesnzi,O
Israelis,Ilasesir,O
with,with,O
familial,fmllaiai,O
cancer,cancer,B
(,(,O
P,P,O
=,=,O
0,0,O
.,.,O
02,02,O
),),O
and,and,O
was,was,O
not,not,O
detected,eetectdd,O
in,in,O
51,51,O
non,non,O
-,-,O
European,Uproeaen,O
Jews,Jews,O
at,at,O
increased,inardesce,O
cancer,cancer,B
risk,risk,O
.,.,O
,,
Colorectal,Colorectal,B
neoplasia,neoplasia,I
occurred,occurred,O
personally,pellorasny,O
or,or,O
in,in,O
the,the,O
families,families,O
of,of,O
13,13,O
of,of,O
20,20,O
Ashkenazi,Ksaahnezi,O
I1307K,7i301K,O
carriers,rcraires,O
",",",",O
8,8,O
of,of,O
whom,whom,O
also,lsao,O
had,had,O
a,a,O
personal,poearnsl,O
or,or,O
family,mlfiay,O
history,history,O
of,of,O
noncolonic,noccoolnin,O
neoplasia,neoplasia,B
.,.,O
,,
CONCLUSIONS,NCSOLUSICNO,O
The,The,O
I1307K,I310k7,O
APC,APC,O
variant,nriaavt,O
may,may,O
represent,represent,O
a,a,O
susceptibility,susceptibility,O
gene,gene,O
for,for,O
colorectal,colorectal,B
",",",",I
or,or,I
other,other,I
",",",",I
cancers,cancers,I
in,in,O
Ashkenazi,Sahknzaei,O
Jews,Jews,O
",",",",O
and,and,O
partially,partially,O
explains,exalpins,O
the,the,O
higher,higher,O
incidence,cinidence,O
of,of,O
colorectal,colorectal,B
cancer,cancer,I
in,in,O
European,European,O
Israelis,Srsleaii,O
.,.,O
,,
Systematic,Systematic,O
analysis,anslyais,O
of,of,O
coproporphyrinogen,coproporphyrinogen,O
oxidase,osedixa,O
gene,gene,O
defects,dfeetcs,O
in,in,O
hereditary,hereditary,B
coproporphyria,coproporphyria,I
and,and,O
mutation,mutation,O
update,apudte,O
.,.,O
,,
Hereditary,Hereditary,B
coproporphyria,coproporphyria,I
(,(,O
HC,HC,B
),),O
is,is,O
an,an,O
acute,acute,O
hepatic,hepatic,B
porphyria,porphyria,I
with,with,O
autosomal,oatoasmul,O
dominant,dominant,O
inheritance,rnaetinhice,O
caused,easucd,O
by,by,O
deficient,deficient,B
activity,activity,I
of,of,I
coproporphyrinogen,coproporphyrinogen,I
III,III,I
oxidase,oxidase,I
(,(,O
CPO,CPO,O
),),O
.,.,O
,,
Clinical,Clinical,O
manifestations,essafmntaoitni,O
of,of,O
the,the,O
disease,disease,O
are,are,O
characterized,crhrzcteaaied,O
by,by,O
acute,autce,O
attacks,attacks,O
of,of,O
neurological,neurological,B
dysfunction,dysfunction,I
often,often,O
precipitated,prcipietated,O
by,by,O
drugs,drugs,O
",",",",O
fasting,ftsiagn,O
",",",",O
cyclical,cyclical,O
hormonal,hormonal,O
changes,enacghs,O
",",",",O
or,or,O
infectious,infectious,B
diseases,diseases,I
.,.,O
,,
Skin,Skin,O
photosensitivity,photosensitivity,O
may,may,O
also,soal,O
be,be,O
present,esrepnt,O
.,.,O
,,
The,The,O
seven,seven,O
exons,eonxs,O
",",",",O
the,the,O
exon,exon,O
/,/,O
intron,intron,O
boundaries,boundaries,O
and,and,O
part,part,O
of,of,O
3,3,O
noncoding,noncoding,O
sequence,seecunqe,O
of,of,O
the,the,O
CPO,CPO,O
gene,enge,O
were,were,O
systematically,systematically,O
analyzed,analyzed,O
by,by,O
an,an,O
exon,neox,O
-,-,O
by,by,O
-,-,O
exon,oexn,O
denaturing,denaturing,O
gradient,gradient,O
gel,gel,O
electrophoresis,erhtelopeorcsis,O
(,(,O
DGGE,DGGE,O
),),O
strategy,strategy,O
followed,lwfeoold,O
by,by,O
direct,direct,O
sequencing,sequencing,O
in,in,O
seven,seven,O
unrelated,tnaelreud,O
heterozygous,heterozygous,O
HC,HC,B
patients,napitets,O
from,from,O
France,France,O
",",",",O
Holland,Holland,O
",",",",O
and,and,O
Czech,Hezcc,O
Republic,Republic,O
.,.,O
,,
Seven,Seven,O
novel,eolnv,O
mutations,mutations,O
and,and,O
two,two,O
new,new,O
polymorphisms,poomylrhsipms,O
were,were,O
detected,eeddttec,O
.,.,O
,,
Among,Onamg,O
these,these,O
mutations,mutations,O
two,two,O
are,are,O
missense,missense,O
(,(,O
G197W,Gw179,O
",",",",O
W427R,W427R,O
),),O
",",",",O
two,two,O
are,are,O
nonsense,nonsense,O
(,(,O
Q306X,Q306X,O
",",",",O
Q385X,Q385X,O
),),O
",",",",O
two,two,O
are,are,O
small,small,O
deletions,deletions,O
(,(,O
662de14bp,662de14bp,O
;,;,O
1168del3bp,e168dbl31p,O
removing,vegroinm,O
a,a,O
glycine,glycine,O
at,at,O
position,otsiniop,O
390,390,O
),),O
",",",",O
and,and,O
one,one,O
is,is,O
a,a,O
splicing,splicing,O
mutation,mutation,O
(,(,O
IVS1,1VIs,O
-,-,O
15c,15c,O
-,-,O
-,-,O
>,>,O
g,g,O
),),O
which,which,O
creates,cretaes,O
a,a,O
new,new,O
acceptor,acopcter,O
splice,scpile,O
site,esti,O
.,.,O
,,
The,The,O
pathological,pathological,O
significance,isgiafccinne,O
of,of,O
the,the,O
point,ioptn,O
mutations,ttmuaions,O
G197W,9g17W,O
",",",",O
W427R,W427R,O
",",",",O
and,and,O
the,the,O
in,in,O
-,-,O
frame,frame,O
deletion,deletion,O
390delGly,el9d3lG0y,O
were,were,O
assessed,essessad,O
by,by,O
their,their,O
respective,respective,O
expression,expression,O
in,in,O
a,a,O
prokaryotic,prokaryotic,O
system,system,O
using,using,O
site,stei,O
-,-,O
directed,dcreteid,O
mutagenesis,etuasenigms,O
.,.,O
,,
These,These,O
mutations,mutations,O
resulted,rtslueed,O
in,in,O
the,the,O
absence,absence,O
or,or,O
a,a,O
dramatic,drcmtiaa,O
decrease,edcsaere,O
of,of,O
CPO,CPO,O
activity,aitcivty,O
.,.,O
,,
The,The,O
two,two,O
polymorphisms,polymorphisms,O
were,were,O
localized,localized,O
in,in,O
noncoding,noncoding,O
part,tpra,O
of,of,O
the,the,O
gene,gene,O
1,1,O
),),O
a,a,O
C,C,O
/,/,O
G,G,O
polymorphism,orlymsiphopm,O
in,in,O
the,the,O
promotor,rrtooomp,O
region,genior,O
",",",",O
142,142,O
bp,bp,O
upstream,upstream,O
from,from,O
the,the,O
transcriptional,transcriptional,O
initiation,oniitatiin,O
site,iset,O
(,(,O
-,-,O
142C,142C,O
/,/,O
G,G,O
),),O
",",",",O
and,and,O
2,2,O
),),O
a,a,O
6,6,O
bp,bp,O
deletion,dnleotie,O
polymorphism,polymihrpsom,O
in,in,O
the,the,O
3,3,O
noncoding,nindcoong,O
part,part,O
of,of,O
the,the,O
CPO,CPO,O
gene,gene,O
",",",",O
574,574,O
bp,bp,O
downstream,downstream,O
of,of,O
the,the,O
last,last,O
base,base,O
of,of,O
the,the,O
normal,normal,O
termination,termination,O
codon,codon,O
(,(,O
+,+,O
574,574,O
delATTCTT,tleADTTCT,O
),),O
.,.,O
,,
Five,Ivfe,O
intragenic,nitnageric,O
dimorphisms,dimorphisms,O
are,are,O
now,now,O
well,lwel,O
characterized,chtadceerizra,O
and,and,O
the,the,O
high,high,O
degree,degree,O
of,of,O
allelic,ellalic,O
heterogeneity,heterogeneity,O
in,in,O
HC,HC,B
is,is,O
demonstrated,dntoeetrasmd,O
with,with,O
seven,nsvee,O
new,new,O
different,different,O
mutations,mutations,O
making,mgnika,O
a,a,O
total,toatl,O
of,of,O
nineteen,ninentee,O
CPO,CPO,O
gene,gene,B
defects,defects,I
reported,reported,O
so,so,O
far,far,O
.,.,O
.,.,O
,,
Coincidence,Cnodcicenie,O
of,of,O
two,two,O
novel,nlevo,O
arylsulfatase,arylsulfatase,O
A,A,O
alleles,alleles,O
and,and,O
mutation,outitamn,O
459,459,O
+,+,O
1G,1G,O
>,>,O
A,A,O
within,within,O
a,a,O
family,yaimlf,O
with,with,O
metachromatic,metachromatic,B
leukodystrophy,leukodystrophy,I
:,:,O
molecular,louealmcr,O
basis,basis,O
of,of,O
phenotypic,phnetopyic,O
heterogeneity,tiyegoreneeth,O
.,.,O
,,
In,In,O
a,a,O
family,family,O
with,with,O
three,ehetr,O
siblings,siblings,O
",",",",O
one,one,O
developed,developed,O
classical,classical,O
late,atle,O
infantile,infnetila,O
metachromatic,metachromatic,B
leukodystrophy,leukodystrophy,I
(,(,O
MLD,MLD,B
),),O
",",",",O
fatal,fatal,O
at,at,O
age,age,O
5,5,O
years,years,O
",",",",O
with,with,O
deficient,deficient,O
arylsulfatase,araluslfyteas,O
A,A,O
(,(,O
ARSA,AASR,O
),),O
activity,yctiaivt,O
and,and,O
increased,secreanid,O
galactosylsulfatide,icllagosyalusfattde,O
(,(,O
GS,GS,O
),),O
excretion,excretion,O
.,.,O
,,
The,The,O
two,two,O
other,other,O
siblings,siblings,O
",",",",O
apparently,aynapeptlr,O
healthy,hehtyal,O
at,at,O
12,12,O
(,(,O
1,1,O
/,/,O
2,2,O
),),O
and,and,O
15,15,O
years,years,O
",",",",O
respectively,reciestpvely,O
",",",",O
and,and,O
their,their,O
father,rathfe,O
",",",",O
apparently,apparently,O
healthy,ltaheyh,O
as,as,O
well,ewll,O
",",",",O
presented,presented,O
ARSA,RAAS,O
and,and,O
GS,GS,O
values,avsuel,O
within,within,O
the,the,O
range,argne,O
of,of,O
MLD,MLD,B
patients,iattensp,O
.,.,O
,,
Mutation,Mutation,O
screening,screening,O
and,and,O
sequence,qncueese,O
analysis,analysis,O
disclosed,disclosed,O
the,the,O
involvement,nevnlvimeot,O
of,of,O
three,hrtee,O
different,different,O
ARSA,ARSA,O
mutations,mutations,O
being,being,O
the,the,O
molecular,mulroclae,O
basis,asbis,O
of,of,O
intrafamilial,taialfnmirial,O
phenotypic,phenotypic,O
heterogeneity,heterogeneity,O
.,.,O
,,
The,The,O
late,atle,O
infantile,infantile,O
patient,iteptna,O
inherited,inherited,O
from,from,O
his,his,O
mother,mother,O
the,the,O
frequent,nreefqut,O
0,0,O
-,-,O
type,type,O
mutation,matotiun,O
459,459,O
+,+,O
1G,1G,O
>,>,O
A,A,O
",",",",O
and,and,O
from,from,O
his,his,O
father,fetrah,O
a,a,O
novel,envol,O
",",",",O
single,single,O
basepair,basepair,O
microdeletion,mioocdeleitrn,O
of,of,O
guanine,gainune,O
at,at,O
nucleotide,nucleotide,O
7,7,O
in,in,O
exon,exon,O
1,1,O
(,(,O
7delG,ldeg7,O
),),O
.,.,O
,,
The,The,O
two,two,O
clinically,liinlcalcy,O
unaffected,ueatfcefnd,O
siblings,slbiinsg,O
carried,carried,O
the,the,O
maternal,maternal,O
mutation,mutation,O
459,459,O
+,+,O
1G,1G,O
>,>,O
A,A,O
and,and,O
",",",",O
on,on,O
their,their,O
paternal,lrtepnaa,O
allele,allele,O
",",",",O
a,a,O
novel,novel,O
cytosine,eitosycn,O
to,to,O
thymidine,nyhiidmte,O
transition,transition,O
at,at,O
nucleotide,nucleotide,O
2435,4325,O
in,in,O
exon,xoen,O
8,8,O
",",",",O
resulting,resulting,O
in,in,O
substitution,substitution,O
of,of,O
alanine,aainlne,O
464,464,O
by,by,O
valine,eanilv,O
(,(,O
A464V,A464V,O
),),O
.,.,O
,,
The,The,O
fathers,eatsfhr,O
genotype,eyntoepg,O
thus,thus,O
was,was,O
7delG,7delG,O
/,/,O
A464V,A464V,O
.,.,O
,,
Mutation,Ttmaoiun,O
A464V,Va644,O
was,was,O
not,not,O
found,oufnd,O
in,in,O
18,18,O
unrelated,unrelated,O
MLD,MLD,B
patients,tepiastn,O
and,and,O
50,50,O
controls,controls,O
.,.,O
,,
A464V,A464V,O
",",",",O
although,although,O
clearly,clearly,O
modifying,minifydog,O
ARSA,SARA,O
and,and,O
GS,GS,O
levels,levels,O
",",",",O
apparently,apparently,O
bears,bears,O
little,ilttle,O
significance,isgnifacince,O
for,for,O
clinical,clicanil,O
manifestation,manifestation,O
of,of,O
MLD,MLD,B
",",",",O
mimicking,mimicking,O
the,the,O
frequent,feqtuenr,O
ARSA,ARSA,O
pseudodeficiency,pseudodeficiency,O
allele,alllee,O
.,.,O
,,
Our,Our,O
results,results,O
demonstrate,demonstrate,O
that,that,O
in,in,O
certain,iertacn,O
genetic,geitnec,O
conditions,conditions,O
MLD,MLD,B
-,-,O
like,like,O
ARSA,ARSA,O
and,and,O
GS,GS,O
values,values,O
need,edne,O
not,not,O
be,be,O
paralleled,peralealld,O
by,by,O
clinical,lainccli,O
disease,dsiease,O
",",",",O
a,a,O
finding,finding,O
with,with,O
serious,serious,O
diagnostic,dignaositc,O
and,and,O
prognostic,trogcpsoin,O
implications,impniactiols,O
.,.,O
,,
Moreover,Moreover,O
",",",",O
further,further,O
ARSA,ARSA,O
alleles,alleles,O
functionally,functionally,O
similar,silaimr,O
to,to,O
A464V,A464V,O
might,might,O
exist,xtise,O
which,which,O
",",",",O
together,gettoher,O
with,with,O
0,0,O
-,-,O
type,type,O
mutations,mittanous,O
",",",",O
may,may,O
cause,cause,O
pathological,lalohpagicot,O
ARSA,ARSA,O
and,and,O
GS,GS,O
levels,eellvs,O
",",",",O
but,but,O
not,not,O
clinical,clinical,O
outbreak,botrueak,O
of,of,O
the,the,O
disease,asdeise,O
.,.,O
.,.,O
,,
Human,Human,O
MLH1,MH1l,O
deficiency,deficiency,O
predisposes,peerospidss,O
to,to,O
hematological,hematological,B
malignancy,malignancy,I
and,and,O
neurofibromatosis,neurofibromatosis,B
type,type,I
1,1,I
.,.,O
,,
Heterozygous,Heterozygous,O
germ,rgem,O
-,-,O
line,lnei,O
mutations,timautons,O
in,in,O
the,the,O
DNA,DNA,O
mismatch,mismatch,O
repair,aepirr,O
genes,genes,O
lead,lead,O
to,to,O
hereditary,hereditary,B
nonpolyposis,nonpolyposis,I
colorectal,colorectal,I
cancer,cancer,I
.,.,O
,,
The,The,O
disease,ssedaie,O
susceptibility,susceptibility,O
of,of,O
individuals,iadlvidunsi,O
who,who,O
constitutionally,linstotntoilaucy,O
lack,lack,O
both,both,O
wild,ilwd,O
-,-,O
type,type,O
alleles,leaells,O
is,is,O
unknown,unknown,O
.,.,O
,,
We,We,O
have,have,O
identified,tdeieifind,O
three,tehre,O
offspring,fposgrinf,O
in,in,O
a,a,O
hereditary,hereditary,B
nonpolyposis,nonpolyposis,I
colorectal,colorectal,I
cancer,cancer,I
family,iymfla,O
who,who,O
developed,edveoepld,O
hematological,hematological,B
malignancy,malignancy,I
at,at,O
a,a,O
very,very,O
early,early,O
age,age,O
",",",",O
and,and,O
at,at,O
least,aslet,O
two,two,O
of,of,O
them,them,O
displayed,eiyplsadd,O
signs,nisgs,O
of,of,O
neurofibromatosis,neurofibromatosis,B
type,type,I
1,1,I
(,(,O
NF1,NF1,B
),),O
.,.,O
,,
DNA,DNA,O
sequence,cequense,O
analysis,yialssna,O
and,and,O
allele,allele,O
-,-,O
specific,cpisfeic,O
amplification,amplification,O
in,in,O
two,two,O
siblings,isnlsbgi,O
revealed,revealed,O
a,a,O
homozygous,homozygous,O
MLH1,MLH1,O
mutation,mutation,O
(,(,O
C676T,C76t6,O
-,-,O
-,-,O
>,>,O
Arg226Stop,Aro2s6T2gp,O
),),O
.,.,O
,,
Thus,Thus,O
",",",",O
a,a,O
homozygous,homozygous,O
germ,germ,O
-,-,O
line,line,O
MLH1,MLH1,O
mutation,matution,O
and,and,O
consequent,cqeseounnt,O
mismatch,mismatch,O
repair,erpari,O
deficiency,defecciniy,O
results,results,O
in,in,O
a,a,O
mutator,mutator,O
phenotype,nhpoptyee,O
characterized,chaaritzrceed,O
by,by,O
leukemia,leukemia,B
and,and,O
/,/,O
or,or,O
lymphoma,lymphoma,B
associated,eastciaosd,O
with,with,O
neurofibromatosis,neurofibromatosis,B
type,type,I
1,1,I
.,.,O
.,.,O
,,
Missense,Ssmseein,O
mutations,nuoasitmt,O
in,in,O
the,the,O
most,most,O
ancient,ancient,O
residues,drsueies,O
of,of,O
the,the,O
PAX6,PAX6,O
paired,paired,O
domain,iomand,O
underlie,urilnede,O
a,a,O
spectrum,upecsmtr,O
of,of,O
human,human,O
congenital,congenital,B
eye,eye,I
malformations,malformations,I
.,.,O
,,
Mutations,Iusattonm,O
of,of,O
the,the,O
human,human,O
PAX6,PAX6,O
gene,gene,O
underlie,deunlrie,O
aniridia,aniridia,B
(,(,O
congenital,congenital,B
absence,absence,I
of,of,I
the,the,I
iris,iris,I
),),O
",",",",O
a,a,O
rare,rare,O
dominant,odminant,O
malformation,malformation,B
of,of,I
the,the,I
eye,eye,I
.,.,O
,,
The,The,O
spectrum,epcstmur,O
of,of,O
PAX6,PAX6,O
mutations,umitatons,O
in,in,O
aniridia,aniridia,B
patients,patients,O
is,is,O
highly,ihlhgy,O
biased,bsiaed,O
",",",",O
with,with,O
92,92,O
%,%,O
of,of,O
all,all,O
reported,reported,O
mutations,mutations,O
leading,legdina,O
to,to,O
premature,premature,O
truncation,truncation,O
of,of,O
the,the,O
protein,protein,O
(,(,O
nonsense,enoesnsn,O
",",",",O
splicing,nslipicg,O
",",",",O
insertions,insertions,O
and,and,O
deletions,eelotidns,O
),),O
and,and,O
just,just,O
2,2,O
%,%,O
leading,leading,O
to,to,O
substitution,substitution,O
of,of,O
one,one,O
amino,amino,O
acid,acid,O
by,by,O
another,aoetnhr,O
(,(,O
missense,missense,O
),),O
.,.,O
,,
The,The,O
extraordinary,extraordinary,O
conservation,caiesrnotvon,O
of,of,O
the,the,O
PAX6,PAX6,O
protein,protein,O
at,at,O
the,the,O
amino,nmaio,O
acid,acid,O
level,level,O
amongst,ogsnmat,O
vertebrates,reeaebtvtrs,O
predicts,predicts,O
that,that,O
pathological,taploilghcao,O
missense,missense,O
mutations,mutations,O
should,should,O
in,in,O
fact,fact,O
be,be,O
common,comonm,O
even,even,O
though,gtouhh,O
they,they,O
are,are,O
hardly,hadlry,O
ever,erev,O
seen,seen,O
in,in,O
aniridia,aniridia,B
patients,tepitnas,O
.,.,O
,,
This,This,O
indicates,indicates,O
that,that,O
there,there,O
is,is,O
a,a,O
heavy,yaevh,O
ascertainment,ascertainment,O
bias,bias,O
in,in,O
the,the,O
selection,teceloisn,O
of,of,O
patients,ptaeitns,O
for,for,O
PAX6,PAX6,O
mutation,muonitta,O
analysis,analysis,O
and,and,O
that,that,O
the,the,O
missing,imissng,O
PAX6,6Apx,O
missense,missense,O
mutations,mutations,O
frequently,frequently,O
may,may,O
underlie,udlernie,O
phenotypes,ptenhoypes,O
distinct,dicitnst,O
from,from,O
textbook,textbook,O
aniridia,aniridia,B
.,.,O
,,
Here,Here,O
we,we,O
present,present,O
four,ufor,O
novel,novel,O
PAX6,6XAp,O
missense,missense,O
mutations,mutations,O
",",",",O
two,two,O
in,in,O
association,assotioniac,O
with,with,O
atypical,apytical,O
phenotypes,phenytesop,O
ectopia,ectopia,B
pupillae,pupillae,I
(,(,O
displaced,displaced,B
pupils,pupils,I
),),O
and,and,O
congenital,congenital,B
nystagmus,nystagmus,I
(,(,O
searching,searching,B
gaze,gaze,I
),),O
",",",",O
and,and,O
two,two,O
in,in,O
association,ansiaocitos,O
with,with,O
more,more,O
recognizable,legoznacibre,O
aniridia,aniridia,B
phenotypes,phenotypes,O
.,.,O
,,
Strikingly,Stgiiknrly,O
",",",",O
all,all,O
four,four,O
mutations,mutations,O
are,are,O
located,located,O
within,within,O
the,the,O
PAX6,AXP6,O
paired,paired,O
domain,dmiaon,O
and,and,O
affect,affect,O
amino,iamno,O
acids,acids,O
which,which,O
are,are,O
highly,highly,O
conserved,conserved,O
in,in,O
all,all,O
known,known,O
paired,paiedr,O
domain,domain,O
proteins,rpiseont,O
.,.,O
,,
Our,Our,O
results,results,O
support,pposurt,O
the,the,O
hypothesis,hypothesis,O
that,that,O
the,the,O
under,under,O
-,-,O
representation,representation,O
of,of,O
missense,issmsnee,O
mutations,mtuaniots,O
is,is,O
caused,caused,O
by,by,O
ascertainment,ascertainment,O
bias,abis,O
and,and,O
suggest,esgsugt,O
that,that,O
a,a,O
substantial,aunstasbitl,O
burden,erudbn,O
of,of,O
PAX6,PAX6,B
-,-,I
related,related,I
disease,disease,I
remains,aenirms,O
to,to,O
be,be,O
uncovered,uncovered,O
.,.,O
.,.,O
,,
The,The,O
chromosomal,rocmmhsooal,O
order,rdoer,O
of,of,O
genes,gnees,O
controlling,controlling,O
the,the,O
major,major,O
histocompatibility,histocompatibility,O
complex,xolcmep,O
",",",",O
properdin,properdin,O
factor,fortac,O
B,B,O
",",",",O
and,and,O
deficiency,deficiency,B
of,of,I
the,the,I
second,second,I
component,component,I
of,of,I
complement,complement,I
.,.,O
,,
The,The,O
relationship,relationship,O
of,of,O
the,the,O
genes,geens,O
coding,coding,O
for,for,O
HLA,HLA,O
to,to,O
those,those,O
coding,iodncg,O
for,for,O
properdin,properdin,O
Factor,Focrat,O
B,B,O
allotypes,yoltlapes,O
and,and,O
for,for,O
deficiency,deficiency,B
of,of,I
the,the,I
second,second,I
component,component,I
of,of,I
complement,complement,I
(,(,O
C2,C2,O
),),O
was,was,O
studied,stddiue,O
in,in,O
families,afmlieis,O
of,of,O
patients,nttaepis,O
with,with,O
connective,connective,O
tissue,situse,O
disorders,desordirs,O
.,.,O
,,
Patients,Tnaietps,O
were,were,O
selected,seteclde,O
because,because,O
they,they,O
were,were,O
heterozygous,heterozygous,O
or,or,O
homozygous,homuzogyos,O
for,for,O
C2,C2,B
deficiency,deficiency,I
.,.,O
,,
12,12,O
families,iaielmfs,O
with,with,O
15,15,O
matings,msintga,O
informative,vnfraiotmie,O
for,for,O
C2,C2,B
deficiency,deficiency,I
were,were,O
found,found,O
.,.,O
,,
Of,Of,O
57,57,O
informative,iermfaotivn,O
meioses,eemoiss,O
",",",",O
two,two,O
crossovers,erossscvro,O
were,were,O
noted,etond,O
between,between,O
the,the,O
C2,C2,B
deficiency,deficiency,I
gene,eneg,O
and,and,O
the,the,O
HLA,HLA,O
-,-,O
B,B,O
gene,nege,O
",",",",O
with,with,O
a,a,O
recombinant,rintmbonace,O
fraction,fraction,O
of,of,O
0,0,O
.,.,O
,,
035,035,O
.,.,O
,,
A,A,O
lod,lod,O
score,eocrs,O
of,of,O
13,13,O
was,was,O
calculated,acdcueatll,O
for,for,O
linkage,knliage,O
between,between,O
C2,C2,B
deficiency,deficiency,I
and,and,O
HLA,HLA,O
-,-,O
B,B,O
at,at,O
a,a,O
maximum,mixamum,O
likelihood,likolohdei,O
value,vuale,O
of,of,O
the,the,O
recombinant,iatomcrnenb,O
fraction,arfcitno,O
of,of,O
0,0,O
.,.,O
,,
04,04,O
.,.,O
,,
18,18,O
families,saeimilf,O
with,with,O
21,21,O
informative,informative,O
matings,gitamns,O
for,for,O
both,both,O
properdin,propendir,O
Factor,Afcotr,O
B,B,O
allotype,aoytllpe,O
and,and,O
HLA,HLA,O
-,-,O
B,B,O
were,were,O
found,onufd,O
.,.,O
,,
Of,Of,O
72,72,O
informative,imforntiaev,O
meioses,mesoies,O
",",",",O
three,ehert,O
recombinants,recombinants,O
were,were,O
found,fnoud,O
",",",",O
giving,giving,O
a,a,O
recombinant,erncmbinaot,O
fraction,fraction,O
of,of,O
0,0,O
.,.,O
,,
042,042,O
.,.,O
,,
A,A,O
lod,lod,O
score,seocr,O
of,of,O
16,16,O
between,between,O
HLA,HLA,O
-,-,O
B,B,O
and,and,O
Factor,Tacofr,O
B,B,O
allotypes,plletyaos,O
was,was,O
calculated,caeullatcd,O
at,at,O
a,a,O
maximum,xammuim,O
likelihood,lokelihiod,O
value,levua,O
of,of,O
the,the,O
recombinant,bcemoirnant,O
fraction,fraction,O
of,of,O
0,0,O
.,.,O
,,
04,04,O
.,.,O
,,
A,A,O
crossover,rrcssevoo,O
was,was,O
shown,shown,O
to,to,O
have,have,O
occurred,ocrruecd,O
between,between,O
genes,egens,O
for,for,O
Factor,Coftar,O
B,B,O
and,and,O
HLA,HLA,O
-,-,O
D,D,O
",",",",O
in,in,O
which,which,O
HLA,HLA,O
-,-,O
D,D,O
segregared,sgergaered,O
with,with,O
HLA,HLA,O
-,-,O
A,A,O
and,and,O
B,B,O
.,.,O
,,
These,Ethse,O
studies,studies,O
suggest,suggest,O
that,that,O
the,the,O
genes,genes,O
for,for,O
Factor,Factor,O
B,B,O
and,and,O
C2,C2,B
deficiency,deficiency,I
are,are,O
located,aceltod,O
outside,outside,O
those,those,O
for,for,O
HLA,HLA,O
",",",",O
that,that,O
the,the,O
order,deorr,O
of,of,O
genese,genese,O
is,is,O
HLA,HLA,O
-,-,O
A,A,O
",",",",O
-,-,O
B,B,O
",",",",O
-,-,O
D,D,O
",",",",O
Factor,Factor,O
B,B,O
allotype,allotype,O
",",",",O
C2,C2,B
deficiency,deficiency,I
",",",",O
that,that,O
the,the,O
genes,genes,O
coding,igdcno,O
for,for,O
C2,C2,B
deficiency,deficiency,I
and,and,O
Factor,Factor,O
B,B,O
allotypes,allotypes,O
are,are,O
approximately,apoixprmately,O
3,3,O
-,-,O
-,-,O
5,5,O
centimorgans,centimorgans,O
from,from,O
the,the,O
HLA,HLA,O
-,-,O
A,A,O
and,and,O
HLA,HLA,O
-,-,O
B,B,O
loci,cloi,O
",",",",O
and,and,O
that,that,O
the,the,O
apparent,ptaarenp,O
lack,lack,O
of,of,O
recombinants,sorembcnanti,O
between,between,O
the,the,O
Factor,Factor,O
B,B,O
gene,gene,O
and,and,O
C2,C2,B
deficiency,deficiency,I
gene,eegn,O
suggests,suggests,O
that,that,O
these,these,O
two,two,O
genes,genes,O
lie,lie,O
in,in,O
close,close,O
proximity,proximity,O
to,to,O
one,one,O
another,another,O
.,.,O
,,
Distribution,Ibisrtdution,O
of,of,O
emerin,meeirn,O
and,and,O
lamins,lanism,O
in,in,O
the,the,O
heart,ahert,O
and,and,O
implications,implications,O
for,for,O
Emery,Emery,B
-,-,I
Dreifuss,Dreifuss,I
muscular,muscular,I
dystrophy,dystrophy,I
.,.,O
,,
Emerin,Emerin,O
is,is,O
a,a,O
nuclear,aculner,O
membrane,mebmnrae,O
protein,rpeiotn,O
which,which,O
is,is,O
missing,missing,O
or,or,O
defective,devetcfie,O
in,in,O
Emery,Emery,B
-,-,I
Dreifuss,Dreifuss,I
muscular,muscular,I
dystrophy,dystrophy,I
(,(,O
EDMD,EDMD,B
),),O
.,.,O
,,
It,It,O
is,is,O
one,one,O
member,member,O
of,of,O
a,a,O
family,limafy,O
of,of,O
lamina,limana,O
-,-,O
associated,associated,O
proteins,pontesri,O
which,which,O
includes,ilunceds,O
LAP1,LAP1,O
",",",",O
LAP2,A2Pl,O
and,and,O
lamin,lmian,O
B,B,O
receptor,receptor,O
(,(,O
LBR,LBR,O
),),O
.,.,O
,,
A,A,O
panel,panel,O
of,of,O
16,16,O
monoclonal,monoclonal,O
antibodies,antibodies,O
(,(,O
mAbs,mBsa,O
),),O
has,has,O
been,been,O
mapped,eamppd,O
to,to,O
six,six,O
specific,icepsifc,O
sites,sites,O
throughout,tugoorhhut,O
the,the,O
emerin,emerin,O
molecule,moleluce,O
using,unigs,O
phage,phage,O
-,-,O
displayed,displayed,O
peptide,ptpeedi,O
libraries,libraries,O
and,and,O
has,has,O
been,been,O
used,used,O
to,to,O
localize,cloailze,O
emerin,eemrni,O
in,in,O
human,human,O
and,and,O
rabbit,rabibt,O
heart,heart,O
.,.,O
,,
Several,Eevsrla,O
mAbs,mAbs,O
against,against,O
different,different,O
emerin,emerin,O
epitopes,epitopes,O
did,did,O
not,not,O
recognize,oecrgnize,O
intercalated,intercalated,O
discs,sdics,O
in,in,O
the,the,O
heart,haret,O
",",",",O
though,ghtuoh,O
they,they,O
recognized,reiegnzcod,O
cardiomyocyte,cardiomyocyte,O
nuclei,cunlie,O
strongly,strongly,O
",",",",O
both,both,O
at,at,O
the,the,O
rim,rim,O
and,and,O
in,in,O
intranuclear,intranuclear,O
spots,optss,O
or,or,O
channels,hlannces,O
.,.,O
,,
A,A,O
polyclonal,oolynapcll,O
rabbit,arbibt,O
antiserum,antiserum,O
against,against,O
emerin,emerin,O
did,did,O
recognize,recognize,O
both,both,O
nuclear,unlreac,O
membrane,bmemarne,O
and,and,O
intercalated,lcternedatai,O
discs,dssic,O
but,but,O
",",",",O
after,after,O
affinity,affinity,O
purification,purification,O
against,against,O
a,a,O
pure,preu,O
-,-,O
emerin,emerin,O
band,band,O
on,on,O
a,a,O
western,western,O
blot,tolb,O
",",",",O
it,it,O
stained,sdainet,O
only,only,O
the,the,O
nuclear,lneucar,O
membrane,membrane,O
.,.,O
,,
These,Sehte,O
results,results,O
would,wldou,O
not,not,O
be,be,O
expected,cepxeted,O
if,if,O
immunostaining,immunostaining,O
at,at,O
intercalated,antletaeicrd,O
discs,isdcs,O
were,were,O
due,due,O
to,to,O
a,a,O
product,product,O
of,of,O
the,the,O
emerin,emerin,O
gene,gene,O
and,and,O
",",",",O
therefore,torrefehe,O
",",",",O
cast,asct,O
some,some,O
doubt,doubt,O
upon,upon,O
the,the,O
hypothesis,hypothesis,O
that,that,O
cardiac,cardiac,B
defects,defects,I
in,in,O
EDMD,EDMD,B
are,are,O
caused,caused,O
by,by,O
absence,absence,O
of,of,O
emerin,emerin,O
from,from,O
intercalated,dntaaceliter,O
discs,cidss,O
.,.,O
,,
Although,Lathohug,O
emerin,emerin,O
was,was,O
abundant,abdnatnu,O
in,in,O
the,the,O
membranes,mmebranes,O
of,of,O
cardiomyocyte,cordaymioycte,O
nuclei,clnuei,O
",",",",O
it,it,O
was,was,O
absent,absent,O
from,from,O
many,many,O
non,non,O
-,-,O
myocyte,myocyte,O
cells,lecls,O
in,in,O
the,the,O
heart,eraht,O
.,.,O
,,
This,Stih,O
distribution,diotriiutbns,O
of,of,O
emerin,nmeire,O
was,was,O
similar,similar,O
to,to,O
that,that,O
of,of,O
lamin,aimln,O
A,A,O
",",",",O
a,a,O
candidate,acddintae,O
gene,gene,O
for,for,O
an,an,O
autosomal,uotasoaml,O
form,form,O
of,of,O
EDMD,EDMD,B
.,.,O
,,
In,In,O
contrast,contrast,O
",",",",O
lamin,amlin,O
B1,B1,O
was,was,O
absent,abetns,O
from,from,O
cardiomyocyte,iardcoocmyyte,O
nuclei,ncluei,O
",",",",O
showing,swohing,O
that,that,O
lamin,lamin,O
B1,B1,O
is,is,O
not,not,O
essential,essential,O
for,for,O
localization,tocllizoaian,O
of,of,O
emerin,nmerei,O
to,to,O
the,the,O
nuclear,nuclear,O
lamina,anmial,O
.,.,O
,,
Lamin,Mailn,O
B1,B1,O
is,is,O
also,also,O
almost,aslomt,O
completely,completely,O
absent,nbstae,O
from,from,O
skeletal,tkesleal,O
muscle,muscle,O
nuclei,nuclei,O
.,.,O
,,
In,In,O
EDMD,EDMD,B
",",",",O
the,the,O
additional,additional,O
absence,absence,O
of,of,O
lamin,liamn,O
B1,B1,O
from,from,O
heart,heart,O
and,and,O
skeletal,lseleatk,O
muscle,muscle,O
nuclei,nuelic,O
which,which,O
already,adrelay,O
lack,lack,O
emerin,ermein,O
may,may,O
offer,rfoef,O
an,an,O
alternative,nltaaevtire,O
explanation,expoalatinn,O
of,of,O
why,why,O
these,these,O
tissues,tissues,O
are,are,O
particularly,iurlpcrtaaly,O
affected,affected,O
.,.,O
.,.,O
,,
Genetic,Neictge,O
mapping,mapping,O
of,of,O
the,the,O
copper,copper,B
toxicosis,toxicosis,I
locus,ucols,O
in,in,O
Bedlington,Bedlington,O
terriers,terriers,O
to,to,O
dog,dog,O
chromosome,chomorsome,O
10,10,O
",",",",O
in,in,O
a,a,O
region,region,O
syntenic,syntenic,O
to,to,O
human,haumn,O
chromosome,crhomoosme,O
region,iogren,O
2p13,31p2,O
-,-,O
p16,p16,O
.,.,O
,,
Abnormal,Amonabrl,O
hepatic,hepatic,B
copper,copper,I
accumulation,accumulation,I
is,is,O
recognized,rceozeignd,O
as,as,O
an,an,O
inherited,inherited,B
disorder,disorder,I
in,in,O
man,man,O
",",",",O
mouse,musoe,O
",",",",O
rat,rat,O
and,and,O
dog,dog,O
.,.,O
,,
The,The,O
major,oamjr,O
cause,cuaes,O
of,of,O
hepatic,hepatic,B
copper,copper,I
accumulation,accumulation,I
in,in,O
man,man,O
is,is,O
a,a,O
dysfunctional,nysiuncdoftal,O
ATP7B,ATP7B,O
gene,gene,O
",",",",O
causing,nausicg,O
Wilson,Wilson,B
disease,disease,I
(,(,O
WD,WD,B
),),O
.,.,O
,,
Mutations,Mutations,O
in,in,O
the,the,O
ATP7B,Ap7tB,O
genes,eesgn,O
have,have,O
also,lsao,O
been,been,O
demonstrated,dtmrnatosede,O
in,in,O
mouse,mouse,O
and,and,O
rat,rat,O
.,.,O
,,
The,The,O
ATP7B,B7PtA,O
gene,gene,O
has,has,O
been,been,O
excluded,excluded,O
in,in,O
the,the,O
much,much,O
rarer,rarer,O
human,muahn,O
copper,copper,B
overload,overload,I
disease,edsiaes,O
non,non,B
-,-,I
Indian,Indian,I
childhood,childhood,I
cirrhosis,cirrhosis,I
",",",",O
indicating,indicating,O
genetic,engetic,O
heterogeneity,heterogeneity,O
.,.,O
,,
By,By,O
investigating,investigating,O
the,the,O
common,ommcon,O
autosomal,autosomal,O
recessive,recessive,O
copper,copper,B
toxicosis,toxicosis,I
(,(,O
CT,CT,B
),),O
in,in,O
Bedlington,Bedlington,O
terriers,eeirrtrs,O
",",",",O
we,we,O
have,have,O
identified,deeftiniid,O
a,a,O
new,new,O
locus,oclus,O
involved,odeilvvn,O
in,in,O
progressive,piosrsgvree,O
liver,liver,B
disease,disease,I
.,.,O
,,
We,We,O
examined,xaeimned,O
whether,whether,O
the,the,O
WD,WD,B
gene,gnee,O
ATP7B,ATP7B,O
was,was,O
also,also,O
causative,causative,O
for,for,O
CT,CT,B
by,by,O
investigating,tnvsegiitaing,O
the,the,O
chromosomal,hcmoroaolsm,O
co,co,O
-,-,O
localization,lacailootzin,O
of,of,O
ATP7B,TPA7B,O
and,and,O
C04107,C04107,O
",",",",O
using,iusng,O
fluorescence,fluorescence,O
in,in,O
situ,suit,O
hybridization,hybridization,O
(,(,O
FISH,FISH,O
),),O
.,.,O
,,
C04107,C04107,O
is,is,O
an,an,O
anonymous,anonymous,O
microsatellite,mirctlaetloise,O
marker,marker,O
closely,ylsoecl,O
linked,klnied,O
to,to,O
CT,CT,B
.,.,O
,,
However,However,O
",",",",O
BAC,BAC,O
clones,clones,O
containing,containing,O
ATP7B,7PTaB,O
and,and,O
C04107,C04107,O
mapped,mapped,O
to,to,O
the,the,O
canine,canine,O
chromosome,ochrmosome,O
regions,reniogs,O
CFA22q11,FAC12q21,O
and,and,O
CFA10q26,C6Aq0f21,O
",",",",O
respectively,respectively,O
",",",",O
demonstrating,demonstrating,O
that,that,O
WD,WD,B
cannot,caontn,O
be,be,O
homologous,goholomous,O
to,to,O
CT,CT,B
.,.,O
,,
The,The,O
copper,cprpeo,O
transport,transport,O
genes,eegns,O
CTR1,CTR1,O
and,and,O
CTR2,2RTc,O
were,were,O
also,also,O
excluded,edcluexd,O
as,as,O
candidate,candidate,O
genes,genes,O
for,for,O
CT,CT,B
since,cnise,O
they,they,O
both,both,O
mapped,mppdea,O
to,to,O
canine,iencna,O
chromosome,chromosome,O
region,region,O
CFA11q22,CFA11q22,O
.,.,O
,,
2,2,O
-,-,O
22,22,O
.,.,O
,,
5,5,O
.,.,O
,,
A,A,O
transcribed,tearrcdibns,O
sequence,sequence,O
identified,efentidiid,O
from,from,O
the,the,O
C04107,00c147,O
-,-,O
containing,containing,O
BAC,BAC,O
was,was,O
found,found,O
to,to,O
be,be,O
homologous,homologous,O
to,to,O
a,a,O
gene,gnee,O
expressed,erpsesxed,O
from,from,O
human,ahmun,O
chromosome,ohrcmoesmo,O
2p13,p231,O
-,-,O
p16,p16,O
",",",",O
a,a,O
region,region,O
devoid,dveiod,O
of,of,O
any,any,O
positional,positional,O
candidate,candidate,O
genes,neegs,O
.,.,O
,,
Molecular,Lrmeculoa,O
analysis,inslaays,O
of,of,O
the,the,O
APC,APC,B
gene,ngee,O
in,in,O
205,205,O
families,ilmifaes,O
:,:,O
extended,extended,O
genotype,genotype,O
-,-,O
phenotype,hoepptyne,O
correlations,correlations,O
in,in,O
FAP,FAP,B
and,and,O
evidence,dcivenee,O
for,for,O
the,the,O
role,role,O
of,of,O
APC,APC,B
amino,amino,O
acid,acid,O
changes,cghanes,O
in,in,O
colorectal,colorectal,B
cancer,cancer,I
predisposition,poeoiiidsstprn,O
.,.,O
,,
BACKGROUND,CABKDNOURG,O
/,/,O
AIMS,AIMS,O
The,The,O
development,doleevptenm,O
of,of,O
colorectal,colorectal,B
cancer,cancer,I
and,and,O
a,a,O
variable,variable,O
range,anrge,O
of,of,O
extracolonic,extracolonic,O
manifestations,maneoistatnifs,O
in,in,O
familial,familial,B
adenomatous,adenomatous,I
polyposis,polyposis,I
(,(,O
FAP,FAP,B
),),O
is,is,O
the,the,O
result,result,O
of,of,O
the,the,O
dominant,dominant,O
inheritance,innaritehce,O
of,of,O
adenomatous,adenomatous,B
polyposis,polyposis,I
coli,coli,I
(,(,O
APC,APC,B
),),O
gene,gene,O
mutations,tutamnois,O
.,.,O
,,
In,In,O
this,this,O
study,sudty,O
",",",",O
direct,direct,O
mutation,mutation,O
analysis,analysis,O
of,of,O
the,the,O
APC,APC,B
gene,gene,O
was,was,O
performed,performed,O
to,to,O
determine,determine,O
genotype,yenpegot,O
-,-,O
phenotype,phenotype,O
correlations,ctarileorons,O
for,for,O
nine,nnie,O
extracolonic,extrcclanoio,O
manifestations,aenisomtftians,O
and,and,O
to,to,O
investigate,investigate,O
the,the,O
incidence,incedcine,O
of,of,O
APC,APC,B
mutations,mottauins,O
in,in,O
non,non,O
-,-,O
FAP,FAP,O
colorectal,colorectal,B
cancer,cancer,I
.,.,O
,,
METHODS,MHOESDT,O
The,The,O
APC,APC,B
gene,enge,O
was,was,O
analysed,analysed,O
in,in,O
190,190,O
unrelated,reuntaled,O
FAP,FAP,B
and,and,O
15,15,O
non,non,O
-,-,O
FAP,FAP,O
colorectal,colorectal,B
cancer,cancer,I
patients,patients,O
using,using,O
denaturing,denaturing,O
gradient,gnadeitr,O
gel,gel,O
electrophoresis,eleoirtphorcses,O
",",",",O
the,the,O
protein,oretpni,O
truncation,truncation,O
test,test,O
",",",",O
and,and,O
direct,idretc,O
sequencing,sequencing,O
.,.,O
,,
RESULTS,SREULTS,O
Chain,Chain,O
terminating,terminating,O
signals,nlssaig,O
were,were,O
only,only,O
identified,identified,O
in,in,O
patients,intptaes,O
belonging,bnloenigg,O
to,to,O
the,the,O
FAP,FAP,B
group,group,O
(,(,O
105,105,O
patients,natiepts,O
),),O
.,.,O
,,
Amino,Amino,O
acid,acid,O
changes,cganshe,O
were,were,O
identified,identified,O
in,in,O
four,rofu,O
patients,sanittep,O
",",",",O
three,heret,O
of,of,O
whom,whom,O
belonged,leboegdn,O
to,to,O
the,the,O
non,non,O
-,-,O
FAP,FAP,O
group,ogrup,O
of,of,O
colorectal,colorectal,B
cancer,cancer,I
patients,patients,O
.,.,O
,,
Genotype,Genotype,O
-,-,O
phenotype,phenotype,O
correlations,conreratoils,O
identified,idenitfied,O
significant,sigaificntn,O
differences,niffercdsee,O
in,in,O
the,the,O
nature,nature,O
of,of,O
certain,certain,O
extracolonic,extracolonic,O
manifestations,manifestations,O
in,in,O
FAP,FAP,B
patients,paitents,O
belonging,oilnbgeng,O
to,to,O
three,three,O
mutation,mutation,O
subgroups,subgroups,O
.,.,O
,,
CONCLUSIONS,NCNSCULIOOS,O
Extended,Edexnetd,O
genotype,genotype,O
-,-,O
phenotype,poynhetpe,O
correlations,correlations,O
made,made,O
in,in,O
this,this,O
study,dtsuy,O
may,may,O
have,have,O
the,the,O
potential,poleatitn,O
to,to,O
determine,determine,O
the,the,O
most,most,O
appropriate,appropriate,O
surveillance,inrvescalule,O
and,and,O
prophylactic,prophylactic,O
treatment,tretemtna,O
regimens,emgiresn,O
for,for,O
those,those,O
patients,ptiaents,O
with,with,O
mutations,mutations,O
associated,asaoiestcd,O
with,with,O
life,life,O
threatening,threatening,O
conditions,conditions,O
.,.,O
,,
This,This,O
study,study,O
also,olas,O
provided,provided,O
evidence,edevcnie,O
for,for,O
the,the,O
pathological,pathological,O
nature,nature,O
of,of,O
amino,amino,O
acid,dcai,O
changes,shaecng,O
in,in,O
APC,APC,O
associated,sasodcatei,O
with,with,O
both,both,O
FAP,FAP,B
and,and,O
non,non,O
-,-,O
FAP,FAP,O
colorectal,colorectal,B
cancer,cancer,I
patients,ipatents,O
.,.,O
.,.,O
,,
Inherited,Inherited,B
colorectal,colorectal,I
polyposis,polyposis,I
and,and,O
cancer,cancer,B
risk,irks,O
of,of,O
the,the,O
APC,APC,O
I1307K,I1k703,O
polymorphism,polimmyrhpso,O
.,.,O
,,
Germ,Germ,O
-,-,O
line,line,O
and,and,O
somatic,soatcim,O
truncating,truncating,O
mutations,umtnaiots,O
of,of,O
the,the,O
APC,APC,B
gene,gene,O
are,are,O
thought,ghohttu,O
to,to,O
initiate,initiate,O
colorectal,colorectal,B
tumor,tumor,I
formation,formation,O
in,in,O
familial,familial,B
adenomatous,adenomatous,I
polyposis,polyposis,I
syndrome,syndrome,I
and,and,O
sporadic,spodcrai,O
colorectal,colorectal,O
carcinogenesis,carcinogenesis,O
",",",",O
respectively,vespcetyerli,O
.,.,O
,,
Recently,Lecrtney,O
",",",",O
an,an,O
isoleucine,isoleucine,O
-,-,O
-,-,O
>,>,O
lysine,ynsile,O
polymorphism,polymorphism,O
at,at,O
codon,oocdn,O
1307,3701,O
(,(,O
I1307K,71i03K,O
),),O
of,of,O
the,the,O
APC,APC,B
gene,enge,O
has,has,O
been,been,O
identified,identified,O
in,in,O
6,6,O
%,%,O
-,-,O
7,7,O
%,%,O
of,of,O
the,the,O
Ashkenazi,Nshkeazai,O
Jewish,Jewish,O
population,population,O
.,.,O
,,
To,To,O
assess,assses,O
the,the,O
risk,irks,O
of,of,O
this,this,O
common,momcon,O
APC,APC,B
allelic,ealllic,O
variant,variant,O
in,in,O
colorectal,cellroctao,O
carcinogenesis,aercicognseisn,O
",",",",O
we,we,O
have,have,O
analyzed,analyzed,O
a,a,O
large,lrgae,O
cohort,cohort,O
of,of,O
unselected,unselected,O
Ashkenazi,Ashkenazi,O
Jewish,Jwesih,O
subjects,subjects,O
with,with,O
adenomatous,adenomatous,B
polyps,polyps,I
and,and,O
.,.,O
or,or,O
colorectal,colorectal,B
cancer,cancer,I
",",",",I
for,for,O
the,the,O
APC,APC,O
I1307K,I1307K,O
polymorphism,pooymiprlhsm,O
.,.,O
,,
The,The,O
APC,APC,O
I1307K,I7310K,O
allele,elella,O
was,was,O
identified,idtneified,O
in,in,O
48,48,O
(,(,O
10,10,O
.,.,O
1,1,O
%,%,O
),),O
of,of,O
476,476,O
patients,pteintas,O
.,.,O
,,
Compared,Coamrped,O
with,with,O
the,the,O
frequency,eneuqfrcy,O
in,in,O
two,two,O
separate,peeatars,O
population,population,O
control,rlnocto,O
groups,ogrups,O
",",",",O
the,the,O
APC,APC,O
I1307K,103i7K,O
allele,llaele,O
is,is,O
associated,associated,O
with,with,O
an,an,O
estimated,estimated,O
relative,relative,O
risk,risk,O
of,of,O
1,1,O
.,.,O
,,
5,5,O
-,-,O
1,1,O
.,.,O
,,
7,7,O
for,for,O
colorectal,colorectal,B
neoplasia,neoplasia,I
(,(,O
both,both,O
P,P,O
=,=,O
.,.,O
01,01,O
),),O
.,.,O
,,
Furthermore,Furthermore,O
",",",",O
compared,compared,O
with,with,O
noncarriers,nnracsrieor,O
",",",",O
APC,APC,O
I1307K,I7k013,O
carriers,irrraecs,O
had,had,O
increased,increased,O
numbers,eumrsbn,O
of,of,O
adenomas,adenomas,B
and,and,O
colorectal,colorectal,B
cancers,cancers,I
per,per,O
patient,intaept,O
(,(,O
P,P,O
=,=,O
.,.,O
03,03,O
),),O
",",",",O
as,as,O
well,elwl,O
as,as,O
a,a,O
younger,ynroueg,O
age,age,O
at,at,O
diagnosis,daisongis,O
.,.,O
,,
We,We,O
conclude,conclude,O
that,that,O
the,the,O
APC,APC,O
I1307K,I1307K,O
variant,variant,O
leads,aleds,O
to,to,O
increased,iecreasnd,O
adenoma,adenoma,B
formation,foioartmn,O
and,and,O
directly,cyredlti,O
contributes,cottnsrubei,O
to,to,O
3,3,O
%,%,O
-,-,O
4,4,O
%,%,O
of,of,O
all,all,O
Ashkenazi,Ashkenazi,O
Jewish,Weijsh,O
colorectal,colorectal,B
cancer,cancer,I
.,.,O
,,
The,The,O
estimated,estimated,O
relative,relative,O
risk,risk,O
for,for,O
carriers,carriers,O
may,may,O
justify,justify,O
specific,ipfeicsc,O
clinical,clciianl,O
screening,screening,O
for,for,O
the,the,O
360,360,O
",",",",O
000,000,O
Americans,Americans,O
expected,expected,O
to,to,O
harbor,hbraro,O
this,this,O
allele,allele,O
",",",",O
and,and,O
genetic,genetic,O
testing,nsetitg,O
in,in,O
the,the,O
setting,setting,O
of,of,O
long,nlog,O
-,-,O
term,rtem,O
-,-,O
outcome,cuootme,O
studies,dsitues,O
may,may,O
impact,cmtaip,O
significantly,siilficgantny,O
on,on,O
colorectal,colorectal,B
cancer,cancer,I
prevention,prevention,O
in,in,O
this,this,O
population,population,O
.,.,O
,,
Localization,Ztcaaillioon,O
of,of,O
human,human,O
BRCA1,ARC1b,O
and,and,O
its,its,O
loss,loss,O
in,in,O
high,high,O
-,-,O
grade,grdea,O
",",",",O
non,non,B
-,-,I
inherited,inherited,I
breast,breast,I
carcinomas,carcinomas,I
.,.,O
,,
Although,Although,O
the,the,O
link,link,O
between,between,O
the,the,O
BRCA1,BRCA1,O
tumour,tumour,B
-,-,O
suppressor,sppursseor,O
gene,gnee,O
and,and,O
hereditary,hereditary,B
breast,breast,I
and,and,I
ovarian,ovarian,I
cancer,cancer,I
is,is,O
established,eisasetbhld,O
",",",",O
the,the,O
role,eorl,O
",",",",O
if,if,O
any,any,O
",",",",O
of,of,O
BRCA1,A1CBr,O
in,in,O
non,non,B
-,-,I
familial,familial,I
cancers,cancers,I
is,is,O
unclear,urcnlae,O
.,.,O
,,
BRCA1,BRCA1,O
mutations,miattuons,O
are,are,O
rare,rare,O
in,in,O
sporadic,sporadic,B
cancers,cancers,I
",",",",O
but,but,O
loss,loss,O
of,of,O
BRCA1,ACRB1,O
resulting,retlusnig,O
from,from,O
reduced,dceuerd,O
expression,piexessron,O
or,or,O
incorrect,nccoriert,O
subcellular,subcellular,O
localization,localization,O
is,is,O
postulated,postulated,O
to,to,O
be,be,O
important,iapomtrnt,O
in,in,O
non,non,B
-,-,I
familial,familial,I
breast,breast,I
and,and,I
ovarian,ovarian,I
cancers,cancers,I
.,.,O
,,
Epigenetic,Eipeenitgc,O
loss,ossl,O
",",",",O
however,however,O
",",",",O
has,has,O
not,not,O
received,received,O
general,general,O
acceptance,acceptance,O
due,due,O
to,to,O
controversy,controversy,O
regarding,regarding,O
the,the,O
subcellular,subcellular,O
localization,colaiazitlno,O
of,of,O
BRCA1,BRCA1,O
proteins,proteins,O
",",",",O
reports,resortp,O
of,of,O
which,which,O
have,have,O
ranged,ragden,O
from,from,O
exclusively,yxcluseveli,O
nuclear,nuclear,O
",",",",O
to,to,O
conditionally,lnntidioyalco,O
nuclear,aecnulr,O
",",",",O
to,to,O
the,the,O
ER,ER,O
/,/,O
golgi,oilgg,O
",",",",O
to,to,O
cytoplasmic,cytoplasmic,O
invaginations,innaionatvigs,O
into,into,O
the,the,O
nucleus,nucleus,O
.,.,O
,,
In,In,O
an,an,O
attempt,tatmpet,O
to,to,O
resolve,rvoelse,O
this,this,O
issue,esius,O
",",",",O
we,we,O
have,have,O
comprehensively,comprehensively,O
characterized,characterized,O
19,19,O
anti,anti,O
-,-,O
BRCA1,1CRAb,O
antibodies,anibotdies,O
.,.,O
,,
These,These,O
reagents,naegerts,O
detect,eetcdt,O
a,a,O
220,220,O
-,-,O
kD,kD,O
protein,protein,O
localized,czlaliode,O
in,in,O
discrete,discrete,O
nuclear,nuclear,O
foci,foci,O
in,in,O
all,all,O
epithelial,eiithaplel,O
cell,cell,O
lines,lines,O
",",",",O
including,incindlgu,O
those,those,O
derived,rdeievd,O
from,from,O
breast,breast,B
malignancies,malignancies,I
.,.,O
,,
Immunohistochemical,Immunohistochemical,O
staining,staining,O
of,of,O
human,human,O
breast,breast,O
specimens,psecmneis,O
also,olas,O
revealed,revealed,O
BRCA1,CABR1,O
nuclear,nuclear,O
foci,ofic,O
in,in,O
benign,ienbng,O
breast,breast,O
",",",",O
invasive,invasive,B
lobular,lobular,I
cancers,cancers,I
and,and,O
low,low,B
-,-,I
grade,grade,I
ductal,ductal,I
carcinomas,carcinomas,I
.,.,O
,,
Conversely,Csneervoly,O
",",",",O
BRCA1,BRCA1,O
expression,oxsrepsien,O
was,was,O
reduced,ruedced,O
or,or,O
undetectable,undetectable,O
in,in,O
the,the,O
majority,mtiorajy,O
of,of,O
high,ghih,O
-,-,O
grade,grade,O
",",",",O
ductal,ductal,B
carcinomas,carcinomas,I
",",",",O
suggesting,sugestging,O
that,that,O
absence,abensec,O
of,of,O
BRCA1,CBRA1,O
may,may,O
contribute,bintrecuto,O
to,to,O
the,the,O
pathogenesis,pathogenesis,O
of,of,O
a,a,O
significant,significant,O
percentage,percentage,O
of,of,O
sporadic,sporadic,B
breast,breast,I
cancers,cancers,I
.,.,O
.,.,O
,,
